Suda granted African patent for Airmist anti-malarial spray

31 July 2015

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that it has been granted a patent in Africa for its novel ArTiMist™ anti-malarial spray. The patent was issued by the African Regional Intellectual Property Organization (ARIPO), which is an intergovernmental organisation for cooperation among African states in intellectual property matters. ARIPO comprises 19 member states, including the major countries in malaria-endemic Sub-Saharan Africa.
The patent covers the pharmaceutical composition of ArTiMist™, the route of delivery, the device and methods for the treatment of uncomplicated and complicated malaria. The patent number is AP/P/2013/006,997 and it expires in 2026.

ArTiMist™ was developed with a child in mind, particularly a child living in a challenging environment where healthcare facilities are far away and in many circumstances not fully equipped to treat paediatric malaria. The Phase III trial in severe paediatric malaria was successfully completed in Sub-Saharan countries. The results overwhelmingly demonstrate the superiority of ArtiMist™ to intravenous quinine. SUDA is currently in dialogue with the Medicines for Malaria Venture, the World Health Organisation and philanthropic groups regarding expanding the opportunity for ArTiMist™ to include its use as an early interventional treatment for malaria in the pre-referral setting.

Mr Stephen J Carter, CEO commented: “This new ArTiMist™ patent further strengthens our intellectual property in key malaria-endemic countries in Africa. The claims in this patent are extremely broad and, hence, ensure our proprietary ownership of artemether delivered in an oro-mucosal spray for the treatment of malaria. We are delighted to add this patent to our ArTiMist™ estate as we advance our discussions with the pharmaceutical industry and other major stakeholders in the field of malaria.”

To download the full announcement, please click on the button below. 

YPB strengthens position in Government document security

31st July 2015, ASX Announcement

Specialist security consulting business Intellectual Property Protection Co Ltd (IPP), a wholly owned subsidiary of anti-counterfeiting technology company YPB Group Limited (ASX:YPB) (“YPB, the Company”) , has signed a Memorandum of Cooperation (MOC) with Foilmakers Australia Pty Ltd (FMA) for the production, marketing and sales of three IPP products.

Under the new deal two of the three products, VariSec Foil and Mul-T-Gram (MTG), will be manufactured FMA with IPP responsible for the marketing and sales of the products. The third product, Bi-Component Security Thread, will also be marketed by IPP with manufacturing to be completed by fiber technologies.

This IPP technology has been adapted into more than 100 million e-Passports worldwide to date, generating approximately $2.5 million in revenue to date.

To read the full announcement, please click here

Folkestone Real Estate Outlook – July 2015 Paper and Presentations

Folkestone is pleased to provide a copy of its six monthly Real Estate Outlook white paper – “This Time It’s Different – Is It Really?” which summarises Folkestone’s outlook for the non-residential, residential and A-REIT sectors. Please click the link below to download a copy of the paper.

“This Time It’s Different – Is It Really?”

Folkestone has partnered with MacroPlan Dimasi for its July 2015 Investment Forum. Greg Paramor, Managing Director of Folkestone provided around the grounds update on the State of the Real Estate Markets in the Year Ahead, whilst Brian Haratsis, Executive Chairman of MacroPlan Dimasi provided a thought provoking presentation on the Big Picture Trends – Ageing and  Health, Technology and Globalisation that will impact the real estate markets over the next 10-20 years.

Please click the links below to download a copy of the presentations from Greg Paramor and Brian Haratsis.

Greg Paramor’s Presentation

Brian Haratsis’s Presentation

What do Lego and Leaf Resources have in common?

  • Both are committed to producing sustainable products from waste biomass

Well known companies like Lego and Coca-Cola are recognising the potential that biomass offers for the production of biobased chemicals and are working towards creating solutions to switch their products from oil derived chemicals.

Lego is working on building a better brick….
Review the report by ‘The Australian’ here>>

  • Leaf Resources announces research agreement with a major Agricultural group

Creating valuable bio-products from agricultural waste

Leaf Resources announced yesterday, that it has signed a research agreement with a major Agricultural group to create valuable bio-products from underutilized waste biomass
Read more>>

  • Leaf in the News

Negotiating the ‘chasm of death’
AusBiotech Feature -
Ag and food biotech in the spotlight

Leaf says fossil fuel era is ending
Business Environment Network

  • Queensland, investing in a renewable future

Could QLD be next to implement legislation to advance the biomanufacturing industry?
Read more>>

  • Proud to be a Top 5 Finalist in the Sofinnova Partners Renewable Chemistry Start-Up Award

Leaf Resources secured a top 5 finalist position for the Sofinnova Partners Renewable Chemistry Start-up Award and Chief Operating Officer, Alex Baker presented to a panel of judges in Montreal.

Alex Baker said “The Sofinnova award top 5 presentations were all of a high standard and the competition was close. While disappointed we did not win, we were very pleased to be a part of the award process and the opportunity to profile Leaf’s innovative technology at the BIO World Congress.”

Read the summary of the awards here
Sofinnova Partners
Bioplastics magazine
BIOtechNOW

Prescient Therapeutics June 2015 Appendix 4C

Melbourne, 30th July 2015, ASX Announcement

Prescient Therapeutics Limited (“Prescient or the Company”) provides a the following Appendix 4C in relation to the quarter ended 30 June 2015.

During the quarter, Prescient secured agreement from the United States Food and Drug Administration (FDA) to transfer sponsorship to Prescient of the Investigational New Drug (IND) – PTX-200, the company’s lead product.

Prescient also announced highly encouraging data from a pre-clinical trial of its novel compound PTX-100 in multiple myeloma at a prestigious U.S. oncology conference. Moffitt Cancer Care scientists examined the effect of Prescient’s small molecule compound PTX-100, a GGT-1 inhibitor that targets one of the RAS signaling pathways, in a mouse model highly relevant to multiple myeloma. They found the compound significantly decreased the percentage of multiple myeloma tumors within the bone and also offered a substantial improvement on mouse median several times.

During the quarter, Prescient appointed an internationally regarded pharmaceutical executive as Chief Medical Officer, Dr Terrance Chew, who will oversee clinical development and regulatory strategy for Prescient’s two novel oncology candidates now in mid-stage clinical trials at leading US cancer centres.

To read the full announcement, please click here.

Universal Biosensors Shareholders Communication July 2015

Thursday 30 July 2015

  • UBI earns 4th milestone payment under Siemens collaboration.  To access the link, please click here.
  • UBI 1HY 2015 Results Update.  To access the link, please click here.
  • Half Yearly Report and SEC Form 10Q for Q2 2015.  To access the link, please click here.
  • No drawdown of additional funds under Athyrium loan.  To access the link, please click here.
  • Half Year Financial Results Webcast.  To access the link, please click here.

Alternatively, all the releases are also available on our web page www.universalbiosensors.com.

Corous360 Launches PLAYe

Singapore, 28 July 2015

Game Changing Platform For Hobbies and Entertainment

 PLAYe – a 3-in- 1 online-mobile-offline (OMO) platform that redefines the Asian play experience through curated content, on-demand concierge and interactive experiential centres
 PLAYe to ride on booming US$43. 1 billion games and collectibles market in Asia-Pacific to target one million premium users and US$200 million sales by 2016
 PLAYe to be an integral part of Corous360’s e-commerce Vertical Domain Coud

Corous360 Pte. Ltd. (“Corous360”), a wholly-owned subsidiary of Catalist-listed firm, DeClout Limited (“DeClout”, and together with its subsidiaries, the “Group”), has today unveiled “PLAYe” – its new 3-in- 1 online- mobile-offline (OMO) platform that will transform the way games and collectibles will be marketed, distributed and consumed in Singapore and the region.

PLAYe is a single, intuitive platform combining the best ways for consumers to enjoy their games and hobbies — all in one place, 24/7!

Among its many key features, PLAYe serves as a digital personal assistant to the consumer showing the latest range of collectibles and gadgets and offering information on the newest games and products at the push of a button. PLAYe also allows the consumer to engage with fellow enthusiasts and experience that toy or game before purchasing.

PLAYe aims to combine one of the largest and most diverse collections of entertainment brands in Asia with specially curated content to engage fans across different platforms – on PC, tablet or mobile as well as physical games stores which will be transformed into experiential centres to satisfy the touch-and- feel demands of hard-core enthusiasts.

“We all love fun and entertainment and the new PLAYe platform puts an incredible experience at every fan’s fingertips,” said Mr Kelvin Tay, Corous360’s CEO.

“The many ways people like to enjoy their games or hobbies have come together in one mobile application (app) – a revolutionary and secure service that is real- time and accessible online, mobile and offline – in an exciting way for fans to connect with each other, enjoy curated content and to get that dream toy or game that they treasure without hassle or frustration.”

Aside from benefiting the consumers, PLAYe is also good news for game retailers as it offers a new business model for products to be created and distributed. Through an alliance with strategic retailers, traditional retail stores can sign on partnerships with Corous360 to expand their sales through PLAYe’s innovative platform.

To read the full announcement, please click here

Financial Statements And Related Announcement from iFast

29th July 2015, iFast Corporation

The initial public offering of shares and listing of iFAST Corporation Ltd. on the Main Board of the Singapore Exchange Securities Trading Limited was jointly sponsored by DBS Bank Ltd. and RHB Securities Singapore Pte. Ltd. (formerly known as DMG & Partners Securities Pte Ltd) as joint issue managers, bookrunners and underwriters (“Joint Issue Managers, Bookrunners and Underwriters”). The Joint Issue Managers, Bookrunners and Underwriters assume no responsibility for the contents of this announcement.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Leaf Resources enters research agreement to use agricultural waste for bio products

29th July 2015, ASX Announcement

A major agricultural group and Leaf Resources have signed a research agreement to create valuable bio-products from agricultural waste.

Many thousands of tonnes of agricultural waste from crops ends up as underutilised biomass in Australia. Should the research programme be successful, making use of this biomass will help generate addiontal revenue for farmers and processors and potenially boost regional employment through new industry development.

The research agreement funded by the other party contemplates testing the agricultural waste with Leaf’s GlycellTM process and if successful, aims at working towards a feasibility study for a commercial operation using the GlycellTM process in Australia. The identity of the other party has not been disclosed at this time sue to the confidential nature of the agreement.

Key to the programme’s success is Leaf Resource’s innovative GlycellTM process.

The unique, Australian-developed technology uses glycerol as a catalyst to make cellulosic sugars – the key component in bio-products – from biomass, such as agricultural waste. And it does so for a fraction of the cost of conventional technologies currently used as alternative to fossil fuel-based industry processes.

To read the full announcement, please click here.  

Charter Hall sells 684 La Trobe Street

28th July 2015, ASX Announcement

Charter Hall Group (ASX:CHC) (Charter Hall or the Group) today announced it has completed the sale of its interest of the development site at 685 La Trobe Street, Docklands, Melbourne for $ 31.5 million (with CHC realising $15.75 million for its 50% share).

The sale price represents a premium to the book value at 30 June 2015 and the proceeds will now be invested to generate operating earnings generated from Property Investments.

To read the full announcement, please click here

APN announces establishment of APN Steller Development Fund

28th July 2015, ASX Announcement

APN Property Development Group Limited (ASX:APD) and Steller Pty Ltd (Steller) today announced the establishment of the APN Steller Development Fund, which has been established to undertake six inner Melbourne medium density apartment developments on behalf of sophisticated investors.

To read the full announcement, please click here

Record Revenues for Big Un Ltd in June Quarter

28th July 2015, ASX Announcement

 Big Un Limited well funded and strategically positioned to accelerate growth 

Highlights 

  • Successful completion of $3 million capital raise, significantly oversubscribed with strong interest from existing and new investors.
  •  Revenues and sales pipeline continue solid growth – 8,000 merchants in the sales pipeline at the end of Q2 2015 (33% up on Q1 2015) with cash revenues for the quarter totaling $232,000 an increase of 164% on Q1 2015
  •  Strategic partnership agreement with CDM Direct Communication Services executed to provide Big Review TV with external sales and marketing capabilities for its rapidly expanding operations
  • Distribution channels expanded through partnership agreement with Site Tour, connecting clients with out-of-home advertisers and providing Big Review TV with third party advertising revenue opportunities
  • Operations expanded into the U.K., U.S., Hong Kong and Singapore
  • Big Un Limited  well funded and strategically positioned to accelerate growth and meet increased demand

To read the full story, please click here

Completion of Bankable Feasibility Study (BFS) by Altech Chemicals

24th July 2015, Altech Chemicals

Our Vision

To be a world leading producer of high purity alumina (HPA)

Sapphire Gemstone

  • Sapphire & Ruby – natural form of high purity alumina (HPA)
  • Formed by mother nature like diamonds
  • Colour from impurities
  • Extremely hard – no. 9 on Mohs scale
  • Third hardest mineral behind diamond
  • Scratch-resistant artificial sapphire glass made from HPA

What is HPA? 

  • Purified alumina (Al2O3)
  • Greater than 99.99% (4N) purity
  • Maximum allowable impurities of 100ppm
  • Smelter Grade Alumina (SGA) ~ 99.5% (5,000 ppm impurities mainly sodium)
  • Bayer Process uses sodium hydroxide (NaOH)
  • Sodium impurity is problem for electronics industry

SGA – Smelter Grade Alumina

To read the full presentation, please click here

Investor Relations July Update from Martin Jetpack

July 2015, ASX Announcement

Marketing Update 

A month has passed since the Paris Airshow and progress continues to be made. At the show we flew the public and potential customers in the simulator with over 500 sorties flown. The Jetpack certainly attracted attention and we featured in the Show press. We had a number of very useful meetings and we are now following up on those.

Our announcements of the Alliancing Agreements between MACL and M2K in India and Martin sro in the Czech Republic were a major step forward in our marketing strategy. Since the show our VP Sales & Marketing has been working with our Czech partners on the marketing model we will test. We will also display the Static at the Czech Airshow at Hradec Kralove on 5th and 6th September and have the simulator available for key potential customer meetings that we already have in place.

We have also been in discussion with Beijing Flyingman and AVIC over the next steps and our focus is setting up the marketing section of our KuangChi Martin Jetpack Joint Venture to allow that business environment to take the lead in moving to supply contacts from the interests we have in China.

We have also announced that following further discussions we have progressed from a Letter of Intent with Avwatch to a Memorandum of Understanding to negotiate delivery of 3 manned and unmanned Jetpack, simulator and support. Subject to successful negotiation these Jetpacks will be used for demonstration as part of the Avwatch capability. Avwatch provides services to a number of Government Agencies and Departments that are within the First Responder community.

 To read the full announcement, please click here

Angeion Acquisitions Announced

We are excited to report the following acquisitions have been made:

  • Angeion Group has acquired an existing Australian Financial Services License (AFSL) for its Investment Services business, TurnKi Portfolio Services;
  • Angeion Group have secured an option agreement to purchase a Mortgage Originator business with over $100M in loans; and
  • Angeion Group have commenced negotiations on a $700M Mortgage Manager business

DON’T FORGET the pre listing price is at a significant discount of up to 20% based on the listing value. Please note this offer is on a first come first served basis.

Applications close Friday 24th of July at 5pm Sydney time. Don’t delay, INVEST TODAY!

Mason Stevens Adds the Folkestone to Managed Account Service

23rd July 2015, Folkestone

Mason Stevens today announced the launch of a new managed account – the Folkestone Maxim A-REIT Securities Portfolio (the Portfolio), which is managed by Folkestone Maxim Asset Management Limited, on its Managed Account service.

Investors will benefit from Folkestone Maxim’s high conviction approach to investing delivered through a transparent, separately managed account structure. The Portfolio adopts a standalone strategy available only in an SMA format, rather than replicating an existing managed fund.

Folkestone Maxim utilises a disciplined investment process combining in-depth fundamental research with disciplined portfolio construction and risk controls to add consistent value over time. The basic premise of Folkestone Maxim’s investment philosophy is that there is a close relationship between the real estate market cycle and the economic cycle.

Managing Director of Mason Stevens Adviser Services, Thomas Bignill, said “Mason Stevens is committed to providing our clients with access to leading investment solutions and best of breed investment managers.” “The depth of experience across Folkestone’s real estate funds platform is remarkable. We’re excited to be able to add the Portfolio to the Mason Stevens Managed Account service,” said Mr Bignill.

To download the full document, please click on the link below. 

What’s driving the real growth of the AREIT sector?

July 2015, APN Property Group

A spotlight on the outlook for earnings growth and asset pricing

As we continue to move down the long, slow path of “lower for longer”, (ie. low inflation, low growth and low rates for longer) optimum asset allocation remains the burning question for many investors. In this article we study a fundamental question that is central to the asset allocation debate – growth. The defensive nature of commercial property underpinned by a stable growth profile is an attractive combination. This article puts the spotlight on the facts as they relate to the outlook for AREIT distribution growth, the likely performance of the underlying assets and conclude with a reminder about the fundamental features of property.

To download the full document, please click the link below. 

Real Estate Agents Who Love Conveyancers

14th May 2015, Legal Practice Intelligence

Conveyance Genius is a new software app used by conveyancers to keep clients and other parties up to date during a conveyancing matter.

Included in the video below is an important reminder about why a conveyancer will be loved by real estate agents simply by keeping them in the loop. That love has to turn into more referrals.

The pricing for the app will be released soon. Legal Practice Intelligence understands that the price is likely to be under $10 per conveyance.

 To read the full article, please click here

Booktrack Pulls In Another $5 Million To Put Audio To E-Books

22nd July 2015, By Christine Magee, TechCrunch

Booktrack, a startup out of New Zealand that creates soundtracks to accompany e-books, has raised another $5 million in funding to make sure that reading is no longer a quiet activity.

Led by COENT Venture Partners and Sparkbox Ventures, the Series B round bringsBooktrack’s funding total to $10 million. Previous investors include Peter Thiel’s Valar Ventures and filmmaker Peter Jackson’s Park Road Post Productions.

Booktrack launched its first two tracks on the app store four years ago, and today the company offers a library of 15,000 titles to its 2.5 million users.

Each booktrack — think movie soundtrack for your book — consists of music, ambient audio and sound effects that automatically sync with your reading pace as you tap through the pages of an e-book.

Book publishers can either create their own soundtracks, or pay Booktrack around $1,000 per novel to create the track for them. According to founder Paul Cameron, around 50 publishing companies including Harper Collins and Random House are using the platform to generate a new revenue stream from both old and new titles.

To read the full article, please click here

Solid Business Effects a 40% Increase in Activity for Investors Central

Finance One experienced record growth in June, after the introduction of a new product Economy Motors, covering motor vehicle lending from $2500 to $8000.

Approved loans were boosted by 40%, smashing industry lending trends nationwide.

Our continued strong performance in an increasingly competitive lending market speaks volumes about the value we offer every day Australians.

As a result of this formidable growth, we are seeking to expand our Investor group. If you are considering increasing your investment or introducing new investors, now is the perfect time.

We will present our Annual Report and Prospectus 2015 on the following dates:

Townsville: 17th September at Jupiters

Brisbane: 18th September at Victoria Park

Sydney: 24th September at Hilton

Melbourne: 25th September at Quay West

Please contact Lynn to add to the invitation list, being aware that seating is limited.

Invitations will be sent in August.

Thank you for your valued ongoing business and we look forward to seeing you soon.

Contacts: jamie@investorscentral.net.au or lynn.moodie@investorscentral.net.au

Initiation of coverage by Edison Investment Research

20th July 2015, ASX Announcement

Anti-counterfeiting technology company YPB Group Limited (ASX:YPB) advises of the initiation of coverage by Edison Investement Research. The report is available on the investor page of the YPB website at http://www.ypbsystems.com/investor/ under the heading YPBJuly 2015 Company Analysis.

To read the full document, please click here

Martin Aircraft Signs MoU with US-based AvWatch

20th July 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft) (ASX:MJP) is pleased to announce that it has signed a Memorandum of Understanding (MoU) with US-based AvWatch,Inc. (AvWatch) to demonstrate airborne technology capabilities for the U.S. Department of Homeland Security, United States Department of Defense, and other U.S. federal, state, and local agencies.

The MoU marks a significant step forward  for Martin Aircraft in the all-important North American market, as it moves towards commercialisation of the Jetpack.

The signing of the MoU builds on the strategic relationship developed with AvWatch during the previous 12 months under an existing Letter of Intent between the parties. The MoU involves the parties working towards negotiating the future delivery of a Martin Aircraft package with an initial tranche of 3 manned Jetpacks, 3 unmanned Jetpacks and a simulator. It wwill also include initial training services and aftrersales support.

To read the full document, please click here

Castle Point Quarterly Investment Commentary – July 2015

The investment team spend a lot of their time thinking about individual stocks, markets and all sorts of other related (or often unrelated) topics. These get filtered through the quarter with the (hopefully) more interesting ones making it into our quarterly commentaries. These can be found below – we hope you find them interesting reading.

July 2015:

  • Sometimes, the higher the better
  • Is the future electric?
  • A question from one of our investors
  • Solving Japan’s financial problems
  • New Zealand’s QE problem
  • Our two drachmas on Grexit

This quarter we kick off with a look at high multiple stocks, followed by a look at how electricity may play an even more important role in the future. We then answer a highly relevant investor question, talk some more on how Japan could solve its debt issue and finish with a couple of short articles on New Zealand and Greece.

To read the full document, please click here

1Above Investor Update July 2015

1Above is pleased to report its launch in USA and Canada is progressing better than expectation.  1Above’s initial retail launch partner, OTG, has agreed to accelerate the roll out across four new key airports based on the metrics being achieved.

In addition to Newark, Minneapolis and Toronto airports, 1Above will be launching in La Guardia, JFK, Washington DC and Philadelphia airports; commencing from later this month and three months ahead of the initial agreed plan with OTG.

Of the $4m being sought, 1Above has raised $3m.  Oversubscriptions may be accepted at the discretion of the board of directors.

Qotient Investor Update July 2015

Qotient is a cloud based sales acceleration platform which is accessible from any device, anywhere and anytime. In June, there were a number of exciting developments for Qotient, including:

  • Partnership announced with an Indonesian based telco that is entering the New Zealand market.
  • Engagement drawing to a close with a large global pharmaceutical company
  • Positive feedback from existing tech sector clients in NZ, reporting a 400% increase in proposals delivered into the market for their managed services offering.

Qotient is raising $1.25 million to fund additional product development, increase sales and marketing and prepare for a US market entry, with $450,000 already committed.

To download the full document, please click on the link below. 

Opal Biosciences Ltd CEO Interview

With the rise in antibiotic resistance, new effective treatments have the potential to be life-saving.Opal Biosciences Limited (“Opal”) is an innovative player in infectious disease treatment. Opal is an Australian biotechnology company committed to tackling a serious global health threat. Our technologies target human infection: a high growth, commercially attractive market segment.

The unmet need for new anti-infectives is due to increasing resistance to existing antibiotics, more widespread and common difficult-to-treat infections, and the paucity of upcoming new treatments. This need has spurred the EU and US to introduce significant financial incentives to encourage development of new anti-infectives.

Our commercial objective is to outlicence or sell our products to a larger pharmaceutical company for final clinical trials and marketing (or beforehand). The growth in number and value of acquisitions of anti-infective technologies internationally is driven by larger companies being drawn back to the anti-infectives market segment by its growing attractiveness, and the need to buy innovation with their own R&D pipelines dry. The most recent was the acquisition of Cubist Inc by Merck & Co in November 2014 in a deal reported as $US8.4bn.

Please listen to Opal Biosciences’ Managing Director, Julie Phillips below. 

Opal’s technology presented at the Australian Society for Microbiology Annual Meeting

Melbourne, 16th July 2015

Australian infectious disease therapy and vaccine development company BioDiem Ltd and its subsidiary company Opal Biosciences, is pleased to announce a presentation on Opal’s technology at the annual Australian Society for Microbiology conference in Canberra on the 13th July.

Doctor of Philosophy (PhD) student Mr Michael Radzieta presented the poster “Investigating the Mechanism of Action of the Novel Antimicrobial BDM-I” for which he won a best poster prize. Mr Radzieta, under the supervision of A/Professor Slade Jensen, has been investigating the mechanism of action of BDM-I against priority disease causing “superbugs” Vancomycin- resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA).

This exciting work is continuing at the Ingham Institute for Applied Medical Research and University of Western Sydney.

To download the full document, please click below.

Proposed Acquisition Of 30.0% Interests Of vCargo Cloud

July 10th 2015

1. INTRODUCTION

The board of directors (the “Directors” or the “Board”) of DeClout Limited (the “Company”, and together with its subsidiaries, the “Group”) wishes to announce that the Company had on 10 July 2015 entered into a sale and purchase agreement (the “Agreement”) with its wholly-owned subsidiary, Corous360 Pte Ltd (“C360”) and the shareholders of vCargo Cloud Pte. Ltd. (the “Target”), pursuant to which C360 will acquire 999,900 ordinary shares in the capital of the Target (the “Sales Shares”), representing 30.0% of the issued and paid-up share capital of the Target from the existing shareholders of the Target (the “Vendors”) (the “Proposed Acquisition”) on the terms and subject to the conditions of the Agreement.

2. INFORMATION ON THE TARGET

The Target was incorporated in Singapore on 20 February 2013. As at the date of this announcement, the Target has an issued and paid-up share capital of S$3,333,000 comprising 3,333,000 ordinary shares. The Target is primarily engaged in the business of providing e-trade services and cargo cloud solutions which enable a myriad of stakeholders in the trade, logistics and supply chain industry (such as shippers, freight forwarders and consignees) to converge and leverage on a unified and secured platform.

Based on the unaudited management accounts of the Target for the financial year ended 31 December 2014 (“FY2014”), the net tangible liabilities value was approximately S$403,000 and the net loss after tax was approximately S$1,106,000. In addition, based on the unaudited management accounts of the Target for the period from 1 January 2015 to 31 May 2015, the net profit before tax of the Target was approximately S$42,000. No
independent valuation was conducted on the Target.

To read the full story, please click here

Issuance Of New Shares Pursuant To The DeClout Performance Share Plan

July 10th 2015

The board of directors (the “Board”) of DeClout Limited (the “Company”) wishes to announce that, on 10 July 2015, the Company has allotted and issued an aggregate of 300,000 new ordinary shares in the capital of the Company (the “New Shares”), to an employee of the Company pursuant to the vesting of the share awards granted under the DeClout Performance Share Plan.

The New Shares rank pari passu in all respects with the existing shares of the Company. The New Shares are expected to be listed and quoted on Catalist on or around 14 July 2015, and trading of the New Shares is expected to commence with effect from 9.00 a.m. on the same date.

Following the allotment and issuance of the New Shares, the total number of issued and paid-up share capital of the Company has increased from 455,100,030 to 455,400,030 ordinary shares.

To read the full document, please click here

Leaf Resources in top 5 for global renewable chemistry award

15th July 2015, ASX Announcement

Pioneering Australian company, Leaf Resources, was selected from an international field of 38 companies to be one of the five finalists for the Sofinnova Chemistry Start-up Award.

The award is being held in conjunction with BIO World Congress on Industrial Biotechnology in Montreal, Columbia from 19-22 July 2015.

Leaf Resources has developed a unique new process that promises to revolutionise bio manufacturing on a global scale, and nudge fossil fuel-based chemicals and plastics out of the market.

Leaf Resources’ Glycell process uses glycerol as the main reagent in their process to make cellulosic sugars – the key component in bio-chemicals and bio-plastics – from biomass such as waste from agriculture. And it does so for a fraction of the cost of technologies currently used as alternatives to fossil fuel-based industry processes.

To read the full announcement, please click here.  

Update on Track Holdings acquisition by Crowd Mobile

15th July 2015, ASX Announcement 

  •  Negotiations continuing for additional debt and mezzanine funding options
  • Financial Due diligence now complete
  • European m-Payment  expansion now complete
  • Record Message Volume of over 700k in June 2015

Crowd Mobile Limited (ASX : CM8) is pleased to provide an update regarding its proposed acquisition of Netherlands-based Track Holdings BV (Track Concepts).

As part of the initial round of funding for the acquisition of Track Concepts, Crowd Mobile has received an indicative term sheet for US$10 million (AU$13 million)  of debt funding. Negotiations are continuing with a number of traditional debt and mezzanine funding providers in Europe, Asia and Australia, and the Company remains on track to complete the acquisition in August 2015.

Commenting on the funding, Chief Executive Officer Domenic Carosa, said: “We remain confident in our ability to close out additional funding negotiations that will ensure the successful completion of the Track Concepts acquisition.”

Deloitte Netherlands has now completed its financial due diligence  report on Track Concepts for the Company, with no significant matters of concern having been identified, and Crowd Mobile’s legal counsel is working on the preparation of the Share  Purchase Agreement.

To read the full document, please click here

NewActon East Property valuation increase

15 July 2015

The NewActon East property (“the Property”) has increased in value by $2.15 million to $47.25 million, since Placer Property acquired it less than a year ago.

Mr. Mario Papaleo, Joint Managing Director of Placer Property, the Responsible Entity of the NewActon East Property Fund (“the Fund”), said: “We are very satisfied with the performance of the Fund. The first year’s income return of 7.75% is forecast to increase to 8.60% in FY2016. The increase in the Property value reflects the solid underlying performance of the Property and Placer’s ability to drive net income growth.”

The valuation of the Property was completed by Knight Frank, Australia. Following the completion of the valuation, the Net Tangible Asset Backing of the Fund increases by 9.2% from 87 cents to 95 cents per unit . The Fund’s gearing reduces from 49.3% to 46.0%.

Mr. Shane Dudley, Head of Distribution, said: “Since the Fund was launched late last year, there have been many positive developments:

• the property is 100% leased;
• interest rate hedges have been put in place to September 2019; and
• the forecast distribution rate has increased by 11% to 8.60% for FY2016.

“The property valuation increase is another positive outcome for investors who are able to buy into an iconic and award winning building and precinct.”

To read the full document, please click here

Opal Biosciences takes on the superbugs

July 13th 2015, By Sarah-Jane Tasker, The Australian

Antibiotic-resistant superbugs are becoming one of the biggest health issues of the 21st century, and Opal Biosciences, a small Australian biotech company, believes it has a drug that can tackle the rapidly worsening problem.

The US is interested in the company’s drug, BDM-I, with the US army keen on using it as a potential counter to biological warfare and the National Institute of Health researching the drug.

Associate Professor Slade Jensen, of the Ingham Institute and the University of Western Sydney, who is studying BDM-I to determine how it works, said bugs were becoming more resistant to the antibiotics available. He said that was combined with the fact that over the past decade big pharmaceutical companies stopped investing in antibiotic discovery because it was no longer profitable.

“We need new drugs now more than ever because some bacteria are becoming pan-­resistant,” Professor Jensen said.

The World Health Organisation’s 2014 report on global surveillance of antimicrobial resistance revealed that antibiotic resistance was no longer a prediction, but was happening now. The report found that without urgent, co-ordinated action, the world was heading towards a post-antibiotic era, in which common infections and minor injuries, which had been treatable for decades, could once again kill.

Opal Biosciences hopes to raise $3.5 million to develop its drug, which has demonstrated activity against a wide range of human disease-causing germs and has the potential to combat dangerous superbugs.

To read the full story, please click here.

Capital Match have S$125,000 committed within 18 hours

Within 18 hours already S$125,000 was committed… hurry up to participate in the listing with 2.2% monthly interest

On the listing we have introduced 18 hours ago S$125,000 out of a total of S$200,000 was already committed. The company harvests, manufactures and sells bird’s nest as well as other traditional Chinese medicine. Hurry up to participate in the listing!

Best wishes,
Pawel Kuznicki

Director | Capital Match

capital-match.com

iFast Propose Subscription Of 694,400 New Ordinary Shares

July 14th 2015, iFast Corporation 

The initial public offering of shares and listing of iFAST Corporation Ltd. on the Main Board of the Singapore Exchange Securities Trading Limited was jointly sponsored by DBS Bank Ltd. and RHB Securities Singapore Pte. Ltd. (formerly known as DMG & Partners Securities Pte Ltd) as joint issue managers, bookrunners and underwriters (“Joint Issue Managers, Bookrunners and Underwriters”). The Joint Issue Managers, Bookrunners and Underwriters assume no “responsibility for the contents of this announcement.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

YPB commences supply to Chinese table salt packaging industry

14th July 2015, ASX Announcement

Highlights:

  • YPB supplying invisible tracer and scanners for the protection of up to one billion salt packages for China National Salt Industry Corporation (CNSIC)
  • A$325,000 per annum potential revenue
  • Approximately 126 million labels already completed

Anti-counterfeiting technology company  YPB Group Limited (ASX:YPB) (“YPB, the Company”) has commenced supply of its tracer technology to China’s largest salt label printing company with an initial focus on provincial table salt manufacturers.

Under the supply contarct with the label printing Company on behalf of China National Salt Industry Corporation (CNSIC) one billion labels will be printed with YPB’s anti-counterfeiting technology per annum. To date YPB has already has already completed 126 million labels.

YPB estimates potential revenue from the contract to be A$325,000 per annum and it expects to reach this in CY2016. In addition, the Company expects this supply contract will run for three (3) years.

To read the full announcement, please click here

DeClout Investor update July 2015

10th July 2015, DeClout 

ABOUT DECLOUT 

Led by a dynamic team of IT veterans, DeClout aims to be the leader in next generation technology driven services, delivering innovative and cost-effective solutions that will make us the partner of choice for leading companies. Listed on the Catalist Board of the SGX-ST in 2012, the Group operates two core business segments – IT Infrastructure Services and Vertical Domain Clouds (VDCs) – out of Singapore, Malaysia, Indonesia, Thailand, Myanmar, Cambodia, the Philippines, US, UK and the PRC. The IT Infrastructure Services segment comprises businesses in data centre hardware and maintenance, cloud computing and systems integration, and telco and network solutions. Our VDC segment draws on the expertise and synergies from our IT Infrastructure Services to capitalise on exciting opportunities, starting with the online games and e-commerce industries.

The following announcements have been uploaded into DeClout website:

 

New listing of S$200,000 at 2.2% p.m. for Capital Match

We have just introduced a new 12-month listing of S$200,000 with 2.2% monthly interest. The company harvests, manufactures and sells bird’s nest as well as other traditional Chinese medicine. The company has 2014 revenues of S$3m. Log in to find out more…

In addition, we are proud to inform you that Capital Match will be surpassing the S$1 million mark with this new loan and will also be bringing on the first “return” borrower soon.

Best wishes,

Pawel Kuznicki
Director | Capital Match

Asian tech start-ups form plan for Australian invasion

July 14th 2015, By Matthew Smith, AFR 

The favourable treatment enjoyed by start-ups in Singapore and Malaysia will play into the hands of Australian investors as a wave of south-east Asian technology companies are understood to be lining up to hit the Australian Securities Exchange.

Up to a dozen Asian tech companies are preparing to make their ASX debut, with about six likely to reach initial public offering stage before Christmas, according to sources working on the possible listings.

The soon-to-be ASX debutants may be small, both in terms of market capitalisation and revenue, but they have high expectations for growth based on the emerging technology habits of the region’s 630 million population.

Spanning e-commerce, entertainment, fintech and software, these Asian start-ups – all of which have developed within tax-free and government co-funded environments – continue to eye the ASX and Australian investors ahead of their own country’s boards.

“The ASX is now looked upon as the listed VC [venture capital] market for south-east Asia,” said Kin-Wai Lau, chief executive of Fatfish Internet Group, the ASX-listed technology company with duel head offices in Malaysia and Melbourne.

Fatfish partners with both the Malaysian and Singapore governments to co-fund start-ups. Singapore, through its Media Development Authority, invests up to $S1.5 for every $S1 that Fatfish invests in an early-stage company.

To read the full article on AFR, please click here.

mm2 Asia CEO Interview

Headquartered in Singapore, mm2 Asia is a producer of movies and TV/online content. As a producer, mm2 Asia provides services that cover the entire filmmaking process including securing financing, producing and distributing as well as securing advertising and sponsorship.

In addition to Singapore, mm2 Asia also has a presence in Malaysia, Hong Kong, Taiwan and the PRC through its group of companies and/or strategic working partnerships. mm2 Asia has co-produced and/or distributed in excess of 20 movies across Asia since 2008 including co-producing well-known films such as the ‘Ah Boys to Men’ series; and distributing titles such as Malaysia’s ‘The Journey’ and Taiwan’s ‘Café.Waiting.Love’.

Please listen to Mr Melvin Ang, CEO of mm2 Asia below. 

Universal Biosensors Annual General Meeting Presentation

ASX Announcement, 9th July 2015

Key Highlights: last 12 months

Acceleration in revenues from blood glucose monitoring 

  • Quarterly Services Fees up to $2.9m in Q1 FY’15 (up 142% on pcp)

First strip manufacturing revenues from blood coagulation monitoring

  • CE Mark and launch of Siemens Xprecia StrideTM Coagulation Analyzer
  • Xprecia StrideTM wins international Red Dot Design Award and Australian Design Award
  • Cumulative revenues from PT-INR strip manufacturing of $288K (to 31st March 2015)

Continued leveraged investment in new product development 

  • Around 70% of R&D investment (last 12 months) funded by partners and R&D Tax Rebates,
  •  Progressing the expansion of our product portfolio;
    - UBI-owned PT-INR test for decentralised and home use
    - Further POC coagulation tests for Siemens
    - Demonstration  of immunoassay platform capability

Revenue growth driving improved financial performance 

  • Two product revenue streams now in play
  • Increasing contribution from Product & Services
  • Cash breakeven in sight

To read the full presentation, please click here.

BioDiem and Griffith University secure grant to continue world class research

10th July 2015

Griffith University’s Institute for Glycomics in collaboration with BioDiem have been awarded a prestigious Australian Research Council Linkage grant of $241,564, to investigate the role of the Biodiem’s (BDM-I) technology in fighting infections.

The project’s researchers Prof Yaoqi Zhou, Dr Joe Tiralongo and Dr Yuedong Yang aim to uncover the molecular targets of BDM-I, a novel antimicrobial candidate owned by BioDiem.

BioDiem Chief Executive Officer Julie Phillips said the exploration of BDM-I’s mechanism of action in certain infections would assist in development of BDM-I products and add to its commercial attractiveness.

“The grant is a tremendous endorsement of the BDM-I technology and a wonderful opportunity to work with Griffith University, one of Australia’s leading research universities,” she said.

Institute for Glycomics Director Professor Mark von Itzstein said the grant enhanced the Institutes focus and commitment to ground breaking research.

“It also reflects the translational focus of our Institute and demonstrates our capacity to engage with industry partners such as BioDiem Ltd,” he said.

This particular project, titled ‘Novel antimicrobial target discovery by an integrated approach’, plans to show the first computational method to integrate target and ligand similarity for proteome-scale target and off-target discovery, which will advance the global fight against drug-resistant microorganisms.

Prof Yaoqi Zhou, lead investigator on the grant, said he was delighted with the award and is confident that he and his collaborators will significantly advance the understanding of how BDM-I targets microbial infections.

The BDM-I anti-infective technology is being developed, through BioDiem’s subsidiary, Opal Biosciences, to develop products targeting serious human infections.

To download the full document, please click below. 

Aussie Startup Troozi Aims Cupid’s Arrow at Choosy Singles in India’s Growing Online Dating Market

Thursday 9 July 2015, By Denham Sadler, Startup Smart

Two former RSVP.com.au executives have teamed up to create a new online dating venture tailored specifically to the booming Indian market.

Australian-based startup Troozi was developed by Lija Wilson and Nikhil Jain, who met in 2005 while working for Fairfax on RSVP.com.au, Australia’s biggest dating website. Wilson says the pair gained an appreciation for online dating during that time, and wanted to explore the enormous opportunities on offer in India.

“We both have a passion for startups and digital growth businesses, and we couldn’t shake our passion for the online dating space,” Wilson says. “India is currently one of the most exciting startup markets in the world.”

Troozi is primarily an online dating site, with an app and a mobile version. The pair, along with fellow co-founder and investment advisor John Wilson, funded the initial development of the product and technology themselves.

They then launched a proof-of-concept phase and quickly hit 100,000 members. Wilson says they’ve so far targeted marketing to just Mumbai and Delhi, but about 28% of users have been gained organically through word-of-mouth.

A small seed round of funding was completed in order to validate the proof-of-concept in marketing. Wilson says they were able to prove their assumptions, and that they could grow the user base rapidly.

“We got where we needed to in a much shorter space of time than we thought,” she says.

Troozi opened for Series A funding in May, with the intent of using the funds to ramp up marketing and user acquisition. Wilson says so fair they’ve raised about 40% of their target for the round.

“We’ve road-showed in Australia and Singapore, and did a trip to India to meet with potential backers,” she says.

“We have a lot of open conversations at the moment.”

To read the full story, please click here

UBI Receives Cash Payment of $8.2M Under the R&D Tax Incentive

ASX Announcement, 9th July 2015

Universal Biosensors, Inc. (ASX:UBI) today announced it has received $8.2M in cash under the research and development tax incentive relating to the Company’s FY14 research and development expenses.

The research and development tax incentive is one of the key elements of the Australian Government’s support for Australia’s innovation system. It was developed to assist businesses to recover some of the costs of undertaking research and development. The research and development tax incentive provides a tax offset to eligible companies that engage in research and development activities.

To read the full announcement, please click here

Sterling First Limited Launches the Sterling Income Trust

Sterling First has rebadged and expanded its Rental Management Investment Trust and relaunched it as the Sterling Income Trust (“SIT”).

The original Rental Management Investment Trust was established in 2012, and has consistently paid quarterly distributions equating to 9.25% pa. These distributions are now 100% tax deferred. The expansion of the trust has allowed Sterling First to incorporate a number of income focused investment unit classes, which will assist Sterling First in funding the construction of houses for the Sterling Seniors Property Trust.

The Sterling Income Trust has four investment classes of units:

a. Income Units – these are the former ordinary units of the Rental Management Investment Trust. All rights associated with the units and the distributions remain the same, with the trust distribution historically being 9.25% pa* and 100% tax deferred.

b. First Mortgage Units – as the name suggests a mortgage backed investment. All funds raised will be loaned on a first mortgage basis to assist in the construction of houses for the Sterling Seniors Property Trust. Funds are loaned on a maximum 65% LVR and the units have a target distribution rate of 12% pa*.

c. Development Units – These are like the First Mortgage Units, but are second mortgage secured. All funds raised will be loaned on a second mortgage basis to assist in the construction of houses for the Sterling Seniors Property Trust. Funds are loaned on a maximum 85% LVR and the units have a target distribution rate of 20% pa*.

d. Blended Units – these units have a spread investment, covering 25% in each of the above units, plus 25% in shares in the holding company Sterling First Limited. The target distribution yield is 10.3% pa* plus any dividends paid by Sterling First Limited.

Distributions are made by the SIT on a quarterly basis.

The minimum investment term in each class of unit is 12 months, after which unit holders can apply for redemption at anytime, with redemptions being paid quarterly.

Please find attached a copy of the Sterling Income Trust summary for your consideration.

The Product Disclosure Statement is available upon request.

* Disclaimer: Investors should note that any reference to past performance is not a reliable guide to future performance. Any reference to target distribution rates are based on the interest rates payable under loan agreements for loans to be advanced by the Sterling Income Trust (“SIT”), the estimated operating costs of the SIT and its investments and the historical performance of the underlying investments. This material has been prepared by Sterling Corporate Services Pty Ltd (ACN 158 361 507) (“SCS”). SCS is appointed as Investment Manager of the Sterling Income Trust (ARSN 158 828 105) by the Responsible Entity, Theta Asset Management Limited (ACN 071 807 684, AFSL No 230920) (“Theta”). SCS is appropriately authorised to perform this function as a Corporate Authorised Representative (Number 444776) of Theta. This material relates to the Sterling Income Trust Product Disclosure Statement dated 18th May 2015 (“PDS”), under which the offer of Units is made.
The information in this update is general information only. It is not financial product advice and has been prepared without taking into account your investment objectives, financial circumstances or particular needs. To make an investment in the SIT, prospective investors should read the PDS in full, seek appropriate independent professional financial advice on any legal, stamp duty, taxation or accounting implications, and how these will apply to you personally and then complete the application form attached to the current PDS.

To download the SIT Fund Flyer, please click on the link below. 

Altech Commences Permitting for Meckering

ASX Announcement, 7th July 2015

 Highlights:

  • Altech has commenced permitting its proposed kaolin mining operation and beneficiation plant at Mecking, Western Australia:
    -Project  application accepted by Department of Environment Regulation (DER)
    -DER confirms the next and final stage permitting prior to construction is Works Appeal
  • Department of Mines and Petroleum (DMP) approval also underway:
    -Mining lease application submitted
    -A Mining proposal and a mine closure plan are well advanced
  • Overall, permitting for both mining and beneficiation is relatively straightforward

Altech Chemical Limited (ASX: ATC) is pleased  to announce that it has submitted a project application with the Western Australia Department of Environment Regulation (DER) as part of the permitting requirements for its proposed aluminous clay (kaolin) mine and associated beneficiation plant, at Meckering, Western Australia (the Project).

The DER has confirmed acceptance of Altech’s project application and confirmed that the next and final permitting requirement for the Meckering beneficiation plant as a Works Approval application, which will also be assessed by the DER. Once the Works Approval is granted, construction of the beneficiation plant can commence. Also, under DER regulations, based on the beneficiation plants processing rate of less than 50,000 tonnes per annum (tpa), the plant may only require registration post construction rather than an application for an Operating License.

To read the full announcement, please click here

Booodl CEO Interview

Booodl is an app that simplifies local shopping by; making it simple to list products you want to buy, locating local stores through geo-notification push reminders and location-based search, instant messaging with stores, and in-app purchasing.  It creates value for retailers by increasing foot traffic to stores, providing a new way to communicate with customers, increasing sales and giving insight into consumer behaviour.

Booodl plans to be the ubiquitous global app for locating local stores that stock products people want, instant messaging with retail stores about products and purchase from them in-app.  If it achieves this ambitious goal it will become an integral part of the retail ecosystem and have significant value.

Please listen to Mr George Freney, the CEO of Booodl below.

Universal Biosensors (ASX:UBI) CEO Interview

Universal Biosensors (ASX:UBI) is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use.

UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood.

The first product developed by UBI with LifeScan (a Johnson & Johnson company) is a blood glucose measurement device and is on the market and generating revenues for UBI. The second product developed by UBI in collaboration with Siemens Healthcare has also been launched.

The global point-of-care diagnostics market is estimated to be worth nearly US$17 billion a year and growing.

Please listen to Mr Paul Wright, the CEO of Universal Biosensors.

Financial Statements And Related Announcement From iFast

July 7th 2015

The Board of Directors of iFAST Corporation Ltd. ( the Company ) wishes to inform that the Company will release its unaudited financial results for the second quarter ended 30 June 2015 before market trading hours on 29 July 2015.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Proposed Subscription Of 694,400 New Ordinary Shares In The Capital Of iFast Corporation

6th July 2015

The initial public offering of shares and listing of iFAST Corporation Ltd. on the Main Board of the Singapore Exchange Securities Trading Limited was jointly sponsored by DBS Bank Ltd. and RHB Securities Singapore Pte. Ltd. (formerly known as DMG & Partners Securities Pte Ltd) as joint issue managers, bookrunners and underwriters (“Joint Issue Managers, Bookrunners and Underwriters”). The Joint Issue Managers, Bookrunners and Underwriters assume no “responsibility for the contents of this announcement.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Footfalls & Heartbeats Raises New Capital From Existing Investors

-New external capital raising launched with 2/3 of target already committed by eager investors-

Smart textile business Footfalls & Heartbeats has launched a new round of external capital raising, after securing 2/3 of its $1 million initial target capital from existing investors.

Footfalls & Heartbeats Managing Director, Dr Roland Toder, says securing 2/3 of the initial NZD$1m target from existing investors is a clear validation that Footfalls’ initial investors remain confident in the direction of the business and are eager to see – and fund – more growth:

“To have over two thirds of our initial $1m target already secured from our existing seed investors puts Footfalls in a strong position to go out and seek new investors in this external raise. Our internal raise took place over just one month, and our investors were keen to put additional capital into the business because the results speak for themselves. We can accept up to $2 million of new investment in total through over-subscriptions so there is plenty of opportunity for new investors to participate.”

Footfalls & Heartbeats’ directors, including the Managing Director, are also investing in the business in the current capital raising round 2.

Toder says; “After securing our first global licensing agreement earlier this year, we are now in negotiations about numerous additional licensing deals, and we are also building our internal leadership team. All of these activities and tangible results send very favourable messages to the investor market.

“With two thirds of our initial target committed, we are now looking to engage with new investors, many of whom will be interested in having a stake in a business that is leading the way in the rapidly growing smart textile industry. The industry is worth over $1b globally, and Footfalls is a powerful platform that provides the underpinning technology for many applications of smart fabrics. “From wearable technology, to medical uses, to high performance sportswear and even public transport, there are many diverse applications of Footfalls & Heartbeats’ IP and technology, so we are excited about the next phase of growth for this world-leading company.”

With three new letters of intent signed in recent weeks from global operators, building on the exclusive licensing agreement Footfalls signed with medical compression company Medi earlier in the year, Footfalls & Heartbeats will use the new capital to propel its growth and expansion into new licensing markets and applications.

www.footfallsandheartbeats.com

Atlantic Navigation Holdings Ltd (SGX:5UL) CEO Interview

Atlantic Navigation Holdings (Singapore) Limited (“Atlantic”) is an investment holding company with a vertically integrated offering of marine logistics services as well as ship repair and maintenance services. It owns, operates, and charters its fleet of 16 offshore support vessels, comprising of a variety of AHT, AHTS, jack-up accommodation barges, barges, tugs vessels and supply vessels, to leading offshore oil and gas companies primarily in the Middle East, India and Africa. It also manages the sourcing and cross-chartering of third party vessels to match customers’ requirements where necessary. Additionally, the Group provides ship repair, fabrication, maintenance, and other services at its workshop facility in Sharjah, UAE. The Group was established in the UAE in 1997, and is listed on the SGX Catalist upon the completion of a reverse acquisition on 30 July 2012.

Over the years, Atlantic has established strong and stable relationships with various leading oil companies, contractors, survey companies, ship owners, ship yards and charterers in the region. The Group support and provide services to national oil and gas companies, oil majors and other clients in the offshore oil and gas sectors. Its majot clients include Abu Dhabi Marine operating Company (ADMA-OPCO)), Saudi Aramco, Qatar Gas, Qatar Petroleum, Bunduq Oil Company, Zakum Development Company (ZADCO), Hyundai Heavy Industries (hhi), Hyundai Design Engineering and Construction (HDEC), J Ray Mcdermott M.E Inc. amongst others.

 Please listen to Atlantic Navingtion Holding’s CEO, Mr Bill Wong. 

FY15 Earning Outlook- Solid Performance Delivered

ASX Announcement, 7th July 2015

  • Full year revenue expected to be in excess of $28m
  • Normalised EBITDA expected to be around $4.0m
  • Performance B Share conversion expected to be 13,333,336 ordinary shares

Bulletproof is pleased to announce that it expects its Full Year FY15 revenue to be in excess of $28m, with normalised EBITDA of around $4.0m.

Bulletproof’s CEO, Anthony Woodward, said “While we have not yet undertaken the formal audit for the Company for the financial year, we are pleased to have closed the year with record revenues, and have a reasonably clear line of sight to the full year EBITDA result. The Company has delivered an excellent performance for the full financial year, and we are looking forward to carrying this momentum into FY16″.

The company has now fully integrated the Pantha Corp business, which was acquired in December 2014. As a result of the acquisition, Bulletproof extended its specialist Professional Services offerings alongside Managed Services. The company continues to see widespread demand from customers for assistance with developing, executing and delivering on their cloud strategy – to transform their business.

To read the full document, please click here

AsiaPhos to acquire China resource group for $36.8m

Singapore July 6th, By Ann Williams, Straits Times

Catalist-listed mineral resource group AsiaPhos announced on Monday that it will acquire the entire issued and paid-up capital of LY Resources (LYR Group) for $36.8 million from Mr Luo Yong, who owns half of the equity interest in Mianzhu Dashan Mining Co Ltd (Dashan), the group’s cooperation partner in China.

AsiaPhos said the acquisition will allow it to acquire the economic benefits of an existing cooperation arrangement presently accruing to its partner Dashan.

It will also facilitate the ownership of a 55 per cent equity interest in Deyang Fengtai Mining Co Ltd, a company incorporated in China, which holds the FengTai licence – an exploration licence for barite rocks in an area situated in the vicinity of the group’s existing mines in China’s Sichuan province.

AsiaPhos CEO Dr Ong Hian Eng said the LYR acquisition will improve the group’s operating cash flows as Dashan’s share of profits from the cooperation arrangement which are recognised as AsiaPhos’ production costs need not be payable to Dashan after the completion of the transaction.

To read the full story, please click here

YPB hits milestone with A$275k invoice to China customer

ASX Announcement, 6th July 2015 
  • First material invoice issued to Shensaier for YPB’s invisible tracer products & T2 scanners
  • Ongoing orders expected from Shensaier imminently under exclusive five-year contract
  • Invoices delivered to additional clients pre 30 June

Anti-counterfeiting technology company YPB Group Limited (ASX:YPB) has delivered its first material invoice to Shenzhen Shensaier Limited (Shensaier) one of it’s recently signed high volume China contracts, for the provision of YPB’s invisible tracer products and T2 scanners.

Now issued, the invoice for approx. A$275,000 is expected to be the catalyst for recurring orders under the contract signed with YPB on 12 January 2015 for its unique anti-counterfeit products. The contract, which runs for an exclusive five year period, is worth a potential US$12.2 million (76 million RMB, AU$16 million) based on projected revenues over this period.

Shensaier is one of China’s largest suppliers of high quality UV printing ink and paints to the liquor and tobacco industries. It will include YPB’s tracer in inks used on tobacco and liquor packaging for major Chinese brands.

“The commercial relationship between YPB and Shensaier is off to an excellent start as evidenced by this significant invoice,” said YPB Group CEO John Houston.

“We expect this to be an important milestone in the journey to supply our tracers and scanners to Shensaier on a consistent basis and realise the revenue potential as a result.”

The invoice also marks a vital step in the ramp up period required before annualised volumes projected by Shensaier are reached. This is expected to culminate in annual revenues of more than US$4.58 million (AU$6 million) for YPB.

The Company expects it’s high volume tracer contracts to continue to ramp-up over coming quarters and deliver significant ongoing revenues over the course of the 4 and 5 year terms.

Prior to 30 June 2015 YPB also issued additional invoices relating to other parts of the business. The company expects to provide the market with an update regarding revenue and financial performance for Q2 in the coming weeks.

YPB CEO, John Houston said:

“June has been the strongest revenue month in YPB’s short listed history and represents a defining moment for the Company plus provides validation of our business model. Having now successfully secured our first acquisitions, bedded down our two high volume scanner-tracer contracts and relaunched the brand reporter business, the foundations have been laid for the Company to generate significant ongoing revenues and deliver shareholder value.”

To read the full document, please click here

MyWave earns $50m valuation as it looks to ride PDA boom

July 3rd 2015, By Cris Keall, NBR

“Personal assistants are the next hot thing. The world’s moving from going online and typing in search to having an intelligent digital assistant who brings things to you based on what your preferences are and your needs.”

So says MyWave founder, chief executive and 51% shareholder Gerlandine McBride, whose company has created a personal digital assistant called Frank.

Frank has competition, from Apple’s Siri to Microsoft’s Cortana to other startups like IPSoft (with Amelia) and XAI (with an assistant who can appear on your smart device as either Amy or Andrew).

Even Google is getting in on the act with Google Now, an assistant that will anticipate your needs and serve up information unrequested (Google still dominates web searches but the company is mindful consumers are spending more and more time in apps and on their phones).

Ms McBride settled in Queenstown after a high-flying career that saw her land top roles with SAP and Dell in the US.

When NBR checked in this time last year, Ms McBride has secured $2.5 million funding and the assistant known as Frank was still in the works.

Now, companies are piloting Frank with customers across Australasia. The chief executive won’t name them but she says they include major retailer, a bank,  a tourism operator and a car company.

Shortly after talking to NBR, she headed to New York where she is currently closing a series B funding round that values MyWave at $US35 million ($50 million).

Ms McBride says her company has $300 million of work in its pipeline.

The three-year startup has had money coming in the door since its first year. “We went from nothing to hundreds of thousands; we’re now in millions; and we’re rapidly moving into tens of millions,” she says.

The company is losing money but could move into the black if it took its foot off the expansion pedal, she says.

To read the full article, please click here.

APN Property Group Ltd (ASX:APD) CEO Interview

APN Property Group Limited (APN) is a specialist real estate investment manager that actively manages real estate funds on behalf of institutional and retail investors.

Established in 1996, APN is listed on the ASX (ASX code: APD) and manages $2.1 billion (as at 31 December 2014) of real estate and real estate securities in 12 funds.

Focused exclusively on real estate funds management and with a core philosophy of “property for income”, we seek to establish and actively manage a suite of real estate funds to provide annuity style income and wealth creation opportunities for retail and institutional investors. This philosophy remains central to APN’s investment offerings across Property Securities, Managed Funds, Private Direct Property Funds and Listed Property Funds.

APN has a longstanding commitment to investment performance and outstanding service. We deliver this through our highly disciplined investment approach, our deep understanding of commercial real estate and our dedicated in-house customer service and registry team.

APN has a market capitalisation of approximately $120 million and delivered a total return to shareholders in excess of 40% over the 12 months to 31 March 2014.

To find out more about APN, please listen to  CEO, Mr Michael Doble.

Castle Point Ranger Fund Update- July 2015

The Ranger Fund monthly Fact Sheet is now available.
The Ranger Fund is a high conviction portfolio of New Zealand and Australian listed companies. The Fund’s objective is to provide equity-like returns over the long run while minimising exposure to extreme share market fluctuations. During periods of market stress, the fund will seek to preserve capital by preserve capital by holding significant amounts of cash and bonds, shorting individual shares, selling index futures contracts and/or buying index put options. The Fund will not be levered or net short.

Performance Commentary:
Our June return was up 1.74%, given the backdrop of falling share markets, this was a really encouraging outcome. For example the NZX50 and the ASX200 were down 2% and 5% respectively.

During the month, Macmahon Holdings announced that it had settled an outstanding dispute in Mongolia for $80m, this left the company with effectively no debt and cash in the bank. We had increased the position to 5% prior to this announcement and made healthy gains from the subsequent 40% increase in its share price. There was also a solid contribution from Boom Logistics which announced that it was continuing to reduce debt and progressing towards a return to profitability. The other news in the Fund was the potential takeover of A2 Milk Company and while this also helped the Fund it was to a lesser degree given it was only a 1% position.

The only real negative contributor was Corporate Travel Management, this appears to be the impact of general share market weakness as the company released no new information to the market, during the month.

To read the full story, please click the button below. 

Capital Match Updates on Listings and Introduces New Product Type

Listing #14: First payment transferred on time

The first payment for listing #14 (travel company) has been settled on time (it is now reflected on the platform). We apologize for the slight delay – most of the time there is a delay from our bank in processing the GIRO deduction. We are working towards improving this process.

Listing #16: Changes and partially re-opened for new investors

While processing the legal documentation for listing #16 (construction company) we discovered that the company has another loan of S$1m from private lenders with an outstanding amount of S$429,000 that was not disclosed to us before. Having performed additional due diligence, we have decided that the borrower is still creditworthy and shall continue with the loan (but with an increased interest rate of 2.5% per month – from 2.2%). However, we gave an option to existing investors to opt out from the loan given changed factual situation and, as of now, 4 people decided to opt out for a total amount of S$9,000.

We have updated the loan request sheet on the platform and you can again commit funds.

We are always investigating all types of financial commitments and bank accounts that the potential borrowers might have (and in a number of cases we have uncovered information that was not disclosed to us in the first place). In this particular situation, however, the liability and the bank account holding it were not disclosed to us, nor were there any inter-bank transactions. Your capital safety is always our top priority so we will continue to remain transparent when it comes to any of such situations.

New product: “Restricted” loans

We understand that many of our users are looking for more lending opportunities. As such, we are introducing a new product type called “Restricted” loans for borrowers that may not meet some of our regular requirements. “Restricted” loans will be characterised by a slightly higher interest rate and individual lenders may only commit up to S$5,000 per loan. The business prospects for borrowers under this product line are more uncertain. “Restricted” loans will be clearly identified by a warning icon on the platform.

Connexion Secures First Retail Sales for Flex

3 July 2015, Melbourne, Australia
  • Connexion expands availability of Flex to the Australian retail market
  • Negotiations underway to make Flex available in retail stores nationwide
  • Expansion to the International retail market to follow
  • $44k retail sales already generated in June

Connexion Media Limited (ASX:CXZ) is expanding availability of its proprietary Flex integrated vehicle management system to the retail market, and has secured its first retail sales in Australia.

The interest from relevant retailers has provided Connexion with a new and exciting market to sell the Flex product.

Initial revenues of $44k have been generated in June, with further retail sales anticipated to grow as the pipeline of retailers expands.

Connexion is actively in discussions with local and international partners which will increase the penetration of the Flex product. More importantly, the new retail market opportunity will provide Connexion with a potentially large and lucrative ongoing revenue stream.

“Identifying a new market opportunity is always exciting. Generating first sales in such a short timeframe is hugely encouraging for us,” said George Parthimos, CEO of Connexion.

“We continue to aggressively explore new market opportunities both locally and abroad, leveraging from our long-standing relationships with some of the largest multinationals in the world.”

Connexion is also in discussions with some global companies in pursuit of its major objective of building international sales of the Flex product.

Singaporean Firm Invests US$10m in New Zealand Cricket Tech Company

16th June 2015, By Gerard Hutching, Stuff 

Wellington-based CricHQ has scored funding worth $14.3 million (US$10m)  from a Singapore private equity firm to expand into a global operation.

Founder and CEO Simon Baker and director and former Black Cap Stephen Fleming announced at a press conference in Singapore that Tembusu Partners would invest in the cricket technology company.

Tembusu Partners manages funds worth more than $300m and CricHQ will be the second investment by Tembusu Growth Fund III – which has a target size of S$150 million.

Baker said the company, which was launched five years ago, was in expansion mode and was not yet making a profit. He expected that phase to continue for another 12-18 months.

The funding would allow the privately-owned company to take on double the staff in India over the next 18 months, from 40 to 80 personnel. They would work on development, sales and marketing in the world’s largest cricketing nation.

In Wellington CricHQ employs 15 people but there are no plans to add to that number.

Baker said there was no other company which covered the gamut of what CricHQ did.

“It’s hard to find a comparative competitor. There are other companies which do different aspects of what we do – for example we do a lot of what Cricinfo does, but our company does administration of national bodies which Cricinfo does not,” Baker said.

So far CricHQ managed the administration of two test countries – New Zealand and Sri Lanka – and was negotiating with others. It has 41 of 106 national governing bodies using its services from club level upwards.

Although it had not yet partnered with English test cricket administration, it was being used by 10 per cent of other English cricketing bodies.

To read the full story, please click here.

Bulletproof Steps Up Cloud Play with New Professional Services Arm

30th June 2015, By Julia Talevski, ARN

ASX-listed Cloud services provider, Bulletproof (ASX:BPF), has launched its new Professional Services unit into the market.

The new unit, which will be led by Bjorn Schliebitz, will provide its channel partners and clients with a range of consulting capabilities including Agile and DevOps enablement, Cloud infrastructure and automation, strategy and innovation, experience and marketplace, integration and API.

In a statement, Bulletproof said it was the first specialist provider in the Australian market to offer a complete suite of end-to-end Cloud services from the initial strategy through to consultation and design, deployment and support of the final hybrid or public Cloud.

Bulletproof co-founder and CEO, Anthony Woodward, said the Professional Services offering formed part of the company’s overarching strategy to help companies take advantage of the evolution in computing.

“We’ve worked closely with our customers to deploy and support their Cloud strategies, leveraging our expertise in this space, but we wanted to engage with them earlier in their journey to ensure they were making the right decisions to take full advantage of the Cloud,” Woodward said.

Bulletproof paid $800,000 cash to Pantha Corp, from existing cash reserves of around $5 million back in December.

The acquisition brings approximately $4 million of annualised existing revenues to the company, with $400,000 of current run-rate EBITDA.

To read the full story, please click here

Universal Biosensors Wholesale Investor Presentation

Universal Biosensors (ASX:UBI) is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use.

UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood.

The first product developed by UBI with LifeScan (a Johnson & Johnson company) is a blood glucose measurement device and is on the market and generating revenues for UBI. The second product developed by UBI in collaboration with Siemens Healthcare has also been launched.

The global point-of-care diagnostics market is estimated to be worth nearly US$17 billion a year and growing.

UBI is now extending its platform technology to new POC applications.

To view the UBI’s latest presentation from the Wholesale Investor Sydney Capital Expo and Small Cap Showcase 2015 please click here

Sun Biomedical Tapping into US$11B Kidney Disease Sector

June 30th 2015 by Proactive Investors

Sun Biomedical (ASX:SBN) is proceeding with the acquisition of platform drug discovery and clinical stage biotechnology company Dimerix Bioscience after satisfying all conditions precedent.

The transaction is now unconditional and should be completed by the close of business on 3rd July 2015.

Dimerix is currently recruiting in to Phase 2 clinical study for its lead therapeutic product DMX200 that is targeted at patients with chronic kidney disease (CKD).

CKD affects over 26 million people in the U.S. alone. The market in exceeds $11 billion in sales per annum and continues to grow.

Dimerix’s initial strategy is to pursue an orphan indication, Nephrotic Syndrome, and subsequently partner the development of programs in larger disease indications.

It is engaged in research collaborations with top pharmaceutical companies using its proprietary GPCR (G protein coupled receptors) drug discovery platform.

To read the full story, please click here.

All Conditions Satisfied for the Acquisition of Dimerix Bioscience

ASX Company Announcement, 30th June 2015

The Board of Sun Biomedical Limited is pleased to advise that all of the conditions precedent to the completion of the acquisition of Dimerix Bioscience have been satisfied.

The conditions were set in the formal sale agreements dated 13 May 2015 between Sun Biomedical and Dimerix Bioscience and are as follows:
• Sun Biomedical obtaining all necessary shareholder approvals;
• All of the Dimerix Shareholders entering into acquisition agreements with Sun Biomedical in respect
to their shareholdings in Dimerix;
• Sun Biomedical receiving firm commitments and cleared funds for the full amount of the Capital
Raising; and
• No material breach of the warranties given in the implementation agreement having occurred.

With the conditions precedent being satisfied, the Board advises that the transaction is now unconditional and the acquisition of Dimerix Bioscience should be completed by close of business on July 3, 2015 upon issuing the placement shares to sophisticated investor clients of Forrest Capital Pty Ltd, vendor shares, transaction options and associated corporate advisor options.

About Dimerix
Dimerix Bioscience Limited is a public unlisted company developing a new therapy for Chronic Kidney Disease that is currently recruiting for a Phase II trial being conducted in Melbourne. In addition Dimerix owns a patented drug discovery technology that is able to identify new applications of previously approved drugs and develop them for new medical indications with high unmet need. Since previously approved drugs
have extensive prior clinical use, the clinical development pathway for Dimerix’s therapies will be significantly shorter.

To download the full document, please click on the link below. 

Surga Central Introduces Virtual Data Room and Expanded Role for Real Estate Stacking Plans

Adept Business Systems has released version 3.1 of Surga Central – a vertical SaaS software solution for marketing and sales of commercial real estate. Using Surga Central, commercial agencies can now email property brochures that give enquirers the ability to immediately access property-related documents held in a virtual data room or a website. In addition, Surga Central has delivered a new form of viewing occupancy at industrial parks and retail centres via the mechanism of an expanded stacking plan.

“When considering commercial property for lease or purchase, enquirers often need instant access to information such as floor plans, contractual terms or an Information Memorandum,” said Steve Clark, CEO of Adept Business Systems. “Rather than waiting for an agent or administrator to service the request, enquirers can now self-serve directly from the PDF brochure to access documents held in a virtual data room or a website,” added Clark.

Surga Central’s interactive stacking plans have proved a popular way of viewing occupancy at multi-storey buildings such as high rise offices. Now, Version 3.1 extends this capability beyond office buildings to single-storey sites, such as industrial parks or retail centres. Using Surga Central’s Expanded View Stacking Plans, a property agent can easily reveal details of occupancy to prospective tenants or investors using an interactive tool available on desktop browsers or an iPad.

Other features of Version 3.1 include a personalised homepage, streamlined processing of partial leases and property photos plus faster entry of contact details.

Z-Filter Pty Ltd Wholesale Investor Presentation

Z-Filter Pty Ltd. is an award-winning company, developing the Z-Filter, filtration technologies and operating contracting services, to clean and separate waste streams from: iron ore, to coal, septic tanks, to tailings dams, and canals.

These technologies are universal with applications in many industries, patented/pending, low cost, light weight, simple, energy efficient, high volume and essential to a high standard of living and a clean environment.

The company recently announced an R&D Collaboration with Monash University and a Technology Evaluation Plan with Fortescue Metals Group.

To view the Z-Filter’s latest presentation from the Wholesale Investor Singapore Capital Expo and Small Cap Showcase 2015 please download the document below.

Bankable Feasibility Study Confirms Altech’s High Purity Alumina (HPA) Project

ASX Announcement, 29th June 2015

HIGHLIGHTS

  • Bankable Feasibility Study (BFS) successfully completed three months ahead of schedule
  • Compelling financial and technical results:
    -Capital cost estimate US$76.9 million (A$98.6million)
    -Payback period 3.8 years
    -Estimated pre-tax NPV of US$326.1 million (A$362.4 million) (@ 10% discount)
    -Highly attractive IRR of 30.3%
    -Long-term sale price forecast of US$23,000/tonne (A$25,560/tonne) for 99.99% (4N) product
    -Cost of goods sold US$8,140/tonne (A$9,050/tonne)
    -EBITDA of US$59.4 million (A$66.0 million) per annum
  • Altech will now proceed to the funding phase of the project

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is delighted to announce the positive results of its Bankable Feasibility Study (BFS) for the development of a 4,000tpa high purity alumina (HPA) processing plant at Tanjung Langsat, Johor, Malaysia and an associated kaolin beneficiation plant at Meckering, Western Australia to provide feedstock for the HPA plant (the Project).

The financial and technical outcomes from the BFS are particularly compelling and it is now the Company’s intention to move to secure the required equity and debt funding that will enable it to rapidly transition the Project to final design and development.

Total capital costs for the Project are estimated at US$76.9 million (A$98.6 million), assuming a USD:AUD exchange rate of 0.78.

Annual revenues at full production (4,000tpa of HPA) are forecast at US$92.0 million (A$102.2 million), with an assumed long-term selling price of US$23,000 (A$25,560) per tonne of HPA, FOB Malaysia. Total annual operating costs, including mining, beneficiation, shipping and processing are estimated at US$32.6 million (A$36.2 million) or US$8,140 (A$9,050) per tonne of final HPA product at full production, resulting in an impressive gross margin of ~65%.

Earnings before interest, tax and depreciation (EBITDA) are expected to be US$59.4 million (A$66.0 million) per annum at full production, the pre-tax Net Present Value (NPV) of the Project is US$326.1million (A$362.4 million) at a discount rate of 10%, and the Internal Rate of Return (IRR) is ~30.3%. Payback of capital is 3.8 years.

The Project presents a robust and attractive business case that delivers high margins, strong cash flows, and the rapid payback of a relatively modest capital investment. Having considered the results of the BFS, the Company will now proceed to secure the required funding and continue with detailed design, permitting and approvals, and subject to funding, commence the ordering of long-lead items, initiate site clearances and then commence construction.

Altech’s managing director Mr Iggy Tan said, “ The BFS was completed three months ahead of schedule, which is testament to the hard work and commitment from our BFS team”.

“The results from the BFS have confirmed the Company’s belief that the unique qualities of its Meckering kaolin deposit, combined with HCl processing to produce high purity alumina, is a technically viable and commercially attractive business case – a potential “company maker”. Subject to successful funding, the development schedule will see campaign mining commence at Meckering around Q4-2016”, he concluded.

To read the full document, please click on the link below. 

Richard Stacker Speaks About High Yield Investment Opportunities to Sky News

18th June 2015

Richard Stacker conducted an interview with Helen Dalley on Sky News Business today where he spoke about the high yield investment opportunities in commercial property, as an alternative to other investment classes.

Click here to watch the interview

ABOUT CHARTER HALL 

Charter Hall Group is one of Australia’s leading fully integrated property groups with over 23 years’ experience managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall has over $12.7 billion of funds under management across the Australian office, retail and industrial sectors. Charter Hall was API Fund Manager of the Year in 2014.

Charter Hall Direct, part of Charter Hall Group, has a strong track record managing unlisted property funds and syndicates since 1995 for investors, including SMSFs and high net worth individuals. Our products are consistently highly rated by external research groups and we are Australia’s leading direct property fund manager, with $1.7 billion of real estate assets under management.

Folkestone Market Update – June 2015

Folkestone is pleased to provide an update on key activities across the Group.

  • Folkestone West Ryde Development Fund
  • Folkestone Truganina Development Fund
  • Direct Property
    -Millers Junction Business, Altona North
    -Millers Junction Retail, Altona North
    -Potters Grove, Officer
    -Potters Northside, Officer
    -Commercial Development, Knoxfield
    -North-West Sydney
  • Pipeline

Please click on this link to read the ASX Announcement.

About Folkestone

Folkestone (ASX:FLK) is an ASX listed real estate funds manager and developer providing real estate wealth solutions. Folkestone’s funds management platform, with $870 million under management, offers listed and unlisted real estate funds to private clients and select institutional investors, while its on balance sheet activities focus on value-add and opportunistic (development) real estate investments.

Glycerol Recycling Reduces Cellulosic Sugar Cost to $47/tonne

23rd June 2015, Australian Securities Exchange Announcement

Highlights

  • Leaf Resources’ cost of producing cellulosic sugars is now $47/tonne.
  • New glycerol recycling process recovers 95% of the glycerol used with higher purity and higher value.
  • This low cost opens up markets for GlycellTM sugars as a cheap, clean feedstock for bio-based products, replacing:
    -Sugars derived from grain and
    -Raw sugar
  • Cellulosic sugars at $47/tonne significantly increase the number of bio-based products that can economically replace petroleum derived products

Leaf Resources is pleased to announce that its GlycellTM process can now achieve a minimum sugar-selling price (MSSP) of $471 per tonne for a plant of 210,000 bone dry tonnes per annum. By way of comparison the market price for raw cane sugar is currently around $280 per tonne.

On May 6th we announced a cost of $151/tonne for GlycellTM sugars produced from a larger plant (based on the assumptions used by the NREL, National Renewable Energy Laboratory of the USA). Our main competition in pretreatment processes, dilute acid, had a cost of 363/tonne2under the same NREL assumptions.

The cost reduction announced today has come about because we have now shown that we can recover 95% of the glycerol input into the GlycellTM process at a higher purity than that input. Higher purity glycerol has a higher value so, in effect, glycerol now becomes an additional co-product delivering a fourth revenue stream to our process (the others being cellulose, hemicellulose and lignin). This significantly improves the commercial viability of GlycellTM cellulosic sugars as a feedstock for bio-based products.

We have again used ResourceInvest Pty Ltd to undertake an analysis of the benefit of this result on the minimum sugar-selling price (MSSP) of the cellulosic sugars produced by the GlycellTM process. We decided to use a smaller scale plant to reflect potential uses of the GlycellTM process in the renewable chemicals markets. ResourceInvest calculated that GlycellTM process produces cellulosic sugars at a MSSP of $47 per tonne on a fully costed basis (i.e. after capital and a return on capital).

To read the full document, please click on the link below. 

DomaCom Ltd Pre-IPO Investor Roadshow Dates Announced

DomaCom Ltd will soon be commencing a pre-IPO capital raising roadshow, consisting of a series of investor briefing sessions around Australia and in Singapore. This is an opportunity to hear directly from the CEO, Arthur Naoumidis where he will be provide an insight into:

  • The DomaCom business model, key drivers and growth strategy and how it significantly differs from other property crowd funding models;
  • An update of recent milestones achieved including key partner agreements, distribution and product development;
  • Details of the current investor opportunity and IPO strategy.

The dates of the upcoming investor events are provided below. Feel free to register via the links provided or email daniel@axstra.com.au to register for one of the briefing sessions.

An Information Memorandum will be available to interested investors at the event.

DomaCom Private Investor Briefings:

Sydney, 1st July:
Two sessions available. 12 noon to 1:30pm & 6 to 7pm. Spaces limited to 10 persons per session.
Venue: Axstra Capital Offices – Suite 701, Level 7, 60 Pitt St, Sydney.

Melbourne, 30th June:
Two sessions available. 12 noon to 1:30pm & 6 to 7pm. Spaces limited to 10 persons per session.
Venue: DomaCom offices – Level 6, 99 Queen Street.

Brisbane, 2nd July:
12 noon-1:30pm.
Venure: Cliftons Brisbane – Level 3, 288 Edward Street.

Adelaide, 6th July:
Venure: 12 noon-1:30pm. Aurora Building “Skydeck” – Level 13, 147 Pirie Street.

Perth, 7th July:
12 noon-1:30pm – DomaCom investor briefing session.
Venure: Frasers Restaurant, Kings Park – 60 Fraser Avenue

Singapore 8th July: 
Two sessions. 1:30pm  & 3-4pm.
Venue: Level 37, Singapore Land Tower, 50 Raffles Place

In addition, CEO Arthur Naoumidis will be speaking at the following presentations:

Sydney, 25th June 6-8pm:
Axstra Capital Client Showcase. Register your attendance here.

Sydney, 15th July:
12 noon-2pm Wholesale Investor Sydney Investor Showcase. Register your attendance here.

Melbourne, 24th July:
12 noon-2pm – Wholesale Investor Melbourne Investor Showcase. Register you attendance here.

Capital Match Latest Listings Completed in 24 hours; New Online Repayment Tool Now Fully Functional

24th June 2015

Two latest listings completed in 24 hours (#00015) and 4 days (#00016)

We are pleased to inform you that our latest listing #00015, which went live on Friday 19 June, was fully funded in 24 hours. Listing #00016 was fully funded in 4 days! We thank you for your support and look forward to providing you with more proposals in the future. A few more requests are also coming up (next one still this week).

We will also soon bring a new category of borrowers with even more attractive, but still manageable, interest rates.

New feature for all Investors: Repayment Schedule

We are glad to announce that the new “Repayment Schedule” feature is fully functional (you can find it under grey “calendar” icon). You can now monitor past and future repayments of all the listings on the Platform with ease. We will still slightly improve the way the information is presented on the screen and soon add additional features (e.g. your individual commitment in the list of open requests).

Updated Terms & Conditions and other updates

As part of our effort to improve your experience using our services, we are updating the Capital Match Terms and Conditions. We want to take this opportunity to notify you about these updates.

Terms &  Conditions

Privacy Policy

The updates will take effect immediately. If you continue to use our services, you agree to the updated terms. If you do not agree, you can choose to discontinue the use of the services and close your Capital Match account within 7 days. If you are a Capital Match Platform user, you will also be notified of them again on the Log In page.

Leaf Resources Investor Update June 2015

23rd June, 2015

The Glycell Process
Glycerol recycling reduces cellulosic sugar cost
Leaf Resources announced today that our proprietary GlycellTM process, can now achieve a cellulosic sugar cost  of $47 per tonne down from the previous $151 per tonne.
Review the full announcement here

The Glycell Process, Investor Presentation
On the 13th May 2015, Leaf Resources Managing Director, Ken Richards attended the Sydney Capital Expo and Small Cap Showcase. This exciting event produced by Wholesale Investor, Bloomberg, DLA Piper, PwC, SGX, NZTE, AusBiotech and OzForez, was held at the Shangri-La Hotel in Sydney.

The business case for the GlycellTM process was presented by Mr Richards. The full presentation can be reviewed here.

Leaf Resources up for Soffinova Partners Renewable Chemistry Start-Up Award
Leaf Resources have been added to the public vote list for the Sofinnova Partners Renewable Chemistry Start-up Award.
Vote here

Changes in Interest of Director at iFast Corporation

June 22nd 2015

The initial public offering of shares and listing of iFAST Corporation Ltd. on the Main Board of the Singapore Exchange Securities Trading Limited was jointly sponsored by DBS Bank Ltd. and RHB Securities Singapore Pte. Ltd. (formerly known as DMG & Partners Securities Pte Ltd) as joint issue managers, bookrunners and underwriters (“Joint Issue Managers, Bookrunners and Underwriters”). The Joint Issue Managers, Bookrunners and Underwriters assume no responsibility for the contents of this announcement.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Environmental Site Assessment Approved For Altech’s Malaysian HPA Plant

ASX Announcement, 19th June 2015

Highlights: 

• Preliminary Site Assessment (PAT) approval by Department of Environment

• Confirmation that an Environmental Impact Assessment (EIA) for the HPA plant is not required

• Next step in the environmental approvals process is equipment approvals and registration

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce that it has received approval from the Department of Environment, Johor (DOE) of its Preliminary Site Assessment (colloquially referred to as a “PAT”) for the construction and operation of its proposed high purity alumina (HPA) processing plant at Tanjung Langsat, Malaysia.

In general, the approval of the PAT confirms that the proposed location of the HPA plant at Tanjung Langsat and its proposed activity are compatible with gazetted structure and local plans, surrounding land use, provision of set-backs or buffer zones and waste disposal requirements.

The DOE, in its response to the Company’s PAT also advised that an Environment Impact Assessment (EIA) will not be required for the HPA plant, as the processing capacity of the plant will be less that 100 tonnes per day. This is a positive outcome for the project which further simplifies the permitting and environmental approval process.

The next stage in the environmental approvals process is the approval and registration of air pollution control systems, chimneys and fuel burning equipment of the HPA plant, which is required under various Malaysian environmental quality regulations. These approvals processes are relatively straightforward and the Company will continue to work with its local environment consultant (Daya Eco Techno Sdn Bhd) to satisfy the requirements.

To read the full document, please click here

New Listings and Insights On Capital Match’s Borrower Assessment Process

The past few weeks have been really exciting here at Capital Match and we pleased to inform you that we have just introduced not one… but two listings on our platform!

Listing #15 – S$100,000 for 6 months at 2.5% interest:

The listing amount is S$100,000 for 6 months at an interest rate of 2.5% per month. The borrower’s core business involves the designing, manufacturing and distribution of corn starch based bioplastic (disposable tableware, bags and packaging). The company was set up in 2008 and is currently the leading producer and supplier of corn starch products in Singapore.

Listing #16 – S$200,000 for 12 months at 2.2% interest:

The listing amount is S$200,000 for 12 months at an interest rate of 2.2% per month. The borrower is a construction company that specializes in steel structures. The company was set up in 2010 by a veteran with 40 years of experience in the industry. NOTE: This company is different from listing #11 which was eventually not accepted by the borrower.

1Above Launches “Jet Lag” Flight Drink in North America

PR Newswire via BevNet, New York, June 18, 2015

Flying takes a heavy toll on Americans’ performance: according to results released today from a 1Above survey conducted online in May by Harris Poll among over 2,000 U.S. adults, 81% of U.S. fliers (Americans who’ve ever flown) whose most recent flight was an hour or longer say they need one full day or more to recover after a flight. Yet results show poor hydration and flying habits abound – factors that greatly exacerbate jet lag symptoms and health risks long after each flight. 1Above, the New Zealand brand behind the flight drink designed to help people combat jet leg and arrive ready, is releasing these findings as they launch in North America this week.

Already popular across Australia and New Zealand, 1Above is now launching in the United States. Founder Roger Boyd’s mission is to introduce a healthier approach to flying to America – a market where, despite the fact that conditions on most flights are drier than the Sahara desert, people are not hydrating. Results show that 71% of U.S. air travelers whose most recent flight was at least one hour long1 did not adequately hydrate2 on their last flight. In fact, the longer the flight, the less people tend to drink.

“Flying takes its toll on our bodies, resulting in a set of symptoms that collectively most of us know as ‘jet lag.’ Yet whether we’re traveling for business or pleasure, most of us are expected to arrive at our destination ready to operate at 100%,” said Roger Boyd, founder of 1Above. “1Above was developed to dispel the misperception that jet lag is an inevitable side-effect of flying, and to help people feel better from take-off to landing and beyond. 1Above is about bringing back the love of flying, and our North American expansion brings us just another step closer to making that a reality.”

The effects of flying and jet lag can be far reaching: from fatigue, low concentration and irritability to swelling in the extremities, headaches and dry skin, nasal and throat membranes. On top of that, the risk of DVT (venous thrombosis) more than triples on long flights, and studies show you are five times more likely to catch the flu or other illness. Dehydration exacerbates these risks, as cabin air at 35,000 feet creates conditions drier than the Sahara. Yet research shows U.S. travelers remain woefully unprepared and dehydrated when flying. Consider these stats:

  • We don’t even realize the cause. Only 11% of Americans believe they experience dehydration when flying, putting the cause of their negative symptoms down to other factors. Yet 71% of air travelers whose most recent flight was at least one hour long1 did not drink sufficient liquids (all drinks excluding alcohol) on their last flight.
  • The longer the flight, the less we drink. On their last flight more than a third of air travelers said they did not drink any water (37%). Instead, many drank beverages that actually cause further dehydration (e.g., coffee, alcohol, soda). In fact, fliers are drinking more of these dehydrating fluids than water.
  • Eighty-one percent of American air travelers whose most recent flight was less than an hour said they need at least one day or more of recovery time after a flight before operating at their best again, and a recent Loughborough University study showed those driving dehydrated commit as many mistakes as those over the legal drunk driving limit3.

To read the full story, please click here

Altech Chemicals – Gold Coast Investment Showcase Presentation

ASX Announcement, Thursday 18th June

Altech Chemicals Limited is aiming to become one of the world’s leading suppliers of a high-value product, 99.99% (4N) high purity alumina (HPA) (Al2O3). HPA is the major source material for scratch-resistant artificial sapphire glass, which is used in the next generation of smartphones as well as a growing range of high performance electronic applications such as LED’s, semi-conductors, and phosphor TV screens. The global HPA market is approximately 19,040tpa and is expected to double over the coming decade.

To view their Gold Coast Investment Showcase Presentation, please click on the link below. 

Booodl’s Lowdown on Facebook’s “Free” Beacons

Facebook made an interesting announcement last week that they were rolling out “free” beacons to US retailers, coinciding with an upgrade to their Place Tips technology. Retail beacons are a sought-after bit of tech right now, there’s no denying that. So should retailers be jumping on the free beacon bandwagon? That’s the topic of this week’s video.

Invitation to Xyec Holdings’s FY2015 Results Briefing

Xyec Holdings Co., Ltd., an established integrated engineering and IT services provider for major manufacturing industries in Japan, cordially invites you to its FY2015 results briefing for the financial year ended 31 March 2015.

The management – Mr Manabu Kobayashi (Executive Chairman, President and Chief Executive Officer) and Mr Takeshi Hosaka (Financial Controller) will be present to review the results and give an update on the latest corporate developments.

The Group’s financial statement was released on the SGX website on 22 May 2015.

Details of the briefing are as follows:

Date: 29 June 2015, Monday
Time: 2.00 pm – 3.00 pm
Venue: August Consulting 101 Thomson Road #30-02 United Square
RSVP: Please RSVP to Dinesh Dayani
Email: dineshdayani@august.com.sg

By 23 June 2015

To download the invite, please click on the link below. 

Avenir Capital Investor Update May 2015

17th June 2015

The Avenir Value Fund returned +4.5% net of all fees and expenses in May 2015.

                                                          Net Return*
Calendar YTD:                                        8.7%
Trailing 12-months:                                 4.7%
Cumulative return since inception:        77.3%
Annualised return since inception:        16.1%
* Net of all fees and expenses

Please click this link to view the Avenir Capital May 2015 Performance Update.

If you would like to discuss how Avenir Capital can complement your investment portfolio, please do not hesitate to contact us.

avenircapital.com.au

Opal Biosciences’ anti-infective technology profiled at 2015 Bio International Convention

Biodiem Ltd, Melbourne, 17 June 2015

BioDiem CEO, Julie Phillips will profile the anti-infective technology of its new wholly-owned subsidiary, Opal Biosciences (Opal) at the 2015 BIO International Convention (BIO) from June 15 -18.

BIO is the world’s largest biotech event and attracts more than 2,500 CEOs and 15,000 attendees. It covers a wide range of life science innovations, providing the ideal global stage to raise funds.

Julie will speak about the next generation of health challenges and will also introduce potential investors to Opal’s promising next generation antimicrobial, Opal Technology.

Resistance to antibiotics is growing rapidly across the world, creating an urgent need for new treatments. Opal is currently developing two Opal Technology antimicrobial products, based on BioDiem’s BDM-I technology:

• Opal-I, an injectable product, and
• Opal-T, which can be applied to skin.

Opal was established to help fast-track BioDiem’s promising BDM-I studies and hold the BDM-I technology to allow outside investment in the project.

The Company is currently undertaking a capital raising of up to $4 million to attract external investment in the technology. This investment will help expedite Opal’s studies and Opal-I and Opal-T will be developed for commercialisation through sale of the technology to a larger company, potentially within two to three years.

The capital raising is open until 15 May 2016 and the incentives associated with early investment close on July 15, 2015. BioDiem shareholders will retain a stake in the BDM-I technology through BioDiem’s shareholding in Opal. Those deemed to be “sophisticated investors” are also eligible to purchase more shares under the offer.

To read the full announcement, please click on the link below. 

Strategic Acquisition Opportunity – Established, High Margin Business with Genuine Barriers to Entry & Strong Growth Prospects

Key highlights of the opportunity include:

  • Proven, established and highly profitable business available for sale
  • Largest provider of services and products in their industry throughout Australia and New Zealand
  • Established for over 5 years, they have a market leading position with genuine barriers to entry
  • Strong relationships with several National brand name clients, on long-term contracts
  • Runs under management with extensive investment in IT systems to support future growth
  • The company is 100% debt free
  • EBIT of $3M+ in 2014 FY and consistent net margins of circa 30% over the last 4 years
  • Potential to double revenue to ~$20M in next 24 months by executing identified growth plan
  • The business is fully prepared for sale, allowing acquirer speed of execution

Information Memorandum available on request to interested parties.

To enquire about this Acquisition Opportunity, please contact Daniel Coombes on 0414 137 212 or email daniel@axstra.com.au

Alternatively please click on the Receive Offer button below for more information.

 

 

Jonathan Shellabear Ioins Sirona Capital as Head of Corporate Advisory

Perth, 16th June 2015

Perth-based private equity and advisory firm Sirona Capital has appointed Jonathan Shellabear to head the company’s Corporate Advisory business.

Mr Shellabear will work closely with managing directors Kelvin Flynn (Head of Private Equity) and Matthew McNeilly (Head of Real Estate), who combined have more than 50 years experience in proprietary investment, corporate finance and investment banking, to provide financial and strategic advice to clients in the natural resources industries.

“We are delighted to welcome Jonathan to the firm. He is a highly experienced resources industry professional with a distinguished career as both a senior investment banker and corporate executive. His understanding of the industry and his extensive global relationships within the sector will provide clients with unsurpassed knowledge and insights. The appointment of Jonathan further establishes Sirona’s expertise in the corporate advisory space and we know that our clients will greatly benefit from his advice,” said Mr Flynn.

Sirona Capital’s Advisory Business is focused on providing mergers and acquisitions, strategic, restructuring, financial solutions and other corporate finance advisory services to corporates, financial institutions and government. It advises in situations where stakeholders require trusted, experienced, independent advice and leadership and where capital needs to be maximised or is at risk.

Mr Shellabear said Sirona Capital was an excellent platform from which to provide truly independent corporate advisory services. “Sirona’s distinguished reputation as a specialist private equity and corporate advisory firm is well-deserved and I am looking forward to being part of a close knit team that is well positioned to grow the business. Both Kelvin and Matthew share my passion and commitment to provide world-class and uncompromised advisory services to clients to assist them achieve their long-term corporate objectives.”

Jonathan has held senior investment banking roles with NM Rothschild & Sons, Deutsche Bank and Resource Finance Corporation and was previously the Managing Director of Dominion Mining Ltd which was acquired by Kingsgate Consolidated Ltd in February 2011. He has extensive capital markets and advisory experience in the resources sector that includes public market takeovers, acquisitions and divestments, restructuring, strategic advice and equity and debt financing. He has advised on numerous transactions to companies including AMP, Anglo American, AngloGold, Areva, LionOre Mining, Mitsubishi, Normandy Mining, Rio Tinto, Shell and WMC Resources.

He holds a Bachelor of Science with Honours in Geology and a Master of Business Administration from the University of Western Australia.

About Sirona Capital

Sirona Capital is a specialist independent private equity, corporate advisory and merchant banking firm with a focus on the Real Estate, Metals & Mining, Oil & Gas and Agriculture sectors based in the global natural resources hub of Perth, Western Australia.

The firm was established in 2009 with a particular focus on special situations and multi-strategy opportunistic investing and high value strategic advice.

Sirona provides a fully established funds management platform with an Australian Financial Services Licence (AFSL) and currently has a team of 10 dedicated professionals.

APN Property Group | Introducing The Little Book of BIG Property

We would like to introduce you to our new educational booklet. “The Little Book of BIG Property” is designed to help investors understand how commercial property investment works.

To download a copy of the book, please click here.

If you would like to order a hard copy or hear more about investing in commercial property, please contact APN Investor Services on 1800 996 456 weekdays between 8:30am and 5:30pm or email us on apnpg@apngroup.com.au

We hope you enjoy our little book and welcome your feedback.

Yours sincerely,
APN Property Group

ABOUT APN PROPERTY GROUP

APN Property Group Limited (APN) is a specialist real estate investment manager that actively manages real estate funds on behalf of institutional and retail investors.

Established in 1996, APN is listed on the ASX (ASX code: APD) and manages $2.1 billion (as at 31 December 2014) of real estate and real estate securities in 12 funds.

Focused exclusively on real estate funds management and with a core philosophy of “property for income”, we seek to establish and actively manage a suite of real estate funds to provide annuity style income and wealth creation opportunities for retail and institutional investors. This philosophy remains central to APN’s investment offerings across Property Securities, Managed Funds, Private Direct Property Funds and Listed Property Funds.

APN has a market capitalisation of approximately $120 million and delivered a total return to shareholders in excess of 40% over the 12 months to 31 March 2014.

NewActon East – FY16 Distribution Forecast Increase to 8.60%

Placer Property, 10th June 2015

Placer Property is pleased to announce the NewActon East Property Fund (“Fund”) forecast distribution for FY16 has increased to 8.60% p.a.

Placer Property Joint Managing Director, Mario Papaleo said, “Since acquiring the property, we have been able to implement operational improvements to achieve cost savings and realise additional income earlier than forecast. Proactive asset management by Placer Property in achieving 100% occupancy earlier than anticipated as well as extracting operating expense savings, have resulted in the FY16 net operating income budget exceeding the initial forecast.

Importantly, the 8.60% forecast distribution is fully covered by the property’s budgeted operating cash flow.”

This is the second increase to FY16 forecast distribution rates announced by Placer Property. Savings achieved from entering interest rate hedging arrangements to September 2019 provided an initial lift in the FY16 distribution forecast, which was announced in April this year.

David Omond, Joint Managing Director said, “NewActon East Property Fund continues to exceed our initial expectations. The higher FY16 forecast distribution rate of 8.60% p.a. compares even more attractively to the current low cash deposit rates on offer.”

The Fund is still accepting new investment applications.

About the NewActon East Property Fund

NewActon East is located at 21-23 Marcus Clarke Street, NewActon, Canberra, and is only three kilometres from Parliament House. NewActon East is a modern mixed-use building comprising retail, offices, 32 residential apartments on the upper levels and 176 car parking spaces. The Fund has acquired the commercial part of NewActon East.

Key investment highlights:

• 8.60% FY16 Forecast Distribution
• Commonwealth Government tenant, ACCC, provides 80% of the property income
• The property is now 100% leased
• Fund gearing is 49%, and interest rate exposure is 100% hedged
• SMSF friendly investment

About Placer Property

Placer Property Limited holds an Australian Financial Services License (AFSL 442806) by the Australian Securities and Investment Commission.

As a specialist property fund manager, the primary objective of Placer Property is to facilitate quality property investment opportunities, such as NewActon East Property Fund, for investors seeking regular and reliable income derived from the ownership of commercial property.

Placer Property draws on the skills and knowledge of senior management who are specialists in unlisted property funds management and the extensive experience of its Directors.

Placer Property is focused on Australian property investment opportunities, primarily in the office and retail sectors.

To read the full document, please click on the link below. 

Folkestone Real Estate IQ – Demand for Non-Residential Property Drives Returns

Real Estate IQ provides our insights on real estate to assist you to navigate the world of real estate investing and enable you to make more informed investment decisions.

Please see below for our latest research paper.

We all know Sydney house prices are making headlines but non-residential property has also been delivering strong returns. Adrian Harrington shows how property has recovered after the GFC and while he likes the prospects, there are risks to watch for.

Click here to read paper

ABOUT FOLKESTONE 

Folkestone (ASX:FLK) is an ASX listed real estate funds manager and developer providing real estate wealth solutions. Folkestone’s funds management platform, with $870 million under management, offers listed and unlisted real estate funds to private clients and select institutional investors, while its on balance sheet activities focus on value‐add and opportunistic (development) real estate investments. www.folkestone.com.au

Invest in Sirona Capital’s Quest Apartment Hotel, Fremantle

As a valued contact, we invite you to consider an investment in Sirona Capital’s Quest Apartment Hotel, Fremantle. This exclusive offer is seeking to raise additional equity up to $2.365 million to facilitate development of the 120 key, 4½ star apartment hotel. Sirona has already received investments totalling $9.675 million which funded the property acquisition and the pre-development costs. The minimum investment is $27,500.

An investment teaser is attached for your information, just click here.

The investment highlights include:

  • 120 key Quest serviced apartment development
  • Prime location in Fremantle’s heritage West End CBD with harbour views
  • Acute undersupply of apartment hotel rooms in the Fremantle market, and Perth more generally
  • Fremantle’s CBD is undergoing significant renewal and Sirona Capital is a major developer/investor across a portfolio of key projects in the CBD, including the flagship Kings Square development
  • 15+5+5+5 year Quest lease with 4% fixed annual escalation (market reviews in years 6 and 11)
  • Key development risks mitigated with all planning approvals in place, a well experienced builder appointed and construction finance in place
  • Significant planning, financing and land barriers for new market entrants limiting supply side competition
  • Attractive cash return on investment over 8 years with initial post construction cash yield of 11.5% pa increasing to 15.1% by year 6 of the Quest lease
  • Substantial depreciation tax benefits available
  • Suitable for wholesale investors and SMSF’s

In summary, Sirona’s core investment thesis is to provide investors with the opportunity to capitalise on the acute shortage of hotel rooms in the Fremantle market. Sirona is a leading driver of the broader rejuvenation of Fremantle and advocates investing in a well located hotel development at an entry level price underpinned by a strong, long term lease covenant.

The fund aims to provide investors with an attractive long-term and considerably tax deferred income yield with the potential for capital and income growth.

Should you wish to secure an allocation in the fund or to receive a full Information Memorandum, please register your interest with us as soon as possible.

All applications will be dealt with on a first in first allocated basis.


VeilMail Accepted into the Microsoft Partnership Program

Turner Technologies with their product VeilMail have just been accepted into the Microsoft partnership program and is now working with Microsoft Singapore to bring secure communication systems to larger corporates and government sectors.

“This is a major step forward for VeilMail enabling marketing to be aligned with Microsoft help with VeilMail utilising the Windows Desk-top and Windows server software in its delivery”, says CEO Greg Roake

VeilMail use is growing rapidly as Turner Technologies seeks to become the preferred secure communications platform for industry globally.

ABOUT VEILMAIL 

VeilMail software provides impenetrable data storage and guaranteed secure digital communications. According to a Cyber Research report in January 2015, VeilMail was found to be the most secure data storage platform available on the market today.

 In 2014, USD67 billion was spent on the Cyber Security market, VeilMail targets the business to business sector of this market.

The sales have been budgeted to build up to $15m per annum over the next 36 months, and trials are under way in numerous countries.

AsiaPhos Receives Approval for Renewal of Exploration Right

Singapore, 12th June 2015

AsiaPhos Limited (“AsiaPhos”) and together with its subsidiaries, the “Group”), a Singapore-headquartered mineral resources company focused on exploring and mining phosphate with a vertically-integrated business model, today announced that its wholly-owned subsidiary, Mianzhu Norwest, has received the renewed exploration right for its Shi Sun Xi mine (“Mine 2”) from the Sichuan Land Department (四川省国土资源厅).

The Mine 2 exploration right, which is for an exploration area of approximately 1.28 square kilometres, expired on 16 June 2014.  The renewed right is valid from from 16 June 2014 to 16 June 2016.

Currently, the Group holds another mining licence for, and operates 2.0237 square kilometres for Mine 2.

Together with its Cheng Qiang Yan mine (“Mine 1”),  Asiaphos’ total measured and indicated phosphate resources is 30.3 million tonnes as at 30 September 2014 according to a NI 43-101 technical report dated 21 November 2014 by geologist Watts, Griffis and McOuat Limited.

Said Dr Ong Hian Eng (王显荣博士), Chief Executive Officer of AsiaPhos Limited,

“With this, both our exploration licences for Mine 1 and 2 have been renewed. This will allow us to step up our exploration activities, which would ultimately help in sustaining the growth in our rock output which we have achieved over the recent years.”

About AsiaPhos Limited

AsiaPhos Limited was listed on the Catalist Board of the SGX-ST on 7 October 2013, and is the first mineral resources company listed on the SGX-ST which is solely focused on exploring and mining phosphate in the PRC with the ability to manufacture and produce phosphate-based chemical products. To make full use of phosphate, which is a valuable and non-renewable natural resource, AsiaPhos is adopting a vertically-integrated strategy which will comprise the mining of phosphate rocks from its existing mines and the production of phosphate-based chemical products.

Led by a management team with more than 10 years of relevant experience in their respective fields, the Group currently owns exploration and mining rights to its two mines and has completed the construction of a Pplant in its new Gongxing site. As part of its future plans, the Group intends to construct more processing facilities. 

China Backs Newground Property in Brisbane

Newground Property has strengthened their international relationships with a recent trip to Shanghai and Hong Kong yielding very strong interest in the firm’s Brisbane based projects.

“There was definitely a sense that Brisbane is on the radar now in light of Sydney’s strong price growth” says Newground’s director Daniel Erez. “Investors are searching for value and yield and both of these can be found in Brisbane right now”

Thefirm came back with a combination of site acquisition, equity funding and project sales mandates.

Locally, Newground is experiencing a steady number of transactions across all projects and is currently evaluating several inner city development sites for its hungry investor base.

“We are confident that the current appetite for the risk adjusted returns on development funding will remain,” he said.

ABOUT NEWGROUND PROPERTY GROUP 

Based in the financial centre of Brisbane Australia, Newground Property is a boutique residential development advisory firm. Founded in 2009, the team at Newground have over 45 years combined industry experience and have amassed an impressive track record of achieving profitable outcomes for their developer and investor clients. Currently averaging in excess of 300 sales per annum with over 350 agents in their network both in Australian and internationally, Newground Property have sold upwards of $400 million in residential development projects to date.

Due to the growth and activity in Brisbane market, Newground Property’s development advisory capability has evolved into the development of boutique residential projects in premium inner city locations in partnership with its top developer clients. In 2013 Newground Property was awarded a place in the Business Review Weekly’s Fast 100. The BRW Fast 100 is a list compiled annually of Australia’s 100 fastest growing businesses.

VMob Annual Report 2015

VMob Group, 12th June 2015

• Triple digit percentage revenue growth, 1,700%+ ACMR growth
• Data processing scale surpasses largest local comparison by 4,200%
• New global clients: Anheuser-Busch, 7-Eleven, McDonald’s USA & Japan

New Zealand end-to-end mobile personalisation SaaS company VMob has rounded off the year with annual report results released today revealing impressive growth, significant scale metrics and the addition of some of the world’s biggest brands to the client roster.

For the year ended 31 March 2015, total revenue grew 474% over the same period last year, with Annualised Committed Monthly Revenue (recurring revenue) growing even more strongly at an increase of 1,707% over 2014. ACMR is a key metric for Software as a Service (SaaS) businesses such as VMob, providing a basis for measuring ongoing performance, growth and value of the business.

The scale at which the VMob platform is processing data now surpasses many of the largest enterprise deployments in New Zealand. As at the end of May 2015, at peak activity rate, the VMob platform was processing 6,800 transactions from mobile devices every second. In comparison, Paymark New Zealand’s peak load was 155 transactions per second on Christmas Eve of 2014.

Other VMob platform performance statistics include:

- 14.6 million mobile apps installed on the VMob platform
- VMob powered apps can be used in 7,000 stores globally
- 129 million new activities accumulated per day
- An additional 258Gb of device activity data stored per day
- Peak rate of activity storage is 43GB per hour

Global brands Anheuser-Busch, 7-Eleven, McDonald’s USA and Japan have all put their marketing budgets behind VMob’s mobile marketing platform in the last 12 months as the worldwide VMob footprint expands.

To read the full documents, please click here

 

Value in the AREIT Sector?

APN, April 2015

In this article we answer some recently asked questions about the value in the AREIT sector. We conclude that different valuation metrics are implying vastly different things. On balance, we believe that the market will still provide APN with the ability to deliver on its stated investment objectives. Accordingly, we conclude that (for our investment style and strategy), value still exists in the AREIT sector. We cannot say the same for more aggressive AREIT investment styles (including Index strategies) that by definition are investing in securities that are higher up the risk/return scale.

Are we comfortable about the relative value in the sector based on existing financial market metrics and the outlook for the yield curve?

  • In many regards, the yield curve remains the issue. We are comfortable that the current consensus view of “lower for longer” will prevail. “Lower for longer” refers to the expectation that global growth and inflammation will be low for an extended period. This will feed into the Australian economy and result in yield curve remainig flat for an extended period. A flat yeild curve means that short term interests rates will perhaps mov lower (or at least be maintained at cuurent levels) while the “long end” (ie 10 year Bonds) will remain compressed based on a pessimistic outlook and the impact of sluggish offshore growth that impacts the US bond market particularly.  It is of course the US bond market  that substantially drives the trajectory of the Australian bond market.
  • The reality is that low interest rates are a significant tailwind for AREITs at the moment. Steadily falling interest expenses have provided an earnings per share (EPS) tailwind for many AREITs.
  • Low interest rates are a key driver of investor preparedness to bid up the market. Private clients who invest directly in the market compare the yield they can achieve in fixed interest investments (~2.5% – 3%) with the yield in AREITs (most yielding in the range of 5% – 8%). Institutional investors often utilise the 10 year bond as the risk free rate in the discounted cash flow valuation process. With the bond trading at all time record low yields, it is little wonder that many valuations support the sector current pricing.

What is the sector premium to NTA, and is this relevant?

  • We are sceptics about the relative usefulness of Net Tangible Asset (NTA)which is used as a primary valuation tool. NTA is a distorted figure in the AREIT market due to the impact of stocks like Goodman Group and Westfield. Because these stocks include significant amounts of corporation earnings, they trade as significant premiums to NTA (currently around 70% – 100%). These two stocks alone represent around 29% of the AREIT market and therefore widely distort the overall market premium to NTA. It is worth noting that there are still a number of AREITs that trade below NTA.
  • The other issue with NTA is the disconnect the exists between listed and unlisted markets. Equity markets look at and price assets well ahead of the physical markets. Indeed, equity markets typically are looking up to 12 months in advance. Property markets can be priced (in the worst case) up to 6-12 moths in arrears. Depending on an AREIT’s valuation cycle and because property valuers are compelled to us often out of date sales evidence when formulating their opinions of value, a property valuation may in fact be based on information that is up to 12-18 months out of date. Accordingly the difference in perspectives (between listed and physical property market pricing) could be as much as 24-30 months. In markets experiencing a rebound in values this of course means that comparisons between listed and physical markets can be problematic.

To read the full document, please click on the button below. 

Footfalls & Heartbeats Secures Three New Licensing Opportunities

Hot on the heels of signing major deal with global healthcare giant Medi

Kiwi tech start-up, Footfalls & Heartbeats, has secured itself as a technology platform play to be reckoned with, in the rapidly growing smart textile market. And the company isn’t skipping a beat, following the announcement of three new letters of intent signed by global operators.

With a sophisticated governance structure and an adept executive team, Footfalls & Heartbeats is now well positioned for expansion. Given its proven model of securing separate exclusive licenses with leading industrial players for many different and high value applications, Footfalls & Heartbeats is one to watch.

As a key enabling player in the growing billion dollar smart textile market, Footfalls & Heartbeats has gained a reputation for making good on its IP and technology, securing a number of commercial deals this year.

Just three months ago, Footfalls signed its first major, exclusive and ongoing licensing deal with one of the world’s largest medical compression bandage companies, German healthcare giant Medi GmbH & Co. KG (Medi). The innovative smart fabric company now has three letters of intent from additional licensing partners for other applications, demonstrating ongoing commercial interest in the business.

Roland Toder, Managing Director, Business Development and International Licensing, says letters of intent with a clinical bed company, a global technical fabrics company, and a wheelchair seat company have been signed in recent weeks:

“Footfalls & Heartbeats is very much on a roll. The three new letters of intent and key commercial terms come hot on the heels of our ongoing agreement with Medi, and they confirm that we’re offering a sound platform technology play to our licensing partners.”

Footfalls & Heartbeats’ IP has many applications from healthcare and medical uses, to commercial fabrics on public transport to office interiors. The company’s first licensing partner, Medi, operates in over 90 countries, so immediately its technology is reaching a vast audience around the world.

Toder says these diverse target sectors are realising the value of applying Footfalls & Heartbeats’ patented IP to their offerings.

“The letters signal to the smart textile sector – and to the investor market – that we are doing the business and getting our technology and IP applied to sectors that will change the way people interact with products, and how information is used.

“Our sensory fabric monitors change in real time, so you can imagine how many areas and organisations would find that extremely useful for data collection and product improvement. Our IP has applications ranging from detecting pressure areas for hospital bed injury prevention, to monitoring how passengers use public transport through seat use, through to understanding and preventing wheel chair pressure injuries.”

Toder says, “We excel at taking the world-leading ideas from our team, and generating commercial leads and deals that take our IP to market. Lots of start-ups come up with exciting technologies and ideas, but there are far fewer that go out and secure major commercial deals.

“We’ve got a laser sharp focus on executing our strategic plan and closing deals that enable further growth and development and these three letters of intent are the tip of the iceberg when it comes to the activity we have going on in the company, and which we’ll be sharing with the market in the months to come.”

www.footfallsandheartbeats.com

VeilMail CEO Interview

Security breaches and any related interruptions in the performance of services or applications, can result in direct financial losses, threaten organizations’ reputations, erode customer loyalties, attract negative press, and trigger significant fines and penalties. VeilMail addresses this by providing impenetrable data storage and guaranteed security in digital communications. Independent studies conducted penetration tests on VeilMail and confirmed it is the most secure messaging platform on the market today.

VeilMail software provides impenetrable data storage and guaranteed secure digital communications. According to a Cyber Research report in January 2015, VeilMail was found to be the most secure data storage platform available on the market today.

In 2014, USD67 billion was spent on the Cyber Security market, VeilMail targets the business to business sector of this market.

The sales have been budgeted to build up to $15m per annum over the next 36 months, and trials are under way in numerous countries.

To find out more about VeilMail, please listen to their CEO Mr Greg Roake.

iFAST Propose Acquisition Of A Stockbroking Firm In Hong Kong

10th June 2015

The Board of Directors of iFAST Corporation Ltd. (“the Company” or together with its subsidiaries, the “Group”) wishes to announce that the Company had entered into an Agreement for the Sale and Purchase of the entire share capital of Winfield Securities Limited (“Winfield Securities”) representing 10,000,000 shares of HK$1.00 each in the issued and paid-up share capital of Winfield Securities (“Proposed Acquisition”) from Messrs Heng Kwai Shan and Chung Wai Mun. The Proposed Acquisition is subject to approval from the Securities & Futures Commission of Hong Kong.

Winfield Securities is principally engaged in securities trading and brokerage in Hong Kong. It is licensed to carry Type 1 (Dealing in Securities) regulated activity under the Securities and Futures Ordinance (CAP571 of the Laws of Hong Kong) and is a Stock Exchange of Hong Kong Limited Participant and Hong Kong Securities Clearing Company (“HKSCC”) Participant. The Proposed Acquisition will allow the Company to conduct securities brokerage services in Hong Kong and expand the range of investment products available on its investment platform.

The purchase consideration for the Proposed Acquisition is the total of HK$4.7 million and the adjusted unaudited net asset value of Winfield Securities based on the Updated Management Accounts at completion date. The purchase consideration was arrived at on a willing buyer willing seller basis, after taking into consideration the unaudited financial statements of Winfield Securities for the year ended 31 March 2015. Based on the unaudited financial statements of Winfield Securities for the year ended 31 March 2015, the total purchase consideration is estimated to be approximately HK$14.7 million. The Company has paid HK$500,000 upon the signing of the Agreement as deposit and part payment of the purchase consideration.

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Crowd Mobile Expands Globally in High Growth m-Payments

10th June 2015

  • Crowd Mobile has entered into a Heads of Agreement (HOA) to acquire Netherlands based company Track Concepts
  • Track Concepts has a high value m-Payments network and industry leading technology platform
  • Acquisition expands Crowd Mobile’s global footprint – Track Concepts operates in 38 countries across more than 140 mobile carriers
  • Track Concepts generated revenue of AUD$24.5m (€17.2m) and EBITDA of AUD$13m (€9m) in CY2014

Crowd Mobile Limited (ASX: CM8 / FWB-XETRA: CM3) (Crowd Mobile) is pleased to announce that it has entered into a Heads of Agreement (HOA) with Netherlands based company Track Holdings BV (Track Concepts), to acquire 100% of its shares for AUD $26.7m (€18.7m) plus Net Tangible Assets (NTA) expected to be circa AUD$5m (€3.5m) plus an earn-out to a maximum of AUD$6.7m (€4.7m).

The transaction is subject to Due Diligence, Execution of a Share Purchase Agreement (SPA) and Funding. It is expected that the transaction will be funded by a combination of equity, debt and convertible note and it’s expected to be completed by August 2015.

Track Concepts owns specialist technologies in m-Payments and an industry leading customer acquisition platform. Its global content distribution network operates in 38 countries within Europe, Central/Latin America, Asia-Pacific and Africa and has connections with over 140 mobile carriers.

Commenting on the agreement, Crowd Mobile Chief Executive Officer Domenic Carosa said:

“This is a game changing acquisition for Crowd Mobile. The strategic benefits we see from the transaction are significant.”

“This is a unique opportunity to bring together Track Concept’s high value m-Payments network with Crowd Mobile’s existing m-Payments network to create one of the leading global platforms in the high growth mobile payments industry. This acquisition will see Crowd Mobile add a network that connects over 140 telecommunication companies globally providing secure and seamless electronic m-Payment transactions for customers.”

“In addition to m-Payments, Track Concepts also has an industry leading technology platform that acquires, retains and manages customers. Its Global Content Distribution provides mobile content, entertainment and apps to millions of consumers worldwide.”

To read the full documents, please click on the links below. 

Christchurch Mountain Bike Park Seeking More Investors

By Alan Wood, Stuff, 10th June 2015

Backers of a multimillion-dollar Port Hills mountainbike project have targeted a group of 50 investors to stump up $100,000 or more for the adventure park.

Project organisers have issued an information memorandum (IM) to the potential investors of a $25 million Christchurch Adventure Park that should open around October 2016 provided enough capital is raised.

The minimum $100,000 investment in the development of 315 hectares of forested Port Hills land into a park should pay off within four years of the park opening, backer Jay Fry says.

“They should expect to get their investment back after four years of operations.”

The IM for the park, located between Dyers Pass, Worsleys and the Summit roads, says the first quarterly dividend was set to be paid in the fourth quarter of 2017.

IMs had been sent to 50 people in the hope of raising $4m.

“We’ve got a number of people emailing us, so we’ve got quite a large list now … I feel pretty confident that some funding will come from there and it will get us over the line,” Fry said.

The park had around $10m of indicative interest from New Zealand and international investors from Singapore and Boston.

“I’ve talked to a number of what I call my hotlist and they’re still there. We’ve got around $10m coming in from them.”

A further $4m was being sought with the recently issued IM helping bring other investors to the surface, Fry said.

A confirmed $2m cash injection from the Government depends on the project meeting milestones.

Bank debt from China Construction Bank (New Zealand) of about $9m had been secured, Fry said.

The borrowings are subject to a $5m “shortfall” guarantee granted by the Christchurch City Council in case of any default on the bank loan.

Qualified investors, willing to stump the minimum $100,000, have until the end of July to commit to the project.

Fry expects the park to be given the go-ahead by the Overseas Investment Office with construction due to start in November.

To read the full story, please click here

SGX Corporate Access June 2015 Presenting Companies

Wholesale Investor and SGX are proud to announce the SGX Corporate Access June 2015.

This unique invitation-only event will showcase 5 SGX-Listed companies in the Entertainment, Healthcare, Energy, Property and Maritime Services Industry.

The Showcase provides an opportunity for Fund Managers, Brokers, Private Banks, Family Offices and Wealth Managers, the opportunity to meet, network, invest and create strategic long-term relationships with the SGX-Listed companies.

You will be able to hear live presentations, and then sign up to speak one-on-one with the C-level executives about their business, gain information straight from the source and discover unseen opportunities.

PRESENTING COMPANIES:

 

Far East Group Ltd (SGX:5TJ) – Singapore’s pioneering comprehensive provider of refrigeration and air-conditioning with clients in China and South East Asia

Founded in 1953, Far East Group Limited (“FEG”) is a pioneer in the refrigeration and air-conditioning business in Singapore. Over the years, it has built up a strong network to become a comprehensive provider of refrigeration and air-conditioning systems and products for the Heating, Ventilation, Air-conditioning and Refrigeration (HVAC&R) industry. It was listed on SGX Catalist on 8 August 2011. FEG has manufacturing facilities in Malaysia and China manufacturing its own “Eden” brand of heat-exchangers and offers total solutions in cooling and refrigeration from consulting to aftersales support. Its customers in China and South East Asia include distributors, dealers as well as refrigeration and air-conditioning contractors for end-users in a wide range of industries.

 

Atlantic Navigation Holdings Ltd (SGX:5UL) – Integrated offshore service provider in the Middle East, India and Africa with 15 support vessels

Atlantic Navigation Holdings (Singapore) Limited (“ATLANTIC”) is listed on the SGX Catalist and is an integrated offshore service provider. It owns a fleet of 15 offshore support vessels and a liftboat and operates and charters them to leading offshore oil and gas companies primarily in the Middle East, India and Africa. ATLANTIC also manages the sourcing and cross-chartering of third party vessels to its customers. Additionally, the Group provides ship repair, fabrication, maintenance, and other services and operates out of Sharjah, the United Arab Emirates.

mm2 Asia Ltd (SGX:41C) - Movie and TV/online content producer of over 20 movies across Asia including some well-known titles 

Headquartered in Singapore, mm2 Asia is a producer of movies and TV/online content. As a producer, mm2 Asia provides services that cover the entire filmmaking process including securing financing, producing and distributing as well as securing advertising and sponsorship. In addition to Singapore, mm2 Asia also has a presence in Malaysia, Hong Kong, Taiwan and the PRC through its group of companies and/or strategic working partnerships. mm2 Asia has co-produced and/or distributed in excess of 20 movies across Asia since 2008 including co-producing well-known films such as the ‘Ah Boys to Men’ series; and distributing titles such as Malaysia’s ‘The Journey’ and Taiwan’s ‘Café.Waiting.Love’.

 

ISEC Healthcare Ltd (SGX:40T) – Comprehensive suite of specialist medical eye care services with ambulatory surgical centres in Malaysia and Singapore

ISEC Healthcare provides a comprehensive suite of specialist medical eye care services with ambulatory surgical centres in Malaysia and Singapore that are equipped with state-of-the-art technology and facilities. Our team of 19 doctors are specialised in the fields of cataract and refractive surgery (including LASIK), vitreoretinal diseases, corneal and external eye diseases, glaucoma, uveitis, oculoplastics, facial cosmetics and aesthetics surgery, adult strabismus and paediatric ophthalmology. We aim to operate, manage and further establish centres which we term as Centres of Excellence specializing in ophthalmology, with the vision of providing high quality, compassionate, world-class eye care at an affordable level to the local and regional community.

TEHO International Inc Ltd (SGX:5OQ) - A multi-faceted solutions provider for the Marine, Offshore O&G and Real Estate industries

TEHO Group has grown from a small local rigging and mooring company to become an international multi-faceted solutions provider, mainly for the Marine, Offshore O&G and Real Estate industries. The main business units under the Group includes Mooring and Rigging Systems, Electrical and Mechanical Engineering Systems, Water and Environmental Solutions, and Property Development, Services and Investment. Our global network has expanded from the headquarters in Singapore to Rotterdam, North Carolina and Shanghai, along with overseas logistics points and agents for our maritime business units, and Cambodia, Taiwan and Malaysia for our real estate business unit. We are assiduously and vigilantly looking for opportunities to expand our business segments and geographical network.

 

 

Altech Partners with SGL Group For Its HPA Project

ASX Announcement, 5th June 2015

Highlights

  • Memorandum of Understanding with SGL Group as HCl system supplier
  • Leading global expertise in materials and equipment for extreme environments
  • Strengthens the Bankable Feasibility Study (BFS) team

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with SGL Group (“SGL”) as its partner for the supply and installation of the Hydrochloric Acid (HCl) gas generation, absorption, recovery and scrubbing plants for it’s high purity alumina (HPA) project.

The recovery, regeneration and concentration of hydrochloric acid are important steps in numerous processes in the Company’s HPA plant. SGL is one of the world’s leading manufacturers of carbon-based products and materials. It has a comprehensive portfolio ranging from carbon and graphite products to carbon fibers and composites. The company is a worldwide leading premium technology provider for chemical and related industry process systems, equipment (e.g. heat exchangers, columns) and after sales services. SGL`s focus is on engineering advanced and sustainable solutions based on high-tech materials for challenging applications.

Commenting on the appointment of SGL by the Company, Altech’s Managing Director, Iggy Tan explained: “our strategy to appoint key equipment and plant suppliers at this stage of the HPA project will enhance the overall design. Specifically, SGL are the experts in the recovery, regeneration and concentration of hydrochloric acid which is an integral part of our process. This will ultimately position the Company for a rapid transition to final detailed design, long lead item procurement and the commencement of construction following the completion of the BFS.

 To view the full document, please click on the link below. 

Martin Aircraft Shareholder Update June 2015

ASX Announcement, 9th June 2015

Martin Aircraft Company Limited (Martin Aircraft), (ASX:MJP) is pleased to provide the following shareholder update as much has happened since our successful listing on 24 Feb on the ASX. This shareholder update seeks to inform you of the rapid progress to date in specific areas.

Personnel

Since the successful listing on the ASX in February, Martin Aircraft Company has entered a rapid growth phase to identify and select suitable candidates to fill the roles required to deliver the commercial Jetpack programme. The 17 positions recently filled are across all disciplines of the Company, from marketing, financial and administration through to mechanical, test, design and electrical engineers, along with an additional test pilot. The individuals we have appointed are well qualified and their experience will be ideal during the commercialisation phase and for future development of the Jetpack.

Engine 

We continue to advance a medium term upgrade to the power plant of the Martin Jetpack and in the meantime, we are introducing an upgrade Mk1 engine, designated Mk1x. In parallel, we have contracted a company to provide an outline for both a V6 two stroke engine and a 4 stroke engine. Both these engines and concepts arising from an independent study reported in March, and will replace the Mkll project that was highlighted in the prospectus. These concept designs will be delivered in late September and a decision will be made whether to take one or both forward to prototype and pre-production. In addition, we are in discussion with an engine manufacturer for an off-the-shelf engine which, with modification, could also meet our powerplant requirement in the timeless required. We will keep you informed on the outcome of these discussions.

This parallel path engine approach leads to a reduction of risk associated with the timeline of the powerplant requirement that the Company highlighted in its prospectus, while improving engine performance of the aircraft.

Saftey Features

We have completed the initial stages of the development of our ballistic parachute. the results in the testing environment to date demonstrate that we may exceed out projected safety requirements. Further testing using the Jetpack is about to commence.

To view the full announcement, please click here

Proteomics Featured in The Australian

By Sarah-Jane Tasker, The Australian, June 9, 2015

Australian life sciences company Proteomics is set to announce today a world first for a predictive test for the diagnosis of diabetic kidney disease.

A $2 million, 576-patient, clinical study completed in Western Australia between 2010-14 has found that 10 per cent of the patient population with diabetes progressed to kidney disease.

“Proteomics’s predictive test predicted with a high level of accuracy the specific individuals in the 576-patient population who constituted the 10 per cent,” the company said.

The test can predict which patients with diabetes will progress to have diabetic kidney disease and which people with normal kidney function, as measured by conventional tests, are at risk of developing the disease.

There is currently no available test for predicting the onset of diabetic kidney disease and Proteomics said its test, which had been validated, represented a breakthrough in the diagnosis and treatment of the disease. The company said the benefits to it successfully commercialising the test were enormous.

“The potential for major pharmaceutical companies to use a predictive diagnostic test for diabetic kidney disease to identify at-risk patient groups and then use their branded therapeutic drugs in a treatment regime has major benefits to the pharmaceutical companies and also to Proteomics, in the form of royalties, licensing fees or other revenue streams they may derive,” Proteomics said.

The company said it was in talks with several global pharmaceutical companies about partnering and licensing opportunities to commercialise the test.

“We will now seek to accelerate these, and also expand them to include other interested parties based on the validation of predictive diabetic kidney disease diagnostic test.”

The Perth-based company specialises in the area of proteomics, the study of the structure and function of proteins. It has one central technology that performs protein analysis across three areas — a service business, a diagnostics business and a drug discovery business. The diagnostic arm focuses testing products for diabetic kidney disease and Alzheimer’s and operates in the biomarkers market, estimated to double in size to $40.8 billion by 2018.

One in ten of the world’s population is tipped to have diabetes by 2035 and according to the US Centre for Disease Control of the 592 million people with diabetes today, 35 per cent of adults have chronic kidney disease.

To read the full document, please click on the link below. 

Proteomics Produces Predictive Test for Diagnosis of Diabetic Kidney Disease

ASX Media Release, 9 June 2015

Life sciences company Proteomics International Laboratories (ASX: PIQ) is pleased to announce that it has produced and validated a predictive test for the diagnosis of diabetic kidney disease (DKD).

The test, called PromarkerD, is the world’s first proteomics-derived predictive (prognostic) test for the diagnosis of DKD, and represents a global breakthrough in the diagnosis and treatment of the disease.

There is currently no available test for predicting the onset of DKD.

The potential global medical benefits and cost savings from PIQ’s predictive test are huge. Diabetes is the fastest growing health issue in the world today and is the largest cause of kidney disease – for example, 35% of adults in the USA with diabetes have chronic kidney disease.

The ability to accurately predict the onset of DKD via a simple blood test and then provide appropriate clinical treatment to prevent the onset of the disease has the potential to save health care systems globally billions of dollars. In Australia alone, the total cost to the health system and in productivity loss attributed to diabetes is estimated at $10.3 billion annually. Of the approximately 1.7 million Australians who have chronic kidney disease, 1.5 million are not aware they have it.

The commercial benefits to PIQ in successfully commercialising the test are enormous. The potential for pharmaceutical companies to market PromarkerD to identify at-risk patient groups and then to provide drugs to manage patients more effectively could provide PIQ with substantial returns in the form of licensing fees and royalties.

Background

The test was developed using PIQ’s world-leading proprietary proteomics platform to measure specific biomarkers (biological signatures) in the blood of patients with diabetes to determine the likelihood of those patients contracting DKD. Specifically, PromarkerD simultaneously measures a panel of 2-6 proteins to determine the patient’s disease state.

Applying its mass spectrometry-based proteomics technology, the Company has developed a deeper understanding of DKD beyond classical pathology, by comparing the differences in the protein make- up of people with and without the disease.

Study Results

The test was developed and validated in a $2 million clinical study of 576 patients with diabetes, followed between 2010 and 2014 in Western Australia.

The results show PromarkerD can predict:

  • Which patients with diabetes will progress to have a significant decline in kidney function better than any other current known measure; and
  • Which people with apparently healthy kidney function as measured by conventional tests are at risk of kidney problems.

Specifically, the clinical study, which is on-going, found that 10% of the patients had a significant and rapid decline in kidney function over the four year study period and that PromarkerD correctly predicted 67% of these individuals.

The samples in the study were cross-validated with an established antibody-based technique broadly accepted by the US Food and Drug administration (FDA), which showed there was excellent correlation between the two methods.

PromarkerD also has a diagnostic component (in addition to its predictive application), which utilises the biomarker panel to diagnose the early onset of DKD in a patient, where current tests for kidney function fail to detect the disease.

To read the full document, please click on the link below. 

Castle Point Ranger Fund Update- June 2015

The Ranger Fund monthly Fact Sheet is now available.
The Ranger Fund is a high conviction portfolio of New Zealand and Australian listed companies. The Fund’s objective is to provide equity-like returns over the long run while minimising exposure to extreme share market fluctuations. During periods of market stress, the fund will seek to preserve capital by preserve capital by holding significant amounts of cash and bonds, shorting individual shares, selling index futures contracts and/or buying index put options. The Fund will not be levered or net short.

Performance Commentary:
During May the Ranger Fund benefited from the positive performance of Boom Logistics, Corporate Travel Management, Macmahon Holdings, Wellcom Group and Contact Energy. The Fund was negatively impacted by the performance by Swick Mining Services and Australian Vintage. During the month the Fund added a position in Contact Energy and increased its position in Australian Vintage.

To read the full story, please click the button below. 

BioDiem Update: Opal Biosciences Ltd.

Biodiem Ltd, Melbourne, 5th June 2015:

BioDiem is pleased to update shareholders about the progress of Opal Biosciences, the new wholly- owned subsidiary of BioDiem. Opal Biosciences Ltd (“Opal”) will develop BioDiem’s BDM-I antimicrobial program. For more information about Opal see www.opalbiosciences.com.

This month there has been a lot of international news about the need to address the antibiotic resistance issue. The UK has released another Jim O’Neill report , the White House held a forum this week on antibiotic stewardship and last month’s World Medical Assembly supported a world action plan to combat antibiotic resistance .

The importance of this issue and the opportunity for BioDiem shareholders has led to the formation of Opal Biosciences.

BioDiem shareholders will be asked to approve the assignment of BDM-I from BioDiem into Opal at a shareholders meeting to be held on 6th July at 5pm.

The Notice of Meeting and Explanatory Memorandum and Proxy Form for this EGM were sent to Shareholders yesterday and accompany this announcement. Shareholders are asked to ensure that our share registry, Computershare, has the correct contact details.

Opal’s progress so far:
• Capital-raising launch at Wholesale Investor Sydney Capital Expo and Small Cap Showcase, held on 15th May, 2015. The video of that presentation is available on the Wholesale Investor website, and also the Opal Biosciences website.
• Presentation and corporate stand at Asia Biotech Invest 2015, Hong Kong on 20-21 May, 2015.
• Various media coverage including interviews with Medify Daily and Biotech Daily, with further media scheduled.
• Investor presentations scheduled in Sydney and Melbourne, and in the US in conjunction with the 2015 Bio International Convention, Jun 15-18, 2015.

On completion of Opal’s fund-raising, BioDiem shareholders will continue to own 33% or more of Opal. The Opal offer is outlined in an Information Memorandum. The offer is not open to the general public. The conditions of eligibility are included in the Explanatory Memorandum.

Shareholders can contact the office for further information or if there are any questions or difficulties please contact our office.

Yours faithfully,

Julie Phillips
Chief Executive Officer
BioDiem Ltd
Email jphillips@biodiem.com

To read the full announcement., please click on the link below. 

YuuZoo Forms E-Sport Joint Venture in China

Singapore, June 4th , 2015

Key Highlights:

  • JV partner XG AMA has existing relationships with over 3,000 online gaming bars in China.
  • Online gaming in China has a penetration rate of 59.5% among total internet users and 33% of mobile users.
  • In-game purchasing is a lucrative source of revenue, with 66% of gamers in China spending money on gaming each month.

Singapore-listed YuuZoo Corporation (“YuuZoo” SGX: AFC.SI) one of the world’s fastest growing third generation mobile social e-commerce companies, today announced it has formed a new joint venture company in China with XG AMA, a leading provider and organizer of e-sport events and related gaming activities through internet gaming bars and cafes in China. Under terms of the agreement XG AMA is committed to deliver a minimum of 5 million active paying users and a minimum profit of 1,5 million RMB in the first 12 months of operations.

The new joint venture company, “YuuGames” will sit within YuuZoo’s virtual shopping mall, fully localized and mobile-optimized for China. It will be managed by Hu Zhi Xiang, the founder of XG AMA and one of the best-known pioneers and entrepreneurs in the internet gaming bar business in China.

YuuGames will target the over 146,000 internet gaming bars in China which serve some 120 million game players. XG AMA already has existing agreements with over 3,000 net bars in place. Most of these bars have thousands of individual members.

YuuGames will leverage these partner bars for an (O2O) business model, wherein the visitors of the partner bars will become members of the YuuZoo social e-commerce network, effectively converting offline customers into online members of YuuZoo. YuuGames is developing a mobile app, which allows interaction be-tween the bars and its users, helping the users find the location of the bar’s and enable the user to reserve seats and arrange matches between e-sport teams. The app will also enable shopping, mobile games broad-cast, game events and video screening, lottery games and voting on mobile for games and events.

At the end of 2013 the online gaming market was worth $13.5 billion (82.1 billion RMB). This is expected to grow to 131 billion RMB by the end of 2015, with mobile gaming accounting for 33.8 billion of the total revenue. Experts predict that the rapidly growing number of smartphone users in the country will mean that mobile will continue to increase its share of the Chinese online gaming market. By 2018, it is expected that the gap in revenue share between online gaming and other gaming will close, with online gaming accounting for nearly half of all gaming spend in the country. It is estimated that in 2015 there will be 266 million Chinese online gamers, spending at least 2 hours per month gaming.

To view the full article, please click here

Charter Hall Complete $225 million Institutional Placement

ASX Announcement, 21st May 2015

Charter Hall Group (ASX: CHC) (Charter Hall or the Group) today announced the completion of its fully underwritten $225 million Institutional Placement.

Approximately 47,071,130 new ordinary securities will be issued to institutional investors at a fixed price of $4.78 per security, representing a discount of 2.8% to the closing price on 20 May 2015.Securities to be issued under the placement will settle on 26 May 2015 with allotment of securities to occur on 27 May 2015, from which time they will rank equally with existing Charter Hall securities and will be entitled to the full distribution for the six months to 30 June 2015.

About Charter Hall

Charter Hall Group (ASX:CHC) is one of Australia’s leading fully integrated property groups, with over 23 years’ experience managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall has over $12.7 billion of funds under management across the office, retail and industrial sectors. The Group has offices in Sydney, Melbourne, Brisbane, Adelaide and Perth.The Group’s success is underpinned by a highly skilled and motivated team with diverse expertise across property sectors and risk-return profiles. Sustainability is a key element of its business approach and by ensuring its actions are commercially sound and make a difference to its people, customers and the environment, Charter Hall can make a positive impact for its investors, the community and the Group.

To view the full document, please click on the link below. 

VMOB Triumph At Microsoft Worldwide Partner Awards

Wednesday, 3rd June 2015

Kiwi-born mobile personalisation business VMob has been recognised as one of the world’s most prominent innovation and technology businesses in the annual Microsoft Worldwide Partner Awards, winning the Cloud Platform: Application Innovation category award and named finalist in the Intelligent Systems category.

Over 2,300 nominations from 108 different countries for the 43 different global award opportunities were received for the 2015 awards. Awarded partners are regarded as truly exceptional, with their accomplishments viewed as examples of global excellence.

VMob CEO Scott Bradley is thrilled to see the partnership applauded on such a prominent level.

“Our partnership with Microsoft is hugely important and exciting for our business, with enormous opportunities to make impact at a global scale for big brands. The success we have already witnessed is testament to the partnership and we are very honoured to be in such good company with the other award winners.”

ShiSh Shridhar, IoT Specialist and Industry Solutions Director, Worldwide Retail Sector – Microsoft Global, observed that in retail and customer service industries, there is an increased focus on collection of data from connected devices, making the VMob partnership even more valuable.

“Businesses are now able to collect more customer data points than ever before,” said Mr Shridhar. “However the real business value then comes from solutions like the VMob platform that can not only collect these large volumes of data, but then take those data sets and straight away start to drive more effective customer engagement.”

“That’s what makes VMob such an exciting partner for us – Microsoft are providing the massively scalable architecture and VMob are using that, along with their software platform, to create real business impact, and it shows in the success their customers are having.

Locally, Brent Kendrick, Director for Microsoft NZ’s SMB and Partner Group, said he was excited to see VMob recognised on the worldwide stage.

“VMob has built an enviable and unique international market position and on behalf of the Microsoft New Zealand team, we’re very proud of the relationship that we’ve built with them as a partner. To see one of our local vendors growing and seeing such success internationally is really rewarding.”

www.vmoblive.com

To download the full document, please click on the link below. 

Charter Hall Latest Media Releases

Charter Hall Group is one of Australia’s leading fully integrated property groups with over 23 years’ experience managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall has over $12.7 billion of funds under management across the Australian office, retail and industrial sectors. Charter Hall was API Fund Manager of the Year in 2014.

Charter Hall Direct, part of Charter Hall Group, has a strong track record managing unlisted property funds and syndicates since 1995 for investors, including SMSFs and high net worth individuals. Our products are consistently highly rated by external research groups and we are Australia’s leading direct property fund manager, with $1.7 billion of real estate assets under management.

LATEST MEDIA RELEASES:

Charter Hall Direct CEO Interview

Charter Hall Group is one of Australia’s leading fully integrated property groups with over 23 years’ experience managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall has over $12.7 billion of funds under management across the Australian office, retail and industrial sectors. Charter Hall was API Fund Manager of the Year in 2014.

Charter Hall Direct, part of Charter Hall Group, has a strong track record managing unlisted property funds and syndicates since 1995 for investors, including SMSFs and high net worth individuals. Our products are consistently highly rated by external research groups and we are Australia’s leading direct property fund manager, with $1.7 billion of real estate assets under management.

Our strong track record is demonstrated by our syndicates and funds consistently beating their benchmark.

To find out more about Charter Hall, please listen to Mr Richard Stacker, Head of Direct Property.

How Should You Value an Early Stage Company?

NBR, By Ralph Shale

Investors should try to use a range of methods to validate what is a reasonable valuation. The only certainty in any valuation is that it will be wrong, in hindsight either too high or too low.

Valuing any business is an art not a science, with a lot of room for personal interpretation. There are a number of valuation approaches that investors can use. The best advice is to cross-check several before determining what is or not a reasonable valuation. My own approach:

Value invested to date
Although this is probably the crudest approach, it is interesting to understand how much has been invested to date to get the company to its current position. This should include both cash and an allowance for time (sweat equity). This ‘replacement’ cost can then be adjusted for the following:

  • What are the barriers to entry for competitors, such as intellectual property rights?
  • How long would it take a competitor to replicate the opportunity?
  • Has the investment to date been 100% effective? If money invested is going down the wrong path, the opportunity should be excluded.
  • What is a reasonable return on the investment, given the risks taken by the entrepreneur and investors?

The last funding round
If the company has raised money before, what was the valuation at that time? What has the company achieved with that investment to change the underlying value? How has the company performed against the business plan that secured those funds? A word of caution: although the earlier valuation is a starting point, do not necessarily accept it was correct.

Potential valuation
The two earlier approaches are backward-looking and are more useful as a reality check; the value of any business is in the future. My next approach is to try to forecast a value at some point in the future, then discount that back to a value today. Consider:

  • If a company is projecting to raise further funding, focus on when that will need to happen.
  • A potential liquidity event, such as sale of the business or stock exchange listing.
  • A time when the company reaches a more ‘normal’ state of growth.
  • The end of the financial forecast period.

You need to consider who the next investor or buyer will be and consider how they will value the business. Then this value is discounted to today’s value taking into account:

  • The returns being sought by the investor.
  • The timeframe from investing to this liquidity event.
  • Dilution that may occur during that time period for subsequent funding rounds.

Market comparisons
The final approach is to look at market comparable transactions. This is obviously more difficult for early stage transactions as there is less public data available and many of the businesses are unique. The New Zealand Venture Investment Fund has released data on its website on a range of valuations for the companies they have invested in, broken down by sector and stage of business.

What a number of entrepreneurs will do is try to point to other company valuations if they are favourable. Two points to remember: comparing international valuations to New Zealand’s is not valid unless the company is raising money internationally and, often in angel and VC deals, the investors have good protection against companies not delivering on the valuation. This allows ‘inflated’ valuations to be reported and is not directly comparable to a straight equity investment.

To read the full article, please click here

Capital Match Successfully Funds a Loan Request Within 24 Hours

Capital Match, a peer-to-peer (P2P) lending platform based in Singapore, has recently funded a S$150,000 loan request within a record time of 24 hours after having listed it on its online P2P platform. The loan request is one of the five loans that Capital Match has successfully funded since the platform officially launched a few months ago. The company is on its way to becoming the leading P2P platform in the region with total processed loans amounting to S$650,000. The company is working towards processing one new loan request per week.

 Top 100 Start-Up in Asia

Capital Match has also been selected as one of the top 100 start-ups in e27 Asia Echelon Summit and will be featured at the summit on June 23 and 24 at the Singapore Expo. The Asia Echelon Summit is a prestigious start-up convention that features only most promising start-ups in the region. Qualifer rounds for the event were held in 14 different countries in Asia and only the top 100 were specially invited to be featured during the event.

 More about Capital Match

Capital Match’s business model is similar to that of popular P2P lending platforms such as US-based LendingClub and Prosper, UK’s Zopa and Funding Circle. Capital Match provides each investor with an online account where they can view available loan listings, make investments and monitor their loan book.

The company’s objectives are two-fold: Provide businesses with the next best interest rates after banks, and to give investors access to attractive returns for their spare capital with a low investment entry amount (S$1,000 per loan). A typical loan sizes range from S$50,000 to S$200,000, with tenures of 3-12 months, and interest rate of 1.5% – 2.5% per month.

Capital Match’s online P2P platform can be found at www.capital-match.com. Register for a Capital Match account on our website to gain access to new fixed-income investment opportunities which you can use to diversify your investment portfolios.

Crowd Mobile Dual Lists On The Frankfurt Stock Exchange

ASX Announcement, 1st June 2015

Dual listing on Frankfurt Stock Exchange reflects the increasing importance of Europe to Crowd Mobile’s global growth:

  • Record European Message Volume and revenue achieved in April
  • Expanded into 10 European countries over the past 8 months
  • Actively targeting potential acquisitions in Europe to accelerate global growth in line with stated expansion strategies
  • Launch of Crowd Mobile services into Mexico

To read the full document, please click on the link below. 

Angeion Group Raises $1.5 Million; Further Commitments Expected For Another $4 Million

In the last fortnight we have marketed extensively in Singapore, as a result we are processing investments totalling $1.5 Million, and we have commitments for another $4 Million which we expect applications for this week. We also anticipate at least another $1.1 Million from Australian investors within the next fortnight.

As we are now also in early discussions with two large venture capital funds that may contribute a total $20 Million, please contact us as soon as possible if you require further information for your potential investment, as there is some capacity left within our “ early stage investors club” who receive the 12% yield.

ABOUT ANGEION GROUP

The Angeion Group is the formation of a new group of companies that will focus initially on mortgage origination, mortgage administration and mortgage wholesale funding. The Group will then expand into corporate trust administration, funds management, financial planning and insurances. The Angeion Group has the capability and experience to establish wholesale residential finance and securitisation activities in Australia, a full funding and securitisation operations platform, including treasury and trust management to support the wholesale mortgage program.

The Angeion Group will differentiate in product offering and client service through its loan products, completed financial modelling, funding structures and all operational planning. It will establish itself with a fully licensed local unlisted public entity with skilled personnel, appropriate legal risk and compliance structure, full operational platform and IT systems that have been secured, to deliver competitive loan products. Furthermore it will identify property investors who have confirmed their interest in refinancing existing loans and financing new loans directly through intermediary owned mortgage originators or via selected and authorised mortgage brokers.

The Angeion Group is offering an unlisted security paying a yield of up to 12% and has a disruptive investment opportunity in the non-bank mortgage and financial services space. Our aim is to fill a gap in the market by providing residential investors with a flexible product offering and client-centric approach. With an experienced team, an impressive track record and a $5B loan book ready for refinancing, this is a truly compelling equity opportunity.

Approval of Acquisition of Dimerix Bioscience

26th May 2015

1. Introduction 

This Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business to be conducted at the Meeting to be held at Level 2, 1 Walker Avenue, West Perth on Tuesday, 30 June 2015 at 10.30 am (WST).

This Explanatory Memorandum should be read in conjunction with, and forms part of, the accompanying Notice. The purpose of this Explanatory Memorandum is to provide information to Shareholders in deciding whether or not to pass the Resolutions set out in the Notice.

A Proxy Form is located at the end of the Explanatory Memorandum.

2. Action to be taken by Shareholders

Shareholders should read the Notice and this Explanatory Memorandum carefully before deciding how to vote on the Resolutions.

2.1 Proxies

A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to appoint a representative (a ‘proxy’) to vote in their place. All Shareholders are invited and encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions thereon. Lodgment of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person.

Please note that:

(a) a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy;

(b) a proxy need not be a member of the Company; and

(c) a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes.

The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms.

3. Resolution 1 – Approval of Acquisition of Dimerix Bioscience Limited 

3.1 Background

The Company announced on 13 May 2015 that it had entered into an implementation agreement with Dimerix (Implementation Agreement) to acquire 100% of Dimerix (Acquisition).

Dimerix Bioscience Limited (Dimerix) is a public unlisted clinical stage drug discovery and development company, based in Melbourne. Dimerix’s lead clinical program is a Phase II study in patients with Chronic Kidney Disease, using its novel combination therapy, DMX-200. The acquisition will transform Sun Biomedical into an advanced clinical stage company with an asset that has the potential to make a considerable impact in the treatment of Chronic Kidney Disease (CKD). Upon successful results from the Phase II study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication subgroup of CKD patients, such as Nephrotic Syndrome, and partner development of the product in the larger CKD indications.

Dimerix’s team has applied its patented GPCR drug discovery technology for its own internal research identifying and developing therapeutic treatments. Dimerix leverages its knowledge of drug target interaction and develops new combination therapies using already marketed compounds for new medical indications. This positions Dimerix’s therapies with a fast route to market due to extensive safety data for the selected compounds removing the requirement for Phase I studies and allowing to proceed directly to Phase Il efficacy studies.

Further information on Dimerix and its activities is set out in Schedule 1.

Dimerix is subject to a range of risks which apply to the biotechnology sector including the risk of failure in the development and commercialisation of its products (for example, through adverse clinical outcomes, failure to achieve necessary regulatory approvals, the product being found to be uneconomic or unable to compete with products marketed by third parties), challenge to its intellectual property rights and obtaining sufficient funding to implement its overall business strategy. These risks and others are discussed in more detail in Schedule 3.

Under the terms of the Implementation Agreement, the Company has agreed to issue the Vendor Shares as consideration to the Vendors.

This Meeting has been called by the Board to seek the necessary approvals required to effect the Acquisition.

3.2 Commercial Terms

Under the terms of the Implementation Agreement, the Company will enter into acquisition agreements with each of the Vendors (Acquisition Agreements) to acquire 100% ownership of Dimerix for total consideration of:

(a) 750,000,041 Shares;

(b) 75,000,040 Class A Performance Shares (convertible into 75,000,040 Shares upon receipt by the Company or Dimerix of a notice of allowance from the United States Patent and Trademark Office in relation to the US patent application number 13/979,127 (or any divisional or continuation thereof) within 24 months of completion of the Acquisition) (Class A Performance Shares);

(c) 75,000,040 Class B Performance Shares (convertible into 75,000,040 Shares upon the Board making an investment decision to proceed to file an application to the US Food and Drug Administration for a pre-Investigational New Drug (“pre-IND”) meeting to progress development of DMX200 following the receipt of data generated under the current clinical trial for chronic kidney disease supporting further progression of the technology within 48 months of completion of the Acquisition) (Class B Performance Shares); and

(d) 75,000,040 Class C Performance Shares (convertible into 75,000,040 Shares upon receipt of ethics approval allowing commencement of a second clinical trial derived from the Dimerix platform and in relation to an indication that is not covered under the existing Austin Human Research Ethics Committee approval within 48 months of completion of the Acquisition) (Class C Performance Shares), (the Vendor Shares).

Resolution 1 seeks Shareholder approval for the issue of the Vendor Shares (refer to Section 3.10 for further details). One of the Directors, Dr Anton Uvarov, has a beneficial interest in 231,000 shares in Dimerix. Approval of the issue of Vendor Shares to Dr Uvarov as a related party for the purposes of Listing Rule 10.11 is being sought in Resolution 3 (see Section 5 for further details).

Under the terms of the Implementation Agreement, the Acquisition Agreements will be subject to certain conditions which must be satisfied or waived by 8 July 2015 (unless extended by agreement between the parties). These conditions have been satisfied with the exception of the following conditions which remain outstanding at the date of this Notice:

(a) the Company obtaining all necessary shareholder approvals as are required to give effect to the Acquisition;

(b) all of the Vendors entering into an Acquisition Agreement with the Company in respect of their shares in Dimerix;

(c) the Company receiving firm commitments and cleared funds for the full amount of the Tranche 2 Placement; and

(d) no material breach of the warranties given in the Implementation Agreement having occurred.

If completion has not occurred under the Acquisition Agreements by 8 July 2015, then the Implementation Agreement and the Acquisition Agreements will be at an end (unless extended by agreement between the parties).

The Implementation Agreement requires the parties to comply with certain obligations prior to completion including:

(a) an obligation on Dimerix to ensure that (other than as agreed between the parties):

(i) Dimerix conducts its business in the ordinary course and does not incur any material liabilities (other than in the usual conduct of business), encumber or dispose of any assets, issue any securities or declare or pay any dividend;

(ii) Dimerix complies with the terms of specified material contracts;

(iii) Dimerix takes:
(A) all steps necessary to maintain in good standing the intellectual property owned by Dimerix; and

(B) all reasonable steps to prevent any infringement of that intellectual property by any third parties;

(iv) Dimerix uses its reasonable endeavours to preserve its assets and goodwill, including preserving its current business relationships; and

(v) nothing is knowingly done by Dimerix which is likely to have a material adverse impact on Dimerix or its assets; and

(b) an obligation on the Company to ensure that (other than as agreed between the parties):

(i) it conducts its business in the ordinary course and will not incur expenditure materially different from its expected expenditure as at the date of the Implementation Agreement, materially change any intellectual property it currently owns or licenses or any current projects it is undertaking or commence any new projects, nor agree to do any of those things;

(ii) it conducts its business in the ordinary course and does not incur any material liabilities (other than in the usual conduct of business), encumber or dispose of any assets, issue any securities or pay any dividend;

(iii) nothing is done by the Company which is likely to have a material adverse impact on the Company and its assets; and

(iv) it complies with the terms of the specified material contracts; and

(v) it uses its reasonable endeavours to preserve its assets and goodwill, including preserving its current business relationships.

Prior to Completion the Company and Dimerix will consult with each other in relation to any material expenditure or unusual items that may arise. The Company will also keep Dimerix informed about the Company’s expenditure and cash position.

The Implementation Agreement contains standard commercial warranties about Dimerix and its assets and limits of vendor liability that are usual for a transaction of this type. If a breach of any of these warranties come to light prior to completion of the Acquisition, the Company will have the right to terminate the Implementation Agreement.

Under the terms of the Implementation Agreement and the relevant Acquisition Agreements, Vendors holding approximately 74% of the shares in Dimerix will agree that the Shares they will receive as consideration for the sale and purchase of their Dimerix shares will be subject to between 6 and 12 months voluntary escrow from the date of issue.

The Vendors have the right to nominate two directors to the Board of the Company, and current Directors, Mr Evan Cross and Mr Peter Webse, will resign with effect from completion of the Acquisition. Mr Webse will continue as Company Secretary.

Under the Implementation Agreement:
(a) the Company will grant up to 60,000,000 Adviser Options to Forrest Capital at an issue price of 0.0001 cents per Option (see Section 9); and

(b) the Company will grant of up to 30,851,594 Transaction Options to past and present employees and consultants of Dimerix for nil consideration (see Section 10).

3.3 Capital Raising and Use of Funds

The Company intends to undertake a placement of up to 160,000,000 Shares each at an issue price of $0.01 to raise up to $1,600,000 (before costs) (Capital Raising) in two tranches with:

(a) the first tranche of 60,000,000 Shares to be issued under the Company’s existing placement capacity following the execution of Acquisition Agreements by all of the Vendors prior to the date of the Meeting (Tranche 1 Placement); and

(b) the second tranche of 100,000,000 Shares to be issued subject to shareholder approval (Tranche 2 Placement),

to fund the Acquisition and expenditure on the assets owned by Dimerix and the existing business of the Company and to provide on-going working capital. Resolution 5 seeks Shareholder approval for the Tranche 2 Placement (refer to Section 7 for further details).

Forrest Capital has assisted the Company with the Capital Raising.

To read the full document, please click on the link below. 

APN Property Group (ASX: APD) Announce Successful Completion of $30 million Equity Raising

We are pleased to announce the successful completion of APN Property Group Limited’s Retail Entitlement Offer.

Total proceeds amounting to $30 million have now been raised through the successful completion of the Entitlement Offer and Placement to further progress APN’s announced growth initiatives.

To view the ASX announcement and Offer Presentation, please click on the links below. 

Qotient Investor News May 2015

We have some very exciting news to share. Qotient has received commitment from K ONE W ONE Limited for $200k for this round of capital raise. K1W1 is a well-respected market investment group and are known for their involvement in investment opportunities in early-stage New Zealand export focused companies.

QOTIENT
Qotient is a cloud based sales enablement platform that delivers a library of sales conversations including insights, sales questions and marketing collateral in real-time, into the hands of the sales team. Sales teams then use these conversations to assist them in converting sales calls into opportunities.

Qotient gives C-Level executives, marketing and sales real-time clarity on the ROI of the sales conversation process across teams or departments.

MARKET UPDATE
Qotient results in increased sales – Insight Enterprises Pty Ltd Insight, a Qotient client in Australia, recently shared this story with its Executive and wider sales team. A business development manager was able to convert a $104k quote into a $198k sale. “By leveraging Qotient, Damon was able to deliver a real-time conversation covering the benefits, pain point solutions and ask relevant questions. By taking advantage of Qotient and the opportunity immediately, Damon was able to provide valuable information on the spot and create an opportunity that closed within 4 weeks.” Matthew Keir, Marketing Manager Insight.

Toshiba Dealer Channel Sales Enablement
Toshiba Australia is showcasing Qotient as their sales acceleration tool at the Dealer Conference in Laguna Beach California during the first week of June 2015. This will provide exposure of our platform to 60 Toshiba partner businesses.

CAPITAL REQUIRED
As you are aware Qotient are looking to raise NZD $750k – $1m on a pre money valuation of NZD$ 2.75m. We are getting good traction on the capital raise and will be using the money to:

• fuel our user experience and platform build out
• sales and marketing investment
• entry into the US market

LEAD INVESTOR UPDATE
Miles Valentine is the lead investor and the primary initial funder having invested $430K into the first round mid-2014. He has invested a further $200k as bridge funding which will convert to equity when this current round closes.

K ONE W ONE Limited is the first to commit $200k during the current round of capital raise. Based on our activities in New Zealand and Australia, we expect more to come.

CAPITAL RAISE ACTIVITIES
New Zealand
During the course of May, Qotient has presented to the Lead Investors’ Forum for the ICE ANGELS and ARCHANGELS of New Zealand. Good expressions of interest has resulted and we’ve entered discussions with multiple parties.

Australia
Qotient presented to 400 investors from the Wholesale Investor community on 15th of May 2015 and which resulted in numerous expressions of interest. We have started one on one engagements with the interested investors (7 parties) and we are excited about the prospect of securing Australian investment.

REBRAND
We are changing the company name from PitchMetrics to Qotient Group Limited. The rebrand is in preparation of the US market entry and will be launched in Auckland and Sydney during the course of June 2015. The launch events are geared towards investors, prospective clients, existing clients and the media.

CONTACT US
Should you wish to discuss the investment opportunities at Qotient, please contact Justin Wright today.
Justin Wright
CEO
Email Justin.Wright@qotient.com

To download the full document, please click on the link below. 

APN Investment Opportunities – Register Your Interest

APN is currently working towards launching a number of new investment opportunities for new and existing clients, to register your interest in these and other opportunities, please click here.

New investment opportunities currently being progressed include:

Multi-asset, convenience retail based fixed term fund.
This unlisted Fund’s focus will be to provide investors with a sustainable income yield (initial distribution yield in the range of 7.0% to 7.5%) with the potential for capital growth over time. The Fund will own quality real estate, anchored by national retailers on long term leases (indicative initial WALE ~10 years+), approximately 40% gearing and is ideally suited to investors seeking an attractive distribution yield, paid monthly, for the term of the Fund.

Multi-site residential development fund.
In conjunction with a leading Melbourne-based residential builder / developer with a demonstrated track record the Fund will develop six projects delivering quality medium density oversized apartments within defined development corridors to cater to the downsizers market in inner south eastern Melbourne. The fund has a strict risk management criteria (including full cost coverage before construction commencement) and aims to provide sophisticated investors with a target ~20% internal rate of return and ~1.50 times on invested capital over a 3- 5 year time horizon.

 

Sirona Capital Launches its Latest Real Estate Investment Fund

Wednesday, 18 May 2015

Sirona Capital (Sirona) has launched a second round capital raise for one of its real estate investment funds, the Pakenham Street Investment Fund (Fund).

Sirona is seeking to raise $2.365 million to facilitate the development of a 120 key, 4 ½ star apartment hotel in Fremantle (Development) underpinned by a 15+ year lease to Quest, Australia’s leading apartment hotel operator. These funds are additional to the first round capital raise of $9.675 million which enabled the acquisition of the development site and pre-construction works to be undertaken.

The key investment highlights of the Fund include:

  • Attractive investment returns – forecast income distribution of 13.0% p.a. (average and post fees, pre-tax) over an 8 year term, with distributions paid quarterly following completion of the Development
  • Prime CBD location with an established tourism market – strategically located in the historic “West End” heritage precinct of Fremantle, a strategic metropolitan centre with a long established commerce and tourism economy
  • Undersupply of hotel rooms – the local hotel market is experiencing an acute supply shortage and leads the nation of key industry metrics (occupancy and RevPAR)
  • Strong leasing covenant – 15+5+5+5 year lease with 4% fixed annual escalation, underwritten by a Quest corporate guarantee
  • Development risks mitigated – all planning approvals have been obtained, a well experienced builder has been appointed under a fixed price contract and pre-construction works completed
  • Construction finance in place – credit approved senior construction and term debt facilities in place with a leading Australian commercial bank
  • Barriers to entry – significant land, planning and financing barriers for new market entrants limiting supply side competition

The Fund has an expected term of 8.0 years.

Please find attached a copy of Sirona’s Pakenham Street Investment Fund flyer for your consideration.  A full investment information memorandum is available on request.

To download the additional document, please click on the link below. 

Connexion Media Shareholder Update

 26 May 2015, Melbourne, Australia

Flex vehicle management service roll out

  • Flex estimated to reach 70,000 paying monthly subscribers by 2018
  • One US automaker will offer Flex throughout North America via its 4,000+ dealer network
  • Strong pipeline of prospective new automakers and other suppliers expected to expand sales

Connexion Media Limited (ASX:CXZ) is pleased to provide further updates on the company’s distribution and sales strategy for the Flex vehicle management service.

Connexion has prepared Flex volume estimates for CY2015-18. The estimates do not include prospective new business opportunities with other partners and affiliates.

Flex is Connexion’s leading innovative cloud based integrated vehicle management service. Flex is designed to work with both new and aftermarket vehicles through both embedded and dongle solutions. The revenue model is based on a monthly subscription service fee per vehicle.

As previously announced, Connexion has been awarded a contract with a major US-based automaker to supply Flex as an embedded service in new production vehicles used in small business fleet vehicles.

The projected ramp up of the customised Flex service is expected to begin later this year. The US automaker will offer the service throughout North America via its over 4,000 dealer network.

At the request of the US-based automaker, Connexion is unable to disclose the party until the official Flex service launch in late 2015.

Figure 1: Flex Estimated Cumulative Volume Projections

 

 

 

 

 

 

The volume projections depicted in the above table are based on:

  • volume estimates resulting from projected and anticipated take up of the Flex service with partners and affiliate 
  • the number of fleet vehicles sold in the US in 2014 were in excess of 1 million
  • the US-based automaker that Connexion is customising its existing Flex service for has a market share in the range of 10-20%

Accordingly, the volume projections in the above table assume:

  • the number of fleet vehicles sold annually equals or exceeds the number of fleet vehicles sold in the US in 2014
  • the US-based automaker’s current market share does not significantly decrease
  • the projected subscription take up rate set out above is consistently achieved

The US automaker will pay Connexion to customise the existing Flex service to meet its market requirements. The subscription-based service is expected to launch in the last quarter of 2015 with revenue generated from the service to be shared by both parties.

The cumulative volume projections based on existing contracts are estimated at 17,500 subscribers in 2016, rising to 70,000 subscribers in 2018.

Connexion has a pipeline of other prospective large scale buyers in trial or negotiation phases. Currently Flex is undergoing trials across the globe in Australia, USA, Germany, Thailand, China and the UK by a number of well-known high profile auto manufacturers and other prospects.

In the US, two major automakers have expressed interest in and are trialling Flex, while in Europe five major automakers are also trialling Flex. These automakers collectively represent 30+% and 20+% of annual sales in their respective markets(1).

Connexion is also receiving strong interest from automotive and consumer aftermarket brands, as well as automaker suppliers.

In addition, Connexion has already signed up a small number of paying customers in Australia, with revenues from these customers expected to be received in the June quarter of 2015.

Flex is achieving cut through success because the offering closely matches the specified needs of automakers, it can be quickly adapted to particular needs, it is co-optimised and can be branded by the automaker, the cost of Australian software engineers is competitive in the Western world and this can all be achieved with a competitive unit price for the consumer.

Further, Connexion has been cultivating the world’s major automakers for many years with the very competitive miRoamer radio and music service. It is using these existing channels with the vehicle giants to promote and sell the Flex product.

The overall fleet markets are vast. In America alone, the total number of industry cars and trucks managed by fleets is 11,876,033 as of January 2014, which is 130,000 vehicles higher than it was in January 2013(2).

It is estimated that the number of active fleet management systems is growing at between 14-22% annually(3). In Europe, China and the Americas expectations are that there will be in excess of 25 million fleet management systems installed by 2019(4). Worldwide, the total market value of fleet management systems is expected to grow over the next five years at an average of 24% per annum from US$12 billion in 2014 to almost US$35.5 billion by 2019(5).

Connexion has estimated that it will reach 70,000 monthly paying subscribers by 2018. This represents less than 1% of the world market for fleet management systems global estimates. Connexion expects to grow its market share considering the numerous automakers and aftermarket suppliers currently trialing the Flex service in USA, Europe, and Asia.

Flex is a new high tech remote vehicle management system, available as either a dongle and/or embedded solution. The service provides the ability to manage an entire fleet of vehicles from a central control point using cellular mobile connectivity. Flex collects data on key performance indicators that is then assessed using customised reporting.

Flex is able to track a range of real time and historical data including vehicle locations, distance travelled, fuel consumption, battery life, engine performance and absolute and average speeds travelled. It is also able to monitor driver behaviour and instantly notify vehicle owners and fleet managers by sending notifications and alarms.

For fleet managers, this technology is vital as it provides analytical data in how the vehicle is being used, that was previously unattainable.

For more information on Flex visit: www.flexvs.com

References:

(1)   Source: IHS 2015 production estimates

(2)   Source: USA Department of Transportation (DoT), Bureau of Transportation and Statistics, February 2015

(3)   Source: Fleet Management System Market in Europe 2014-2018 (October, 2014: Infiniti Research Limited). Fleet Management in Europe, Fleet Management in the Americas, Fleet Management in China (Berginsight.com – M2M Research Series 2014), Fleet Management Market to See Healthy Growth in North & Latin America (30 September 2014, www.gpsbusinessnews.com/Fleet-Management-Market-to-See-Healthy-Growth-in-North-Latin-America)

(4)   Source: ibid

(5)   Source: Fleet Management Market – Global Forecast to 2019 (November, 2014) www.researchandmarkets.com (at businesswire.com November 7, 2014)Source: IBIS World, OD4546 Fleet Telematics Systems Industry Report, March 2015

IMPORTANT NOTE:

It should be noted that if any of the assumptions underlying the information in Table 1 are incorrect or do not materalise, the volume estimates depicted in Table 1 may not be achieved. It should also be noted that, at this stage, Connexion has been contracted to customise its existing Flex service at the US-based automaker’s cost only. Theservice offering is therefore yet to launch and accordingly, Connexion does not have any contracts in place as part of these arrangements that guarantee any ongoing or significant sales or revenue in respect of the Flex based service offering. The above projections are not guarantees of future sales or revenue and involve a number of uncertainties and assumptions that are beyond the control of Connexion. Connexion gives no assurances that the volume estimates above will actually occur and the market is cautioned not to place undue reliance on these volume estimates.

About Connexion Media

Connexion Media Ltd (ASX:CXZ) is a technology company specialising in developing and commercialising software apps and services for the web connected car, mobile device and connected consumer electronics markets. It is based in Melbourne Australia, with a sales office in Cambridge UK.

Xyec Holdings Unaudited Full Year Financial Statement

Xyec Holdings Co., Ltd. (the “Company”) was listed on Catalist of the Singapore Exchange Securities Trading Limited (the “SGX-ST”) on 18 September 2013. The initial public offering of the Company (the “IPO”) was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the
“Sponsor” or “PPCF”).

This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor for compliance with the SGX-ST Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship, at 16 Collyer Quay, #10-00 Income at Raffles, Singapore.

Background

The Company was incorporated as a stock corporation (kabushiki kaisha) with the name “UFD Holdings Co., Ltd.” in Japan on 9 September 2005. Shortly after the incorporation, on 26 December 2006, the Company completed an absorption-type merger with former Xyec Holdings and Kowa Sekkei, in which the Company was the surviving entity. The Company’s name was then changed from UFD Holdings Co., Ltd. to its current name “Xyec Holdings Co., Ltd.”.

The Company registration number is 0104-01-058968 and the registered office address is 9F Keikyu Daij yu Bldg, 3-26-33 Takanawa, Minato-ku in Tokyo, Japan.

The Company, together with its subsidiaries (the “Group”), aims to be a leading integrated engineering and IT services provider for major manufacturing industries, such as the automobile, machinery, telecommunications and electronics industries.

To download the full document, please click on the link below. 

YuuZoo’s Revenue Has Increased 58%

Singapore, 15 May 2015

Singapore-listed YuuZoo Corporation Limited (“YuuZoo”) (SGX: AFC) is pleased to commence the financial year with 58% growth in revenue and a positive EBITDA of 5.1 million versus a negative EBITDA of 0.3 million in the corresponding quarter of 2014.

YuuZoo’s unique business model incorporates a payment model developed by a Big Four audit firm whereby the franchisee pay YuuZoo for the franchise license by issuing to YuuZoo, shares in the company owning and operating the license. This enables YuuZoo to achieve two key objectives; to over time get a significantly higher share of the recurring revenues from the advertising, e-commerce, gaming and payments revenue generated by the franchisee, and to correctly determine the value of the asset over time as the business of the franchisee develops. The assets will periodically be assessed to determine whether there has been any change in the value of the shares. Any such increase or decrease will be reflected by adjustment to the book value of the asset when the assessment is made. The next assessment is planned for at the end of 2015.

The Company earlier, in its full year 2014 results announcement, stated that it will recognize as revenue the full value of the assets (in the form of shares) it has received as payment for the licenses when franchisees commence operations. The Company has however decide to take a more conservative approach, and will recognize only 50% of the already heavily discounted valuation done by Big Four audit firm, with the balance 50% recognised when the franchisee has achieved its second-quarter targets.

Operational Highlights

YuuZoo commenced trading on the main board of the Singapore Stock Exchange in September 2014.

During Q1/2015, YuuZoo also announced the acquisition of IAHGames, a leading distributor of online and box games in South East Asia the acquisition, which is to be paid for 100% by issuing YuuZoo shares to the vendors, is subject to SGX approval.
During eight years of operations, IAH has built a registered user base in SEA of over 35 million users. The company holds regional rights to distributing and or publishing leading game titles such as Grand Theft Auto, Counterstrike Online and Granado Espada.

IAH’s publishing and marketing partners include in Vietnam the government-owned VTC Online, subsidiary of TV monopoly Vietnam Multimedia Corporation (VTC), with a reach to a large portion of Vietnam’s 90 million inhabitants, and in Thailand, with 66 million inhabitants, True Digital, a subsidiary of True Corporation, a communications conglomerate controlling Thailand’s largest cable TV provider TrueVisions, Thailand’s largest ISP True Internet, and its third largest mobile operator True Move.

The Company in Q1/2015 also significantly strengthened its management team by hiring experienced experts in key areas, including the hiring of Rio Inaba, former CEO of Indonesia for Rakuten, the world’s third largest e-commerce company and former Global President & Director of New Market Development, to manage YuuZoo’s e-commerce expansion.

Outlook for FY2015

YuuZoo is, through its unique partnership and franchise model, positioned strongly in the social e-commerce space. The company at the end of April announced the launch of a weekly 45-minute football show and 5-minute advertorial on TV in China at the Great Sport Media network channel of Shanghai Media Group, a TV channel with a reach in excess of 300 million TV viewers. It also announced a joint venture with Africa’s largest TV network NTA. The Company in the second quarter is expecting to start the local marketing of its virtual shopping mall with a growing number of partners and franchisees it earlier has signed agreements with. It also expects to sign new agreements with other partners and franchisees in several markets where it is in discussions.

Please click here to view the full announcement. 

Xyec’s FY2015 earnings jump five-fold to JPY191.4 million

  • Revenue up 12.2% to JPY 8,480.4 million
  • All three business segments – Engineering Services, IT Services and IT Solutions – delivered good performances in FY2015
  • Maintained a healthy cash position of JPY 2,371.4 million as at the end of FY2015

Xyec Holdings Co., Ltd. (“Xyec” or the “Company”, and together with its subsidiaries, the “Group”), an established integrated engineering and IT services provider for major manufacturing industries in Japan, today reported a 429.5% surge in net profit attributable to equity holders of the parent to JPY 191.4 million (S$2.3 million) for the 12 months ended 31 March 2015 (“FY2015”) compared to JPY 36.2 million (S$0.5 million) of the preceding financial year (“FY2014”).

This was achieved on the back of 12.2% increase in the Group’s revenue to JPY 8,480.4 million (S$99.8 million) from JPY 7,558.6 million (S$95.0 million) in FY2014, underpinned by stronger revenue contribution from the Engineering Services segment.

Accounting for 49.7% of the Group’s total revenue in FY2015, the Engineering Services business segment achieved a 22.4% increase in revenue to JPY 4,216.7 million (S$49.6 million) in FY2015 from JPY 3,444.4 million (S$43.3 million) in FY2014. This was mainly due to the recovery in the automobile industry which led to higher demand for engineering services, as well as a full year’s contribution from the Company’s 95% owned subsidiary, Techno Like Us Co., Ltd., compared to only five months of revenue contribution in FY2014. Techno Like Us Co., Ltd. was acquired by the Company in November 2013.

Revenue recorded in FY2015 by the Group’s two other business segments, IT Services and IT Solutions, rose 3.0% and 5.8% to JPY 3,252.6 million (S$38.3 million) and JPY 1,011.1 million (S$11.9 million) respectively. The increase in revenue from the IT Solutions business segment was mainly attributable to higher contribution from the Company’s wholly-owned subsidiary, NT Solutions Co., Ltd.

The Group’s gross profit in FY2015 increased 11.4% to JPY 1,786.2 million (S$21.0 million), while the gross profit margin remained relatively constant at 21.1%.

As a result, the Group’s earnings per share increased to JPY 1.78 (2 Singapore cents) in FY2015 from JPY 0.37 (0.5 Singapore cents) in FY2014. The Group’s net asset value per share remained relatively constant at JPY 19.11 (S$0.22) as at 31 March 2015 compared to JPY 18.06 (S$0.23) as at 31 March 2014.
The Group ended FY2015 with a robust balance sheet – with cash and cash equivalents amounting to JPY 2,412.5 million (S$28.4 million) as at 31 March 2015.

Dividend

The Group has proposed a first and final dividend of JPY 0.4 (0.5 Singapore cents) per ordinary share for FY2015, which translates to a dividend payout ratio of 22.5%. Separately, the Group declared a special dividend of JPY 0.5 (0.6 Singapore cents) per ordinary share on 11 September 2014, which was paid to shareholders on 28 November 2014.
Note: Financial numbers in S$ are calculated based on the average exchange rates of JPY 84.98 and JPY 79.57
to S$1:00 for FY2015 and FY2014 respectively.

Outlook and Future Plans

Economic recovery is underway for the Japan economy following a string of economic policies introduced by the government to stimulate the economy. According to FocusEconomics, a weak yen, low oil prices and an improving labour market are expected to drive Japan’s economic growth this year .

In addition, the depreciating yen has a positive impact on the all-important export sector. With most of the Group’s clients being domestic manufacturers, Xyec expects this trend to lead to higher demand for all its business segments.

During FY2015, the Company’s controlling shareholder Mamezou Holdings Co., Ltd. (“Mamezou”), successfully completed a partial offer to acquire 31,825,000 ordinary shares in Xyec. Pursuant to the completion of the partial offer, Mamezou’s aggregate shareholdings in Xyec had increased from approximately 29.89% to 59.92%.

Commenting on the partial offer, Mr Manabu Kobayashi, Executive Chairman, President and Chief Executive Officer of Xyec said: “Mamezou is principally engaged in the provision of IT solutions, which will provide a strong business synergy and help boost our IT Solutions business segment. The Group will also be able to tap on Mamezou’s resources and operating system to further enhance our suite of complementary services. From a geographical strategy standpoint, we will be able to tap on Mamezou’s regional presence within China and Indonesia to develop and conduct more businesses in Asia.”

“Since the completion of the partial offer in March, Mamezou has no intentions to introduce any major changes to the Group’s businesses and we continue our business as usual. We are pleased to end FY2015 on a strong note and will continue to grow our customer base as well as seek to further expand into the ASEAN region,” added Mr Kobayashi.

About Xyec Holdings Co., Ltd.

Incorporated in 2005, Xyec Holdings Co., Ltd. (“Xyec”) is one of the key players in providing integrated engineering and IT consultancy and services, to major manufacturing industries in Japan, such as automobile, aerospace, machinery, telecommunications and electronics. Xyec has a diversified and well-established customer base comprising several multinational companies, including affiliate companies of the Denso group, the Fujitsu group, the Hitachi group and the Toyota group.

To read the full document, please click on the link below. 

R&D Collaboration between Monash University and Z-Filter

19 May 2015

Monash University is located in the greater Melbourne area in the State of Victoria and is one of Australia’s top Research Universities. Monash University is also in the top 1% of Research Universities in the world and is home to the leading Material Science and Engineering Research Programme in Australia.

Z-Filter has approached us to review and characterize their Z-Splitter technology. Based on our limited testing to date we find that the Z-Splitter ability to separate and clean coal in a liquid form to provide a “liquid coal fuel” can provide unique solutions to the problems that have been holding back the development of brown coal as a clean fuel.

Attached are the results from first characterization tests on three different processed coal types provided by Z-Filter Pty Ltd. The tests conducted and the results obtained are described in the attachment. These early test results show that the provided samples are approaching the Z-Filter Pty Ltd goal of particle size <50µm and Monash University is prepared to engage with Z-Filter Pty Ltd to further characterize and develop this promising technology for wide ranging liquid coal and stable clean fuel applications.

This is a very exciting program with global implications, with the potential for the generation of prosperity and great benefits to the environment.

Sincerely

Professor Frieder Seible
Vice President (Academic), Dean, Faculty of Engineering and Dean, Faculty of Information Technology

Attachment: Initial Test Results on Z-Filter Coal Samples

Z-Filter Pty Ltd approached Monash University to examine the particle size distribution of three slurry samples prepared from different coals using their proprietary technology. Monash University tested the three samples using a Commercial Diffraction Particle Sizer.

For every sample, at least two repeats were carried out, while within each repeat runs, three sets of measurements were taken to establish variability of the size distribution, if any. These are:

Sample 1: Coal type unknown, tested at Monash University on May 1, 2015
Sample 2: Victorian brown coal slurry generated by Z-Filter on 19 March, tested at Monash University on May 19, 2015
Sample 3: Victorian Yallourn brown coal slurry generated by Z-Filter on 19 March, tested at Monash University on May 19, 2015.

The measured size distributions are presented in the following page, but the salient points to note are:
Sample 1:
90% of the particles in the measurement volume were below 52.7 µm size
50% of the particles in the measurement volume were below 19.6 µm size
10% of the particles in the measurement volume were below 4.1 µm size
This sample did not show any sign of agglomeration during the measurement

Sample 2:
90% of the particles in the measurement volume were below 51.9 µm size
50% of the particles in the measurement volume were below 19.7 µm size
10% of the particles in the measurement volume were below 4.3 µm size
This sample did not show any sign of agglomeration during the measurement

Sample 3:
90% of the particles in the measurement volume were below 40.2 µm size
50% of the particles in the measurement volume were below 12.6 µm size
10% of the particles in the measurement volume were below 2.7 µm size
This sample showed some sign of agglomeration towards the end of the measurement. Only 5.4% of the particles in the measured volume are above 50 µm size
The results show a clear trend of significant improvement towards the target value, which according to Z-Filter Pty Ltd is 100% below 50 µm size. To meet this target, our preliminary recommendation is for a well-designed test program in the near-term that will include at least the following:
• Optimise the slurry production technology through multi-pass separation of the >50 µm size
particles
• Prove the technology for a range of brown coal and black coals from Australia and around the
world
• Stabilization of the slurry (without permanent agglomeration)
• Identify the nature of the coarse particles (>50 µm) through electron microscopy
• Increase the solid loading in the slurry without affecting the target particle size

To download the full document, please click on the link below. 

3 Trends Shaping Retail by Booodl

This is the first of our bi-weekly business updates where we’ll be sharing interesting industry news, our ‘Inside Booodl’ videos and a snapshot of our numbers. As always, if there is anything else you’d like included or you have some feedback, just let me know.

I presented at the Wholesale Investor conference on May 15th, where I touched on three of the big retail trends right now. I’ll share the full video with you soon, but in the meantime here’s a snapshot of what they are and how they’re underpinning our strategy at Booodl:

George Freney
Booodl Founder & CEO

Patent accepted for Diagnostic Test for Diabetic Kidney Disease

ASX/Media Release, 21 May 2015

  • Ability to accurately detect early onset of Diabetic Kidney Disease via a simple blood test has potential to save health care systems globally $100s of millions annually.
  • Treating end stage kidney disease with dialysis will cost $12billion every year in Australia by 2020.

Life science company Proteomics International Laboratories Ltd (ASX: PIQ) is pleased to announce its Australian patent for its Diagnostic Test for the diagnosis of Diabetic Kidney Disease has been accepted.

The Company has received a Notice of Acceptance from IP Australia for its Australian Patent Application 2011305050 entitled, “Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions”. The patent is due to grant in August and will be valid until September 2031.

This is an important milestone in the development and commercialisation of PIQ’s Diagnostic Test for the early diagnosis of kidney disease. Current detection methods are not robust and lack sensitivity, and doctors, patients and healthcare providers could benefit from having better tests
that can deliver more effective diagnosis, prognosis and help monitor treatment.

PIQ’s patented test was developed from the Company’s world-leading proprietary proteomics-based technology platform. It uses protein biomarkers found in the blood to provide an accurate detection of the presence of disease. The patent also provides a means to develop new drugs for treating diabetic kidney disease.

The Company is seeking to secure patent protection for its Diabetic Kidney Disease Diagnostic Test in all major global markets including the USA, Europe, China and India.

Market Opportunity
The potential medical benefits and cost savings from PIQ’s diagnostic test are huge; in the USA nearly 10% of the population have diabetes, and 35% of adults with diabetes develop chronic kidney disease and 20% end up with kidney failure.

The ability to accurately detect the early onset of Diabetic Kidney Disease via a simple blood test and then prescribe appropriate medicine to prevent the condition progressing to dialysis or kidney transplant has the potential to save health care systems globally $100s of millions annually.

In Australia, diabetes in the fastest growing chronic disease with a total of 1.1 million with either Type 1 or Type 2 diabetes, and around 100,000 new cases reported each year. The total cost to the health system and in productivity loss is estimated at $10.3 billion annually. A large proportion of these cases (up to 60%) may be prevented by early diagnoses.

About PIQ’s Diagnostics business unit
Diagnostics are a key component of the Company’s operations. It focuses on utilising its proprietary proteomics-based technology platform to discover new diagnostic tests based on the differences in the protein make-up of people with and without a particular disease. By comparing blood or other samples taken from both sick and healthy people, PILL is able to produce a set of biomarkers (biological signatures) that can be used to test for a particular condition, and to provide personalised medicines – rather than a one-size-fits-all approach to treatment. Biomarkers represent a massive global market which is estimated to double in size to $40.8 billion by 2018.

About Proteomics International Laboratories (PILL)
PILL is an ASX listed (ASX: PIQ) life science company focused on the area of proteomics – the industrial scale study of the structure and function of proteins. Proteomics is an integral part of the biotechnology and life sciences industries and plays a key role in understanding disease and
biological systems. It represents a massive global market estimated to be worth $20.8 billion by 2018.

PILL is an established, revenue generating business and is recognised as a global leader in its field. It received the world’s first ISO 17025 laboratory accreditation for proteomics services, and operates from state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth, Western Australia. The Company’s business model uses its proprietary technology platform which operates across three synergistic proteomics-based business units in massive growth markets:

1. Analytical services: Specialist contract research, analytical testing and consultancy – fee for service model.
2. Diagnostics: Biomarkers of diseases and personalised medicine – focus on diabetic kidney disease and Alzheimer’s disease. The biomarkers market is estimated to double in size to $40.8 billion by 2018.
3. Drug discovery: Therapeutic drug discovery with a focus on painkillers and antibiotics. The peptide therapeutics market is currently estimated to be worth $17 billion.

About the study of proteomics
Proteomics is the large-scale study of the structure and function of proteins. The protein make-up in our bodies differs from cell to cell and changes considerably over time. For example, a cancerous cell will have significantly different proteins to a healthy cell. Understanding proteomics can speed up diagnosis and the identification of drugs that can be used to treat diseases. As recently as 12-15 years ago, identifying a single protein (a process called sequencing) took around 24 hours, and required comparatively large amounts of highly purified sample. Today, PILL can identify a protein in 10 seconds and complex mixtures can be quickly and accurately analysed. This drives the Company’s business model across its three areas of operation.

To read the latest announcements, please download the documents below.  

Investors & Wealth Advisers Have Access To Bonds And ETFs On iFAST Singapore

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Z-Filter Announces FMG EVA Technology Evaluation Plan

May 20th 2015, Singapore

Z-Filter are proud to announce the FMG EVA TECHNOLOGY EVALUATION PLAN which will bring to commercial production a series of new
technologies in iron ore wet plant upgrade performance.

These technologies include the Z-Splitter which is designed to split materials according to size; keeping the coarse materials and rejecting the fines below a fixed particle size down to 20 microns. In this way the Z-Splitter can reject the dirt/dust/ultra-fines and keep the coarse high grade ore, as well as the combined technologies of our Z-Filter filtration systems to wash, clean and responsibly recycle the wash water. Finally to dry, the now cleaned ore, using the Z-Dryer; to provide a clean dry ore for transport.

Mr Neil Graham, Director, Z-Filter Pty Ltd said “Z-Filter invented the Z-Splitter technology (code named EVA) and we have been actively working on its development for commercialisation since 2011. With the active involvement of Fortescue Metals Group Limited, Australia’s third largest iron ore producer for the last year, we believe the new technology now holds the promise of delivering a step change in iron ore wet plant operations.”

“Our task now is to scale up these breakthroughs in technology from pilot scale to the full production capacity required for FMG’s operations. “

Z-Filter Pty. Ltd. is a private limited, company situated in Canning Vale in Western Australia, developing the Z-Filter, filtration technologies and operating contracting services, to clean and separate waste streams from: iron ore, to coal, septic tanks, to tailings dams, and canals.

For information on the Z-Filter development program or contracting, please contact Managing Director, Rodney Baxter on rod.baxter@z-filter.com

To read the full document, please click on the link below.

iFast Changes in Interest of Substantial Shareholders

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcement has been uploaded onto iFAST Corporation Investor Relations website:

Sun Biomedical Limited to Acquire Dimerix Bioscience

ASX Company Announcement, 13th May 2015

Highlights

  • Dimerix is a platform drug discovery and clinical stage biotechnology company;
  • Dimerix is currently recruiting in to Phase 2 clinical study;
  • Dimerix’s lead therapeutic product, DMX200, is targeted at patients with Chronic Kidney Disease (CKD);
  • CKD is a large problem with over 26 million people affected in US alone. CKD market in US exceeds $11B in sales per annum and continues to grow;
  • Dimerix initial strategy is to pursue an orphan indication, Nephrotic Syndrome, and subsequently partner the development of programs in larger disease indications;
  • Dimerix is engaged in research collaborations with top pharmaceutical companies using its proprietary GPCR (G protein coupled receptors) drug discovery platform;
  • Management team and advisory board are in place and ready to take the lead project forward. Near term value inflection point – data from Phase 2 study Part A in patients with proteinuria; and
  • Capital raising of $1.6M via the placement to sophisticated clients of Forrest Capital to accompany the acquisition resulting in available working capital of approximately $3.5M.

13 May 2015 - The Board of Sun Biomedical Ltd, an Australian biotechnology company, is pleased to announce that the Company has signed an implementation agreement to acquire 100% of Dimerix Bioscience Ltd (Dimerix), a public unlisted clinical stage drug discovery and development company, based in Melbourne. Dimerix’s lead clinical program is a Phase 2 study in patients with Chronic Kidney Disease, using its novel combination therapy, DMX200. The acquisition will transform Sun Biomedical into an advanced clinical stage company with an asset that has the potential to make a considerable impact in the treatment of Chronic Kidney Disease. Upon successful results from the Phase 2 study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication, such as Nephrotic Syndrome.

Dimerix’s team has applied its patented GPCR drug discovery technology for its own internal research identifying and developing therapeutic treatments. Dimerix leverages its knowledge of drug target interaction and develops new combination therapies using already marketed compounds for new medical indications. This positions Dimerix’s therapies with a fast route to market due to extensive safety data for the selected compounds removing the requirement for Phase I studies and allowing to proceed directly to Phase Il efficacy studies.

Overview of the Transaction Subject to executing acquisition agreements with all Dimerix shareholders and Sun Biomedical shareholders approving the transaction, Sun Biomedical will:

  • Acquire 100% of the issued shares of Dimerix Bioscience Limited (Dimerix) (Acquisition); and
  • In connection with the Acquisition, undertake a placement of up to 160,000,000 fully paid ordinary shares in the Company (Shares) to sophisticated and professional investor clients of Forrest Capital each at an issue price of $0.01 to raise up to $1.6 million (before costs) (Capital Raising). 60 million shares of the placement will be issued following execution of acquisition agreements by all Dimerix shareholders using the Company’s share issue capacity under ASX Listing Rule 7.1 and 7.1 A, with the balance of 100 million shares subject to shareholder approval at a meeting of shareholders in June 2015;
  • Issue 60 million Advisor Options to Forrest Capital (or its nominees) exercisable at A$0.010 per option on or before 30 June 2017
  • The Company will enter into an acquisition agreement with each of the Dimerix shareholders (Vendors) (to acquire 100% ownership of Dimerix for total consideration of:
    • 750,000,041 Shares;
    • 30,851,592 management options exercisable at A$0.020on or before 30 June 2017;
    • 75,000,040 Class A Performance Shares convertible into 75,000,040 Shares upon receipt by the Company or Dimerix of a notice of allowance from the United States Patent and Trademark Office in relation to the US patent application number 13/979,127 (or any divisional or continuation thereof) within 24 months of completion of the transaction;
    • 75,000,040 Class B Performance Shares convertible into 75,000,040 Shares upon the Company’s board of directors making an investment decision to proceed to file an application to the US Food and Drug Administration for a pre-Investigational New Drug (“pre-IND”) meeting to progress development of DMX200 following the receipt of data generated under the current clinical trial for chronic kidney disease supporting further progression of the technology within 48 months of completion of the transaction; and
    • 75,000,040 Class C Performance Shares convertible into 75,000,040 Shares upon receipt of ethics approval allowing commencement of a second clinical trial derived from the Dimerix platform and in relation to an indication that is not covered under the existing Austin Human Research Ethics Committee approval within 48 months of completion of the transaction),
  • Completion of the transaction will be subject to certain conditions which must be satisfied or waived within 2 months of the date of the implementation agreement, including: o Sun Biomedical obtaining all necessary shareholder approvals; o all of the Dimerix shareholders entering into acquisition agreements with Sun Biomedical in respect of their shares in Dimerix; o Sun Biomedical receiving firm commitments and cleared funds for the full amount of the Capital Raising; and o no material breach of the warranties given in the implementation agreement having occurred.
  • Voluntary escrow provisions will apply in the case of Vendor Shares to be issued to directors and promoters of Dimerix and their related parties as well as some seed shareholders of Dimerix. These details and other particulars of the transaction will be outlined in a notice of meeting which will be mailed to all Company shareholders as soon as available.

To view the full announcement and other recent ASX updates, please download the documents below.

Altech Chemicals Appoints Simulus as EPCM Partner for Meckering

ASX Announcement, 14th May 2015

Highlights:

• Appointment of local company Simulus Engineering as EPCM partner for Meckering
• Simulus was instrumental in testwork and development of flowsheet
• Simulus is the key engineering contractor on the BFS

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce that it has now appointed Simulus Engineering Pty Ltd (Simulus) as its Engineering, Procurement, Construction and Management (EPCM) partner for its proposed kaolin beneficiation plant at Meckering, Western Australia.

Simulus has been the key engineering partner during the bankable feasibility study (BFS) phase of the project. The Meckering beneficiation plant will enable the initial simple wet processing of kaolin to remove oversize silica, followed by drying to reduce moisture content. The resultant upgraded kaolin will be packed into 1-2 tonne “bulka bags” for containerised shipment to Johor Baharu, Malaysia, via the port of Fremantle, Western Australia. The Meckering plant has been designed to produce approximately 18,565 tonnes of beneficiated kaolin per annum at full capacity

Simulus is a multidisciplinary engineering company that has conducted project assessments in over 25 countries around the world for over 75 companies. Simulus has laboratory test work facilities as well as process simulation capabilities which were major aspects of Altech’s BFS. Simulus has previously conducted the Company’s laboratory pilot plant test work and Integrated Plant Study (IPS) in 2013-2014. In addition, Simulus has been responsible for the BFS’s engineering concept development, including the process flowsheet for both Meckering and Malaysia’s proposed operations.

The appointment of Simulus follows the Company’s 10 March 2015 announcement of M+W Group as the EPCM partner for the HPA plant in Malaysia, and the appointment of Castle Equipment Pty Ltd as mining contractor and processing plant operator for the Meckering beneficiation plant on 15 April 2015.

About Altech Chemicals (ASX: ATC) 

Altech Chemicals Limited (Altech/the Company) is aiming to become one of the world’s leading suppliers of 99.99% (4N) high purity alumina (HPA) (Al2O3). HPA is a high-value product because it is the major source material for scratch-resistant artificial sapphire glass. Sapphire glass is used to produce a range of high-performance electronic applications such as LEDs, semi-conductors, phosphor display screens, as well as new emerging products such as smartphones and tablet devices. The global HPA market is approximately 19,040tpa (2014) and is expected to at least double over the coming decade.
Current HPA producers use an expensive and highly processed feedstock material such as aluminium metal to produce HPA. Altech produces 4N HPA directly from an ore feedstock, aluminous clay, from its Meckering deposit in Western Australia. The Company is now advancing a Bankable Feasibility Study (BFS) to develop a full-scale 4,000tpa HPA production facility. The Altech process employs conventional and proven “off-the-shelf” plant and technology to extract HPA from its low-cost and low-impurity aluminous clay feedstock, which results in lower operating costs.

Altech is a chemical processing group focused on creating a high-margin product to meet the growing global demand for the next generation of high-performance technologies.

To download the full document, please click on the link below. 

Folkestone Awarded a Recommended By Atchinson Consultants

Media Release, 14 May 2015

Folkestone Maxim is pleased to announce that the Folkestone Maxim A-REIT Securities Fund has been awarded a Recommended Rating from Atchison Consultants.

According to Atchison Consultants “the Fund has comfortably outperformed the selected peer group over all measured periods to 31 March 2015, with the exception being over the three month period.”

“The management team are highly experienced and in our view have the correct focus when prioritising management investment behaviours as a fundamental driver of their investment decisions. Management have demonstrated a high degree of on the ground knowledge and insight into location specific property market issues and we have confidence in their ability to effectively manage the Fund in the future” said Atchison Consultants.

Mr Winston Sammut, Managing Director of Folkestone Maxim Asset Management said “we are pleased with the positive rating from Atchison Consultants. It confirms our view that a high conviction active manager of A-REIT securities can add value.”

“A-REITs have performed strongly in recent years driven by falling bond yields and investor’s strong appetite for yield. As a value-oriented investor we believe given concerns about the future direction of bond yields it will certainly be a stock picker’s market. As Atchison Consultants noted in their report, we have a strong qualitative approach to investing with a distinct focus on management capability and behaviours. As a result, our portfolio will favour listed real estate securities with good management, high quality assets, sustainable earnings and distribution growth and appropriate capital structures.”

The Folkestone Maxim A-REIT Securities Fund is a high conviction fund providing access to a diversified portfolio of quality ASX listed real estate securities which own office, retail and industrial, residential and real estate related social infrastructure assets. The Fund’s investment style follows an active management style coupled with a disciplined approach focusing on a top down/bottom-up process. Securities are selected on a concentrated portfolio basis built on individual merit and not benchmark weights.
Atchison Consultants Recommended Rating: The Manager’s product has consistently outperformed the median manager across our assessment criteria. We expect the manager to perform ahead of a reasonably appropriate risk and return objective for the product over a full investment cycle. Atchison Consultants recommend that investors read the detailed information in the PDS. Investors should read the Analyst Interest and Certification, Warning (General Advice Only) and Disclosure (Commissioned Research) at the end of the Report. Investors should contact Folkestone for a copy of the Report.

As at 31 March 2015, the Fund’s investments comprised 18 ASX listed securities totalling 96.7% of the portfolio. Of these, 14 securities were constituents of the S&P/ASX 300 A-REIT Index with the remaining 4 being Ex Index securities. The remaining 3.3% of the portfolio was held in Cash/Liquid investments.

About Folkestone 

Folkestone (ASX:FLK) is an ASX listed real estate funds manager and developer providing real estate wealth solutions. Folkestone’s funds management platform, with more than $870 million under management, offers listed unlisted real estate funds to private clients and select institutional investors, while its on balance sheet activities focus on value add and opportunistic (development) real estate investments.

About Folkestone Maxim

Folkestone Maxim Asset Management is a wholly owned subsidiary of Folkestone and specialises in the management of A-REIT securities.

About Atchison Consultants

Atchison Consultants was established in 2001 by Ken Atchison and consists of a team of investment professionals based in Melbourne with extensive experience in all aspects of financial markets. The principal focus of the business is the provision of advice, research and analysis across all components of managing investment portfolios by financial institutions, superannuation and insurance funds and investment managers.

To download the document, please click on the link below. 

BioDiem Shareholder Update May 2015

BioDiem Ltd, Melbourne, 14 May 2015

Dear Shareholders,

We are full speed into 2015 with a lot of good news to report to you.

LAIV Royalties

BioDiem is about to receive its first royalties from the Serum Institute of India, from the Indian sales of their product Nasovac-S™, the seasonal influenza vaccine based on our LAIV technology. The payment for the first quarter of 2015 will be approximately AU$40,000 and a similar amount is anticipated for the next quarter. Growth in sales is expected once the Nasovac-S product is approved for export following WHO pre-qualification approval. This is expected to occur within a few months.

Introducing Opal Biosciences Limited

We would like to introduce you to the newly established, Opal Biosciences Limited (“Opal”) – a wholly-owned subsidiary of BioDiem. It is envisaged that Opal will hold the BDM-I technology to allow external investment and faster development of the program. As recently as this week, another call for new antibiotics was made by the G7 group. The rise of “superbugs” plus increasing resistance to existing antibiotics are both driving the growth in the novel anti-infectives market.

Opal will remain under BioDiem’s control leading up to the conclusion of a set of development studies to produce two products: Opal-I and Opal-T, injectable and topical products, respectively. BioDiem shareholders will retain a stake in the technology through the shareholding held by BioDiem.

Over the next weeks you will receive a notice of a Shareholders’ Meeting to approve this. The rationale and the potential advantages to shareholders will be outlined in the Explanatory Memorandum in the papers to be sent to you. Our plan is to position the technology for a  commercial exit at an enhanced valuation.

Opal Biosciences (“OPAL”) To Develop BDM-I Technology

External investment for Opal will be sought through an Information Memorandum. I will present Opal Biosciences in Sydney on May 15th at the Wholesale Investor Sydney Expo, and also in Hong Kong at the AusBiotech Asia Invest series on May 20-21. BioDiem shareholders who are “sophisticated investors” will be eligible to participate in the fund raising, and all BioDiem shareholders will retain an interest in the BDM-I technology through the BioDiem shareholding in Opal.

New US Patent for BDM-I

Additional claims for BDM-I have been granted in the US to cover infections of the gastrointestinal tract. This adds to the existing coverage in the US for protozoal infections, skin and soft tissue infections and female genital infections; and to the global patents already in place.

Vale Don Brooks

On a much sadder note, we were very upset to hear of the passing of our director, Mr. Don Brooks. Don was dedicated to the success of BioDiem and was instrumental in all BDM’s major negotiations with Merck, Nobilon, the World Health Organisation and our LAIV sublicencees.

Don Brooks became a director of BioDiem in December 2001 when BioDiem Ltd was formed. With a strong legal and big pharma (US) background, Don was a great asset to a small start-up company. Being US-based he was well placed for the company’s significant transactions with Merck, and other licencees, but being in the US meant he had to take our board calls at 6 or 7am. Don was very generous with his time and always highly enthusiastic about BioDiem’s prospects. We were very privileged to know Don. Our deepest condolences go to his wife, Suzanne and their family.

Once again I invite you to join our email list to stay in contact with us, and please do call the office if you have any questions about your shareholding or trading.

Thank you for your ongoing support.

Julie Phillips,
Chief Executive Officer
BioDiem Ltd

About BioDiem Ltd

BioDiem is an Australian biopharmaceutical company that is focussed on developing and commercialising vaccines and infectious disease therapies. BioDiem’s business model is to generate income from partnerships including with other vaccine and infectious disease treatment companies through existing and new licences to its LAIV vaccine and other technologies. Income comes from licence fees and royalties on sales.

BioDiem’s lead technology is the LAIV (Live Attenuated Influenza Virus) vaccine technology used for production of seasonal and pandemic influenza vaccines and is given intranasally. This technology is licensed currently to two commercial partners, in India and China, and is licenced to the World Health Organisation as part of the Global Pandemic Influenza Action Plan to Increase Vaccine Supply. Serum Institute of India’s Nasovac-S™ is based on BioDiem’s technology and is already marketed in India. For additional information, please visit www.biodiem.com.

To read the full announcement, please click on the link below. 

Booodl Hits Major Product Milestone

Booodl, the Sydney-based local shopping app, hits major product milestone.

The Booodl app enables users to connect with and instant message nearby stores, will send location-based notifications when shopping list items are nearby, and facilitates in-app transactions with its ‘Tap + Buy’ feature.

Smart, location-based notifications are at the core of the product, and today marks 5,000 being sent to users in Sydney reminding them to buy products that were in the vicinity.

Other key numbers to date include:

•    Over 1,500 supported Sydney stores
•    Over 160,000 products on Booodl
•    Over 16,000 products added to users’ lists
•    Over 2,000 messages sent using the ‘Chat’ feature
•    9 in-app transactions using ‘Tap + Buy’ feature

Folkestone Announces Two New Developments

ASX Announcement, 13 MAY 2015

  • Enters into an option agreement to acquire a 3.4 hectare site at Altona North
  • Second JV with Wilmac Properties to develop strata office/warehouse/retail mews at Knoxfield

Stage 3 – Altona North 

Folkestone is pleased to announce that it has entered into an option agreement with BWP Trust and Bunnings Group Limited to purchase the former Bunnings site adjacent to Folkestone’s Millers Junction mixed use development in Altona North, Victoria.

Subject to planning approval, the 3.4 hectare parcel will be consolidated with Folkestone’s existing Stage 3 land holding of 4.4 hectares to create a substantial development opportunity which will include traditional retail, large format and social infrastructure investments.

In line with FLK’s strategy of growing its funds management platform, FLK may establish a fund to own the completed development in Stage 3 as FLK did with Stage 1 when it developed the 21,639 square metre large format retail centre known as Millers Junction Home for the Folkestone Real Estate Income Fund at Altona North.

Mr Ben Dodwell, Folkestone’s Head of Real Estate said “this provides an excellent opportunity for Folkestone to complete the final stage of its Millers Junction precinct. We are delighted with the success of Stage 1 with the opening in September 2014 of Millers Junction Home that includes Bunnings, Officeworks and other large format retailers together with the opening of Aldi in April 2015. The recent launch of Millers Junction Business which is a strata office/warehouse/retail development on the Stage 2 land will further enhance the Millers Junction precinct as a leading retail and business hub where local people can shop and work.”

Commercial Development – Knoxfield

Folkestone is also pleased to announce that it has agreed terms to enter into a second 50/50 JV with Wilmac Properties to develop approximately 85 strata office/warehouse/retail mews in Knoxfield, Victoria.

Knoxfield is 27 kilometres south east of the Melbourne CBD and the site lies within an established business park precinct with excellent access to the Eastlink and M1 Motorways.

The $30 million Knoxfield project is FLK’s second with Wilmac, the first being Millers Junction Business in Altona North. Wilmac are an experienced developer with a successful track record in delivering this popular product around Melbourne.

The Knoxfield site has been acquired on deferred settlement terms (April 2016) and together with the multi-stage project will result in relatively low funds employed by FLK of approximately $2.1 million.

Mr Dodwell said “We are excited about partnering with Wilmac again on our second strata office/warehouse/retail mews development. The project will provide small-medium businesses in Melbourne’s east with excellent accommodation, close to nodes of commercial activity and at a very competitive price, especially in the current low interest rate environment”.
“Our first JV with Wilmac at Millers Junction Business in Altona North has started well with 66% of the first stage pre-sold with construction expected to commence in September 2015” said Mr Dodwell.

About Folkestone

Folkestone (ASX:FLK) is an ASX listed real estate funds manager and developer providing real estate wealth solutions. Folkestone’s funds management platform, with $870 million under management, offers listed and unlisted real estate funds to private clients and select institutional investors, while its on balance sheet activities focus on value‐add and opportunistic (development) real estate investments. www.folkestone.com.au

To download the document, please click on the link below.

OzForex Member Benefits for Wholesale Investor Clients

Wholesale Investor recognises a growing international investment exposure and is dedicated to partnering with high value partners to support members in their international business venture.

We’re excited to announce our partnership with OzForex to bring you a range of highly competitive foreign exchange services with Preferential Rates for Wholesale Investor clients & fee free transfers.

Register with OzForex for free today to gain direct access to live rates immediately.

Proud partners of Wholesale Investor

In recognition of  investors, SME and corporates with international payments exposure, OzForex can assist with the following unique benefits:

  • Fee Free for life for Wholesale  Investor members
  • 24 hour online access, seven days a week
  • 24 hour phone support, five days a week
  • Personalised service from a dedicated dealing desk to help you manage your international payment strategies or one-off transactions
  • Access to a wide range of FX hedging tools ie Limit Orders and Forward Exchange Contracts
  • Access to daily and weekly market commentary to help you keep across market movements

OzForex – A Global Company

With six international offices, we can service your needs wherever your work or life may take you.

OzForex has managed international payments for more than 180,000 customers globally and is represented in Sydney, London, Toronto, San Francisco, Hong Kong and Auckland.

To save money on your next transfer, register for free today.

YuuZoo Strenghtens Board With Appointment Of International Investor & Venture Capitalist

Yuuzoo, Singapore, May 12th, 2015: 

Singapore-based YuuZoo Corporation (“YuuZoo” SGX: AFC), one of the world’s first third generation social e-commerce companies has strengthened and internationalized its board with the appointment of investor and venture capitalist Ozi Amanat as an Independent Director.

The appointment of Ozi Amanat adds significant global expertise in the areas of private equity, investments, and asset management, helping YuuZoo reach out to key institutional and large family offices globally.

Ozi Amanat is the Chief Investment Officer of Singapore-based Indian conglomerate Spice Global which is involved in telecom, finance, entertainment, and technology. Aside from his new appointment at YuuZoo, Ozi Amanat is a member of the board of trustees at Silicon Valley venture firm Astia Angels and an advisory board member of social enterprise OneHope Wine, Mount Sinai Hospital, and Seeds of Peace—all of which are based in the US. He is also the founder and chairman of K2 Global, a VC firm focused on pre-IPO tech ventures.

His philanthropic work and proficiency in asset management have garnered him accolades. He won the Seeds of Peace’s Young Peacemaker Award and was nominated as CIO of the Year by the Family Office Review Awards North America.  Ozi has a degree in business from Harvard University and also serves as the Chairman of the Entrepreneur Committee of the Harvard Club of Singapore.

Commenting on the appointment of Ozi Amanat, Mr. Thomas Zilliacus, Chairman and CEO of YuuZoo, said, “I am very pleased to welcome Ozi to the YuuZoo family. His expertise in the areas of asset management and investments are valuable assets as we grow the YuuZoo brand globally.

YuuZoo is building a very strong management team with vast international experience and a strong proven track record, with senior members who have built and managed leading global billion-dollar companies. We are expanding and restructuring our board so that it can support our management with expert advice in key areas, as we build YuuZoo into an international market leader.”

For investor queries, please contact:

Sabrina Tay
Head of Investor Relations
Email: sabrina.tay@yuuzoo.com

ABOUT YUUZOO®:

Headquartered in Singapore and listed on the SGX mainboard (SGX: AFC), with access to over 85 million registered users and over 800 million TV viewers in 164 countries, YuuZoo in a unique way combines social networking, e-commerce, gaming and payments in a mobile-optimized, fully localized virtual shopping mall, where the consumer can access hundreds of targeted social networks, targeted shops and targeted entertainment through one single login. All networks are localized for each market as comes to language as well as merchandise and design. To see the networks, log into: www.yuuzoo.com and www.yuuzoo.cn  For more information about the company, please log on to: www.yuucorp.com or www.yuuinvestor.com.

Connexion Awarded Major Contract with USA-Based Multinational Automaker

11 May 2015, Melbourne, Australia

 Connexion Media Limited (ASX:CXZ) has been awarded a contract with a major USA-based automaker as the supplier for a new small business vehicle management service based on the Flex service.

The introduction of the customised Flex service is expected later this year. The USA-based automaker will offer the service throughout the USA via its dealer network, which has in excess of 4,000 locations.

The automaker will pay Connexion to customize the existing Flex service to meet their market requirements. The subscription-based service is expected to launch in the last quarter of 2015. Any revenues generated from the service will be shared between the automaker and Connexion.

“This is a great result for Connexion shareholders as it potentially opens up our biggest revenue channel to date.” said Mr George Parthimos, CEO & Managing Director of Connexion.

Flex was formally launched in March in Australia on a subscription basis. Connexion has already signed up a small number of paying subscribers.

Flex is a new high tech remote vehicle management system that provides the ability to manage an entire fleet of vehicles from a central control point using cellular mobile connectivity. It provides tracking information so key performance indicators can be assessed including customised reporting.

Flex is able to track a range of real time and historical data including vehicle locations, distance travelled, fuel consumption, battery life, engine performance and absolute and average speeds travelled. It is also able to monitor driver behaviour and instantly send notifications and alarms to vehicle owners and fleet managers.

For more information on Flex visit: www.flexvs.com

About Connexion Media
Connexion Media Ltd (ASX:CXZ) is a technology company specialising in developing and commercialising software apps and services for the web connected car, mobile device and connected consumer electronics markets. It is based in Melbourne Australia, with a sales office in Cambridge UK.

About Flex
Flex is a cloud based, integrated vehicle management system that gives you control over your entire fleet of cars, trucks and other vehicles from a central point. It simultaneously tracks – in real time – all key performance indicators of your vehicles such as geo-location, fuel, distance, engine, and speed. It also helps improve productivity, driver behavior, and increase awareness of vehicle or fleet performance.

www.flexvs.com

Castle Point Ranger Monthly Fact Sheet May 2015

The latest Ranger Fund monthly Fact Sheet is now available. Please click here to view.

The Ranger Fund is a high conviction portfolio of New Zealand and Australian listed companies. The Fund’s objective is to provide equity-like returns over the long run while minimising exposure to extreme share market fluctuations. During periods of market stress, the fund will seek to preserve capital by preserve capital by holding significant amounts of cash and bonds, shorting individual shares, selling index futures contracts and/or buying index put options. The Fund will not be levered or net short.

During April the performance of the Ranger Fund was negatively impacted by the performance of Boom Logistics, Swick Mining Services, Corporate Travel Management and Macmahon Holdings. The Fund benefited from positive performance by Wellcom Group, Vista Group International, Touchcorp and Paperlinx Trust. During the month the Fund maintained its current positions.

To download the full document, please click on the link below. 

Troozi Opens its Series A Capital Raising for $1.5m

Troozi is pleased to be opening the Series A raise for Troozi to Australian Investors today. The round is for $1.5m and limited to 8,500,000 shares at $0.18.

The model is planned around 2 subsequent raises of $3.0m ( Series B, Nov 2015 ) and $3.5m ( Series C, April 2016 ) naturally at higher prices.

Troozi has had a great response with pre-registrations both here and in Asia so would be happy to discuss any questions or details with interested parties as soon as possible

The business has been tracking well against all key forecasted metrics and as you may have read this week, India continues to provide one of the most exciting tech opportunities for startups globally right now, there is an interesting article from the AFR just this week if you missed it.

We anticipate the offer closing fairly quickly.  Should you wish to apply for the Series A, please advise as soon as possible.

To download the Troozi Investor Briefing or the Information Memorandum documents, please click on the links below. 

Bulletproof Investor Presentation May 2015

ASX Announcement, 6th May 2015

Bulletproof Group Limited (ASX:BPF)  is a publicly listed company with offices in Sydney and Melbourne, Australia, and California, USA. Bulletproof Group shares are listed on the Australian Securities Exchange (ASX) and are traded under the code BPF.

Founded in 2000, Bulletproof is the leading cloud services provider to business, enterprise and government customers. Bulletproof has consistently been first to market with public and private cloud based services and innovations. Bulletproof was the first company in Australia to launch a public cloud service in 2006 and the first to launch a managed Amazon Web Services (AWS) offering in 2012. Bulletproof became an AWS Premier Consulting partner in 2013 and was re-certified in 2014. Bulletproof’s recent acquisition in the Cloud Consulting space has further enabled the company to help companies leverage the cloud as they disrupt their market, by simplifying the complexity of cloud and enabling its customers’ rapid transformation.

Please click on the link below to download. 

Disclosure Of Interest / Changes In Interest Of Directors / Chief Executive Officers of iFast

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

The following announcements have been uploaded into iFAST Corporation Investor Relations website:

iFast Announces Employee Stock Option / Share Scheme

iFAST Corporation Investor Relations Announcement, 4th May 2015

The Board of Directors of iFAST Corporation Ltd. (the “Company”) wishes to announce the grant of share awards pursuant to the iFAST Corporation Performance Share Plan (“iFAST PSP”). Details of the grant of share awards as follows:

(a) Date of Grant : 1 May 2015

(b) Number of share awards granted : 70,500

(d) Market Price of shares on date of : $ 1.365 grant

(e) Number of share awards granted to each director and controlling shareholder (and each of their associates), if any:
A total of 70,500 shares were granted to the following Directors:

- Lim Wee Kian: 7,100
- Low Huan Ping: 9,300
- Ling Peng Meng: 10,400
- Yao Chih Matthias: 15,900
- Ng Loh Ken Peter: 14,600
- Kok Chee Wai: 13,200

(f) Vesting period of the share awards : Approximately One-third of the share awards will vest after 2 years from date of grant. Approximately Two-third of the share awards will vest after 3 years from date of grant.

To download the full document, please click on the link below. 

3rd Party Report Confirms Economic Advantages of Leaf Resources Glycell Process

ASX Announcement, 6th May 2015

Highlights:

  • Report confirms an almost 30% cost advantage of GlycellTMprocess over NREL dilute acid (full costing basis before co-products allowance)
  • Advantage increases to almost 60% when co-products are included
  • Full cost of production for GlycellTM $151/t compared to dilute Acid $363/t
  • Report predicts GlycellTM process to have a 25% capital advantage over dilute acid
  • At $151 per tonne Leaf Resources’ GlycellTM sugars could economically replace corn starch as a feedstock for ethanol production

Leaf Resources recently commissioned a report from ResourceInvest Pty Ltd to independently compare Leaf Resources’ GlycellTM process with a dilute acid pretreatment process as described by National Renewable Energy Laboratory (NREL). The executive summary of that report stated:

Leaf Resources ’ GlycellTM pretreatment process offers compelling cost advantages over current practice dilute acid pretreatment.

Our modelling takes dilute acid process economic data from the US Government’s National Renewable Energy Laboratory (NREL) and compares it with the GlycellTM process to determine a minimum sugar selling price (MSSP). Sugars are an intermediate product in the formation of biofuels or biochemical products, and the MSSP represents one of the major costs in this production stream.

The NREL process uses a corn stover biomass feedstock. We have assumed a comparable bagasse biomass feedstock for the GlycellTM process.

The conversion efficiencies achieved by the GlycellTM process offer almost a 30% cost advantage in sugar production compared with our normalised NREL sugar production model.

The GlycellTM sugar price is US$219 per tonne compared with US$301 per tonne for the normalised NREL model, or a 27.3% cost advantage, on a pre return on investment and capital allowance basis. On a post return on investment and capital allowance basis the cost advantage is $269 to $384 per tonne, or 29.9%. This cost differential is also before any allowance is made for co-product credits, which in the GlycellTM case may be substantial.

A viable lignin co-product stream from the GlycellTM process, where lignin is sold at US$450 per tonne, reduces the overall cost of sugar production (including a 10% return on investment and capital allowance) to US$151 per tonne compared with US$363 per tonne for the NREL model where the waste product is burnt for steam and electricity generation. This is an almost 60% cost advantage.

To read the full document, please click on the link below.

Troozi May Investor Update

Current Business Highlights

  • Troozi reached the milestone of 100,000 members in April
  • Series A opens in Australia with a $A1.5m raise this month
  • Initial interest has been strong, over 50 pre-registrations have been received to date from Sophisticated Investors in Singapore, USA and Australia
  • Android App now at 6,000 downloads following soft launch in March
  • Troozi iOS App is due for release in June
  • Troozi welcomes the Head of Product and UX to the team

Marketing Update

Troozi opens May with 108,000 members following a very successful month. Over 25% of members are now coming in from word of mouth, a positive sign that Troozi is building a loyal and engaged membership base who are now advocating the product. Troozi was also featured in some trade PR this month.

Read the write up in Online Personals Watch, the news source for the online dating industry globally - click here

Technology Update

Troozi’s Android App has now recorded 6,000 downloads following the March release. It has received positive feedback and an average rating of 4.3 (out of 5).

This month, Troozi releases a new update on the m.site and in June, the iOS App is due for release. Over 80% of member sign ups are now coming from mobile handsets.

Troozi Welcomes Alexei Petrou To The Team

Alexei has over 12 years of product management experience with companies including ninemsn, Fairfax Digital and Lloyds TSB.

Alexei has prior experience in online dating industry, he worked previously with Lija and Nikhil at RSVP. Responsible for overseeing product development, Alexei’s role included transitioning RSVP to the Fairfax network, executing the Fairfax Digital product development process and launching the VIP subscription product.

Alexei is also a successful entrepreneur, founding Australia’s first online deal aggregation platform in 2010. His company, All The Deals, now also operates in UK and US and is part of iAccelerate advanced business accelerator program. Alexei is passionate about digital business and is an active member and mentor in the Australian start-up community. He has a BSc Psychology (Hons) and post grad diploma in Information Systems.

Investment Update

The Investor presentation and Information Memorandum for Series A is available from May 7, 2015. If you are interested in receiving a copy, please email requests to John Wilson jwilson@troozi.com

We look forward to sharing more milestone updates in the next investment update.

iFAST (SGX:AIY) Announcement May 2015

iFAST Corporation Investor Relations Announcement, 30th April 2015

The Board of Directors of iFAST Corporation Ltd. (“the Company”) is pleased to announce that the Company’s wholly-owned subsidiary, iFAST Financial Pte Ltd (“iFAST Financial”) has obtained approval from the Monetary Authority of Singapore (“MAS”) to its application to extend its conduct of dealing in and providing custodial services for securities to include bonds and exchange-traded funds (“ETFs”), subject to additional licence conditions proposed by MAS.

The approval will allow iFAST Financial to broaden the range of investment products that it can distribute.

iFAST Financial is planning to commence the distribution of bonds and ETFs in Singapore during the second quarter of 2015.

To read the full document, please click on the link below. 

Bulletproof Group Ltd (ASX:BPF) CEO Interview

Bulletproof Group Limited is a publicly listed company with offices in Sydney and Melbourne, Australia, and California, USA. Bulletproof Group shares are listed on the Australian Securities Exchange (ASX) and are traded under the code BPF.

Founded in 2000, Bulletproof is the leading cloud services provider to business, enterprise and government customers. Bulletproof has consistently been first to market with public and private cloud based services and innovations. Bulletproof was the first company in Australia to launch a public cloud service in 2006 and the first to launch a managed Amazon Web Services (AWS) offering in 2012. Bulletproof became an AWS Premier Consulting partner in 2013 and was re-certified in 2014. Bulletproof’s recent acquisition in the Cloud Consulting space has further enabled the company to help companies leverage the cloud as they disrupt their market, by simplifying the complexity of cloud and enabling its customers’ rapid transformation.

Please listen to Anthony Woodward, CEO and Executive Director, to find out more.

The Genius of Settling For More

24th April, By Laura Daquino, Brisbane Business News

A WORLD-FIRST platform bringing transparency to an industry that perhaps needs it the most has just emerged from Brisbane.

Shaneal Sharma, the founder of Conveyance Genius, says his startup is “the smartest way to settle properties” as it provides a measuring stick that can save everyone time and money.

“Every day thousands of property sales fall through simply because someone doesn’t know about a potentially deal-breaking issue,” says Sharma.

“And when they do – usually because of something as trivial as a missed call or lost email – the buyer loses their dream home, the seller loses the sale, the agent loses their commission, and the conveyancer has to chase partial payment.

“Conveyancers don’t traditionally have measuring sticks for where things are at – that’s where we come in with progressive technology that cuts out the ambiguity to make the process fully transparent.

“Everyone can see exactly what’s happening, in real time, and the conveyancer doesn’t have to waste hours calling and emailing everyone whenever something changes or needs to be done.”

Sharma is not yet 30, but having bought his first property at 17, he has had enough firsthand experience to know what’s working and what’s not in the industry.

“I always knew I had to be in property but couldn’t see myself working for a real estate agency,” he says.

“I’ve gotten here in a roundabout way, working as a music producer and writer in Los Angeles for the past five years introduced me to owners of large-scale properties and opened my eyes to the changing face of the real estate industry.

“I knew it was the right time to turn my passion into a career.”

Anyone involved in a project uploaded by a conveyancer to Conveyance Genius can be granted access to the project’s timeline, including buyers and sellers, finance providers, real estate agents, property developers and legal practitioners.

To read the full article, please click here